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SOMMAIRE
L’ischémie du myocarde induit des altérations de l’électrophysiologie cardiaque
selon un mode biphasique. Les anomalies les plus profondes sont associées a la phase
précoce, l’ischémie aigue du myocarde (AMI). Elles sont caractérisées par une
,. + + 4’
accumulation extracellulaire d ions K ([K 10— i), un raccourcissement de la duree du
potentiel d’action (PA) et de l’intervalle QT (APD—L ou QT—1-), ainsi qu’une
accumulation de métabolites de phospholipides, les lysophosphatidylcholines (LPCs).
Lors de la deuxième phase, on observe un rallongement de l’APD et de l’intervalle QT
ainsi qu’une synthèse “de novo”, une accumulation de métabolites de sphingolipides, les
céramides, et de TNf-Œ. Ces modifications sont associées à l’ischémie chronique du
myocarde (CMI).
Ces changements opposés de I’APD/QT sont associés à différents types
d’arythmies. Il a été montré que la relation entre les perturbations électriques et
métaboliques joue un rôle clef dans la genèse des arythmies ischémiques et la mort subite.
Cependant les mécanismes ioniques et métaboliques impliqués dans ces modifications
séquentielles de l’APD/QT restent mal compris.
Notre hypothèse est que les désordres électriques ischémiques sont la conséquence
de la conjugaison de stress métabolique et de déséquilibres électrolytiques. Plus
spécifiquement, le courant IKr/’HERG est augmenté durant la phase précoce, l’AMI. Cette
augmentation est principalement causée par une surproduction et une accumulation de
LPCs. La potentialisation de IIJJHERG par les LPCs contribue de façon critique à la perte
de K intracellulaire, a la diminution de l’APD, et par la même, aux arythmies associées a
l’ischémie. En revanche, lors de la CMI et l’insuffisance cardiaque, la diminution de
l’expression de HERG induite par les céramides et le TNF-Œ contribue a l’augmentation
tardive de I’APD/QT et par conséquent entraîne l’apparition de troubles du rythme.
Afin de vérifier cette hypothèse, nous avons réalisé des études à différents niveaux.
En passant par l’organe, la cellule, pour terminer à l’échelon moléculaire. Ces
expériences ont été réalisées en utilisant différentes approches combinées,
l’électrophysiologie, la pharmacologie, la biochimie, et la biologie moléculaire.
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Tout d’abord, nous avons montré que les LPCs augmentent le courant IHERG
exprimé dans des cellules HEK-293, et que cette augmentation du courant ‘HERG entraînait
un raccourcissement de l’APD ainsi qu’un potentiel de membrane plus négative; LPC-16
augmentait ‘HERG de façon plus prononcée pour des potentiels plus négatifs, ceci associé à
un raccourcissement plus important de I’APD. De plus, seulement la forme amphiphile
avec 16 hydrocarbonés comme le I -Palmytoyl-lysophosphatidylcholine (LPC- 16) et le 1-
palmitoyl-lysophosphatidylglycerol (LPG-16) entraînait une augmentation significative
du courant ‘HERG, ainsi qu’un déplacement de son activation vers des potentiels plus
négatifs.
En utilisant le modèle d’ischémie sévère du myocarde chez le lapin, nous avons
montré que le LPC-16 exogène mimait l’effet de l’ischémie de faible perfusion
correspondant à une augmentation de [K]0 et de l’intervalle QT ces effets étaient
prévenus par des bloqueurs de Ij tel que le doflétilide, les autres bloqueurs des canaux
+ ‘ ‘K n ayant pas d effet. De façon consistante, le dofletilide suppnme efficacement, les
tachyarythmies induites par l’ischémie ou le LPC-16. De plus, le LPC-16 raccourcis de
façon remarquable l’APD dans les myocytes ventriculaires gauche de lapin, augmente, de
façon réversible et dépendante au potentiel, l’amplitude du courant I)Cj dans les myocytes
ventriculaires de cochon d’inde. Le doflétilide supprime cet effet sur le courant ‘“HERG,
et limite ainsi le raccourcissement de l’APD.
Nous avons montré que lors de la mise en place de la CMI, le courant Ii<
transporté par les canaux HERG était une cible majeure pour l’action des céramides et du
TNf-Œ. L’incubation continue de cellules exprimant les canaux HERG, ou de myocytes,
avec des céramides ou du TNF-cL diminue de façon significative le courant Iy ou la
fonction des canaux HERG. Ces effets sont médiés par la stimulation de ROS (réactive
oxygène species) intracellulaires. Puisque les antioxydants tels que la vitamine E ou le
MnTBAP suppriment l’effet dépressif des céramides ou du TNF-Œ sur JjJHERG. De plus,
le céramide comme le TNF-Œ augmentent de façon importante le niveau intracellulaire de
ROS, cet effet est prévenu par la vitamine E ou le MnTBAP.
En conclusion, nos résultats suggèrent que l’accumulation de LPC-16 conjuguée a
l’augmentation du courant ‘HERG démasquent un réel couplage entre un catalyseur
métabolique et une voie de signalisation ionique, qui conduit à une augmentation du
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courant potassium sortant et une réduction de l’intervalle QT lors d’un épisode
ischémique. L’ensemble de ce travail constitue la première évidence de l’implication du
courant ‘KJJHERG dans l’augmentation post-ischémique du courant potassium sortant et
par ce biais dans la diminution de l’intervalle QT. L’inhibition de la production de LPC
16 ainsi que la réduction de son accumulation pourrait constituer une stratégie
thérapeutique prometteuse en vue d’atténuer les arythmies létales associées aux maladies
ischémiques du coeur. D’un autre côté, la réduction du courant IHERG par les céramides ou
le TNF-Œ principalement en augmentant la production de ROS semble contribuer a la
prolongation de l’intervalle QT lors de l’ischémie prolongée du myocarde, ainsi que dans
l’insuffisance cardiaque.
Mots clefs: ischémie du myocarde, arythmies, canaux potassium,
lysophosphatidylcholine, céramides, TNF-cx, ROS.
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ABSTRACT
Ischemic myocardium demonstrates characteristic bi-phasic aiterations in cardiac
electrophysiology. The most profound abnormalities associated with the eariy phase of
acute myocardial ischemia (AMI) are extracellular K accumulation ([Kj0—t) and
shortening of action potential duration or QT interval (APD—I- or QT4) as well as
accumulation of phospholipid metabolites iysophosphatidylcholines (LPCs). These are
followed by the subsequent lengthening of APD or QT inteiwai (APD—t/QT—t) and de
nova synthesis and accumulation of sphingolipid metabolite ceramide and tumor necrosis
factor—a, as the most prominent electrical and metabolic disturbances in chronic
myocardial ischemia (CMI). The opposite changes ofAPD/QT are often accompanied by
different types of arrhythrnias. It has been shown that the interplay between the electrical
and metabolic perturbations is pivotai in the genesis of ischemic arrhytbmias and sudden
cardiac death. However, the ionic and metaboiic mechanisms underlying the sequential
changes of APD/QT remained poorly understood.
We proposed that ischemic electricai disorders are a consequence of inteneiated
metaboiic stress and electrolyte disturbance. More specificaily, I}cj/IHERG is enhanced
during the eariy stage of AMI and the enhancement is mainly caused by overproduction
and accumulation of LPCs. The enhancement of ‘Kr/’HERG by LPCs is a criticai contributor
to intracelluiar K ioss/[Kj0—t and APD—J,- thereby the associated ischemic arrhythmias.
Whereas in CMI and failing heart, where HERG impairment by ceramide and TNF-a
contributes to the late APD—t/QT—t, leading to cardiac arrhytbmias. To examine our
hypothesis the studies at different ievels including organ, ceilular, and molecuiar ieveis
were carried out with combined approaches of electrophysioiogy, pharmacoiogy,
biochemistry and molecular bioiogy.
We first revealed that LPCs enhance ‘HERG expressed in HEK293 ceil and the
enhancement of ‘HERG manifested with shorter APD and at more negative potentiai; LPCs
increased IHERG to a greater extent at more negative potentiais and with shorter APD.
furthermore, oniy the amphiphile with 16 hydrocarbons such as 1-palmitoyl-
iysophosphatidyicholine (LPC- 16) and 1 -palmitoyl-lysophosphatidyiglyceroi (LPG- 16)
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were found to produce significant enhancement of ‘HERG and negative shifts of HERG
activation.
By using a rabbit model of acute global myocardial ischemia, we found that
exogenous LPC-16 mimicked the low-perfusion ischemia to produce significant [K]0—t
and QT4, which were prevented by Iy blocker dofetilide but not by blockers for other
K channels. Consistently, dofetilide efficiently abolished the ventricular tachycardia
arrhythmias induced by LPC- 16 or ischemia. Moreover, LPC- 16 remarkably shortened
APD in rabbit lefi ventricular myocytes, reversibly and voltage-dependently increased the
amplitude of Iy in guinea pig ventricular myocytes. Dofetilide abolished the ‘KrI’HERG
enhancing and APD shortening caused by LPC-16.
In the setting of CMI, we identified IgjHERG K channel as a new target for the
action of ceramide and TNF-a. Chronic exposure of HERG expressing ceils or cardiac
myocytes to ceramide or TNf-Œ significantly impaired HERG K channel or Iy- function.
The impairment of channel function is mediated by stimulating intracellular reactive
oxygen species (ROS) because antioxidants vitamin E or MnTBAP abolished the
depressing effects of ceramide or TNF-Œ on IcjHERG. Moreover, either ceramide or
TNF-Œ remarkably elevated the intracellular ROS levels, which was prevented by vitamin
E or MnTBAP.
In conclusion, our resuits suggest that LPC-16 accumulation and HERG
enhancement form the coupling between metabolic trigger and ionic pathway that may
account for ischemic [Kj0—t and QT—1-. This represents the first documentation of
I/HERG as the ionic mechanism for ischemic [Kj0—t and QT—..L. Inhibition of LPC-16
production and accumulation andlor ofI/HERG may be a promising therapeutic strategy
to attenuate the incidence of lethal arrhytbmias associated with ischemic heart disease. On
the other hand, HERG/IK impairment by ceramide or TNF-Œ mainly via ROS
overproduction may contribute to QT prolongation in prolonged ischemia of myocardium
and heart failure. The inhibition of ceramide and TNF-&TNfR1 signaling may be an
effective strategy to prevent not only the arrhythmogenesis but also the cardiac sudden
death in chronic myocardial ischemia and CHF.
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PART I
INTRODUCTION AND THE REVIEW
0F THE LITERATURE
CHAPTER I
Electrical and Metabolic Disturbances Underlying
Iscliemic Arrliytlimias in Hearts
2
The overall purpose of this chapter is to review the updated experimental findings
and notions that have shed light on the mechanisms of electrophysiological and metabolic
dismrbances during myocardial ischemia and iscliemic arrhythmias. The specific goals
are (1) to set a theoretical foundation for forming my project hypothesis; (2) to raise the
questions, which are related to the research project; and (3) to propose the hypothesis and
the objectives of the project.
I-1 Perspective: Ischemic Heart Disease
— A Global Health Problem
Although a substantial reduction in death rate from cardiovascular causes dunng
the past 50 years, ischemic heart disease (IHD) remains the leading cause of morbidity
and mortality in the industrialized world. In the United States, IHD afflicts in excess of 6
million Americans annually (American Heart Association, 2004), it causes about 152,000
deaths per year in UK, and world-wide, one in eight deaths is attributed to 1H]) (Ghuran
& Camm, 2001). Retrospectively, data from clinical electrophysiological studies and
randomized trials have revealed that the majority of IHD deaths are caused by ischemic
anhythmias, which appear as the most common pathophysiological cascade involved in
lethal arrhythmias degenerating first to ventricular tachycardia (VI), and then to
ventricular fibrillation (Vf) and later to asystole and sudden cardiac death (SCD) (Mehta
et al., 1997; Myerburg & Castellanos, 1997; Zipes & Wellens, 1998).
Furthermore, SCD rates also parallel the rates of IHD as a whole in less-developed
countries (Huikuri et al., 2001; Zipes & Wellens, 1998). It has been predicted that
between 1990 and 2020, mortality from IHD in developing countries is expected to
increase by 120% for women and 137% for men. Predictions for the next 2 decades
include a near tripling of IHD mortality in Latin America, the Middle East, and sub
Saharan Africa (Leeder, 2004). Not only is acute myocardial ischemia (AMI) the most
common factor triggering VI, thereafier SCD (Davies, 1992), but the risk of SCD in the
population who have had chronic myocardial ischemia (CMI) is four-folds higher than the
normal population as well (Abildstrom et al., 2002). Therefore, great efforts have been
devoting to understand the mechanisms underlying ischemic anhythmias, and to set the
ways for effective treatment, and ultimate prevention of IHD.
3
Myocardial ischemia (MI) is a condition in which normal myocardial perfusion is
arrested, leading to cascades of metabo lic and electrophysiological alterations, which are
interrelated and are caused by metabolic stress. The resuits are failure of contraction,
deterioration of electrical behavior, and eventual death of the myocytes. At the organism
level, the end point may be lethal anhythmias or mechanical pump failure. Despite a
remarkable progress of understanding of the pathophysiological and biochemical aspects
of MI, our knowledge of which patients with MI will develop sustained VI remains
unclear, and the mechanisms underlying the fatal cardiac arrhythmias triggered by MI are
far from elucidated. Apparently, more studies, especially the integrated investigations
combining in vitro electrophysiological and molecular biological studies and in vivo
electrophysiological and biochemical investigations are needed to c1arif,’ the mechanisms
so as to interfere with the pathological process of MI and to open the novel avenue in the
treatment and prevention ofIHD.
I-2 General Features of Ischemic Arrhythmias
Temporally, ischemic arrhythmias can be categorized into three phases based on
the time when they appear: phase I arrhythmias occurring during the first 30 min of
ischemia; phase II seen between 5 to 72 hours and phase III arrhythmias of the chronic
stage after an infarct. Phase I can be further subdivided in la (between 2 and 10 min of
ischemia, while the first burst of VT normally occurs) and lb types (between 15 and 30
mm), with the lb type especially dangerous because they frequently evolve in Vf and
SCD in human (Carmeliet, 1999; Pogwizd & Corr, 1987).
VT is the most pronounced arrhythmia in MI. It is defined as three or more
consecutive beats arising below the atrioventricular node (AVN) with an RR interval of
less than 500 ms (>120 beats/min), being frequently diagnosed with the advert of
intensive care unit (ICU) monitoring and long-term ambulatoiy electrocardiogram (ECG)
recordings (Akai et aÏ., 2000). VI may be classified by morphological criteria
(monomorphic, polymorphic, bundle branch block pattem and axis), by duration
(sustained or nonsustained) or by the underlying mechanisms (enhanced automaticity,
triggered activity or re-entiy). Clinically, MI has been occasionally found to precede the
4
onset of a monomorphic VI. More frequently, however, AMI triggers the occurrence of
polymorphic VT that may predispose to VF rather than a sustained monomorphic VT.
VI followed by Vf is the lethal arrhythmia that disposes patients who suffer from
MI to sudden death. Ihe earlier and more frequently obseiwed abnormalities in ECG
recording are the alterations in QT interval, and the changes of SI segment as well. Very
intriguingly, ischemic myocardium demonstrates characteristic sequential alterations in
electrophysiology with early QT inten’al shortening (QT-1’) in acute ischemia and
subsequent QI interval lengthening (QT-t) after a prolonged ischemic period, which are
associated with different types of arrhythmias (Boyden & Jeck, 1995; Carmeliet, 1999;
Singer et aï., 1981). For instance, in phase I, especially phase la of AMI, QI-J- lias been
frequently observed in a wide variety of animal modals and in human (Friedman et al.,
1973; Lazzara et aï., 1974; Lazzara et aL, 1978). In coincidence with the QI-.L, the most
profound electrophysiological disorder in this phase of MI may be extracellular potassium
accumulation ([K110-t). In contrast to the QT-L’ in early phase of AMI, QI-t lias been
found to be a universal change in the CMI (Eick et al., 1976; Lazzara et al., 1975; Wit &
Friedman, 1975). Either AMI or CMI, at the cellular and multicellular levels, the
electrophysiological disturbances are characterized as depolarization, prolongation of the
effective refractoiy period (ERP), decrease in conduction velocity, and change in
excitability. Ihe basis of the electrophysiological disturbance is a group of ions and
exchangers, which interplay to set the mechanisms of the electrophysiological
disturbances in ischemic myocardium.
I-3 Our Current Understanding of the Potential Ionic Mechanisms for Ischemic
Arrhythmias
Cardiac myocytes make electrical continuity as a tissue through low-resistance
intercellular gap junction. Each individual cardiocyte is like a small battery with the
voltage of -50 to -90 mV across its sarcolemmal membrane (measured from the
intracellular space with respect to the bathing solution ground). Depolarization is defined
as a change in membrane potential (Em) to more positive voltage, which is mediated by
+ 2+channels or transporters that enable positively charged ions such as Na or Ca to enter
the cell (inward currents) (van Ginneken & Giles, 1991); whereas repolarization refers
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to any change to more negative voltage, which is rnainly rnediated via a variety of K
channels allowing K movement from the intracellular to extracellular side (outvard
ct,rrents) (Marban, 2002; Nattet, 2002). The heart beat is initiated by slow diastolic
depolarization of the sinoatrial node (SAN), which drives the membrane potential after
action potential (AP) toward the threshold for firing the next AP. Multiple ionic currents
with complex interactions are invoÏved in spontaneous diastolic depolarization (Schram et
ai, 2002; Boyett et aï., 2000).
Rapid voltage changes of the mass of the heart are detected as miÏtivolt-sized
changes in the surface ECG. Figure I depicts the temporal relationships between the
electrical activity ofa typical ventricular rnyocytes, as measured using cellular recordings
ofthe transmembrane AP (paner A), and the corresponding ECG (panel B).
À 4.2. 4.3) t
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Figure 1. The temporal relationships between the ventricular AP and the corresponding
surface ECG. A, a typical ventricular AP with inward current (downward arrows) and outward currents
(upward arrows). The molecular basis of each current is indicated in parentheses. Numbers indicate the
phases of the AP. B, a schematic ECG. QRS complex, P wave, T wave and QI interval are indicated.
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The upstroke of the AP at the onset of depolarization produces the spiky ‘QRS
complex’; repolarization is manifested as the gently rolling T wave. As a first
approximation, the time between the beginning of the QRS complex and the end of the T
wave the ‘QT inten’al’ — can be used to deduce the overail timing and duration of
ventricular depolarization and repolarization. The frequency of QRS complexes and their
sequence relative to the smaller P waves produced by atrial activity allow the clinical
detection of normal rhythm or arrhythmias.
I-3-1 Properties of Ionic Channels Underlying Cardiac Action Potentials
Over the last 50 years patch-clamp techniques combined with molecular biology
have revolutionized the study of ion chaimels underlying cardiac AP. The AP is virtually
an electrical signal integrating with a variety of inward and outward cttrrents, which
result from the orchestral opening or closing of number of ion chaimels and transporters
in the sarcolemma membrane. Transmembrane APs form the cellular basis for pacemaker
activity, impulse spread, and control of cardiac excitation-contraction coupling (Splawski
et aÏ., 2002). APs that originate in the SAN (Lacinova, 2004) and transmit sequentially
throughout the atria, atnoventricular node (AVN), His-Purkinje system, and the ventricles,
are a summation of precisely orchestrated openings and closings of distinct populations of
ion channels. Perturbations in ion channel function andlor structural malformations in
heart underlie various cardiac arrhythmias. Moreover, aberrant ion channel function
underlies a wide range of diseases in both man and other species (Ashcroft, 2000).
Strategic molecular targeting of these proteins will therefore yield novel forms of
antianhythmic therapy (Ackerman & Clapham, 1997).
Traditionally, the AP can be divided into five phases. In the resting ventricular
rnyocyte (membrane potential around -90 mV), voltage-gated sodium channels are closed.
A propagating impulse causes the membrane potential to become less negative, therefore
the sodium channels are opened, and the resulting large rapid inward Na flux (‘Na)
produces phase O depolarization. The initial phase 1 repolanzation results from the
opening of the transient outward potassium channels (Ito). During this phase, calcium
channels also open, and the long phase 2 plateau of the AP corresponding to ventricular
systole (Sorrentino & Reggiani, 1999) reflects a balance between inward calcium current
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(JCa) and outward potassium curreni through delayed rectifier channels (IK-, 1, and 1r in
atrial myocytes). Inactivation of calcium channels in phase 3, together with ongoing
outward K flux through delayed rectifier and inward rectifier channels (IKI) completes
repolarization to resting phase 4. Phase 4 corresponds to ventricutar fihling during
diastote (relaxation) and is rnaintained by the open ‘K. In pacemaker myocytes including
SAN, AV node celis, and Purkinje fibers (Knopf et aÏ., 1990), the ceils begin a
spontaneously slow depolarization forming pacemaker current (Ii) rather than rernain at
the resting potential. This is also referred as phase 4 (Coraboeuf & Nargeot, 1993; ten
Eick et aÏ., 1992).
AP configuration and duration vary in specific regions (e.g., atrium versus
ventricle) as well as in specific areas within those regions (figure 2).
Atrium
RA
Ventdces
Figure 2. Action potential waveforms are variable in different regions of the heart. Schematic
representation of the heart; action potential waveforms recorded in different regions of the heart are
illustrated. Action potentials are displaced in time to reflect the temporal sequence of propagation through
the heart. [Modified from (Nattel & Li, 2000; Pinto & Boyden, 1999)].
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Such physiologic heterogeneities likely reflect variations in expression or function of the
repertoire of ion channels and other proteins that constitute cardiac ion currents (Schram
et al., 2002). Exaggeration of these heterogeneities, by changes in rate, ion channel
mutations, andlor drug exposures, promotes reentrant excitation, a common mechanism
for many cardiac arrhythmias. The acute electrophysiological response of a myocyte to
exogenous stressors such as myocardial ischemia, autonomic activation, or drugs likeiy
reflects changes in fiinction and gating ldnetics of individual ion channels, including
channels activated by specific stimuli such as adenosine triphosphate (ATP) depletion,
muscarinic stimulation, or stretch.
I-3-1-1 Sodium (Na) Channels
In the heart, voltage-gated Na channels determine the amplitude and siope of the
AP upstroke, which are especialiy important in the control of impulse conduction velocity,
and in the maintenance of appropriate waves of excitation through the working
myocardium. Dysfunction of these channeis can iead to at least 6 types of cardiac rhythm
disorders: long QT syndrome (LQTS) (Wang et al., 1995b; Wang et al., 1995a; Wang et
al., 1996; Wang et al., 1998a), Brugada syndrome (Brugada & Brugada, 1992;
Antzelevitch et al., 2002), idiopathic ventricular fibrillation (Bezzina et al., 2001; Akai et
aÏ., 2000), nonfamilial arrhythmia susceptibiiity (Splawski et al., 2002), conduction
system disease (Schott et al., 1999), and sick sinus syndrome (Benson et ai., 2003). These
conditions are characterized by ventricular tachyanhythmia, heart block, or atrial
bradyarrhythmia. Very recently, Na channels have been identified to be associated with
atrial fibrillation and heart failure (Oison et aÏ., 2005; Chen et al., 2003b). Ah those
disorders can be traced to the abnormal molecular structure and expression of Na
channels.
Na channels are believed to consist of a principal pore-forming Œ-subunit
(260 kDa) and two auxiliary J3-subunits (36 and 33 kDa each) (Fozzard & Hanck, 1996).
In mammals, the genes encoding Na1.1, 1.2, 1.3, and 1.7 (human genes $CN1A, SCN2A,
SCN3A and SCN9A) are clustered on human chromosome 2q and appear to have arisen
as duplications of a founder gene (Lopreato et al., 2001). There is a second cluster of
three genes on human chromosome 3p, ah of which encode tetrodotoxin (Satin et al.,
9
1992)-resistant charmels. One of these, SCN5A (also designated as hHl) encoding
NavI .5, is expressed in heart and brain (Head & Gardiner, 2003).
The Œ-subunit bas four structurally similar domains (DI-DIV); each domain has
six helical transmembrane segments (S1-S6). The S4 segments of each domain contain a
large number of positive charged residues serving as voltage sensor for channel activation
and coupled-inactivation (Kontis et al., 1997). The short intracellular segment between
DIII and DIV has been identified as the fast inactivation gate. The charme] pore is formed
by four P-loop regions (P region) linldng $5 and $6 segment in each domain. The P
region is deduced to be composed of twenty-residues forming the lining of the outer
vestibule responsible for ion selectivity and toxin affinity. The more detailed
investigations reveal that the primary structure in each P-loop of Na channels is unique,
which differs from Ca2 channels in which each P-loop is the same, therefore rendering
each of them to different function. for instance, a lysine in the P region of DII critically
selects for Na over Ca2 (Heinemann et al., 1992); a cysteine in the P region of DI
renders the cardiac channel insensitive to blockade by tetrodotoxin (TTX) or saxitoxin
(STX), but sensitive to Cd2 or Zn2 (Satin et al., 1992).
The (3-subunits consist of a single transmembrane domain, a small intracellular C-
terminal region and a large extraceflular N-terminal domain with an immunoglobulin-like
fold (Stevens et al., 2001). Three different isoforms of auxiliary (3-subunits are expressed
in cardiac tissue from a range of species including rodents, sheep and human (Dhar et al.,
2001; Fahmi et al., 2001; Qu et al., 1995) and are known to modulate the kinetics ofthe
cardiac sodium channel Œ-subunit (Kupershmidt et al., 1998), as well as to regulate the
expression of sodium channel a-subunits in the heart (Dhar et al., 2001), and therefore
attribute to the electrical properties ofwhole channels.
I-3-1-2 Calcium (Ca2) Channels
Voltage-dependent calcium channels (VGCCs) in cardiac myocytes are essential
for regulating the influx of Ca2 ions across the sarcolemmal membranes, in response for
the upstroke of the AP in the SAN and AVN and play an important role in determining
the plateau and eventual spike-dome appearance of the AP in other cardiac cells.
Moreover, the Ca2 influx behalves as the electrical signaling player involving in
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initiating intracellular events such as Ca2 induced Ca2trelease (CICR) from
sarcoplasmic reticulum (SR) (Singer et al., 1981), excitation-contraction (E-C) coupling,
and modulation of gene expression. Intracellular concentration of Ca2 ([Ca2j) also
modulates the conductance of Ca2tactivated K and CF currents (Wehrens & Marks,
2004). The blockade of Ca2 entry through the cardiac VGCC represents one of the
principal approaches for the treatment of IHD.
On the basis of electrophysiological and pharmacological characteristics, VGCCs
have been classified into T-, L-, N-, P-, Q-, and R-types (Yunker, 2003). In the
sarcolemmal membrane of heart celis two types of Ca2-permeable channels have been
described and differentiated: the L-type (“long lasting” and “large”) and T-type
(“transient” and “tiny”) channels and a background channel (McDonald et al., 1994). The
heterogeneity of the T- and L-type channel density in different region of the heart has
been long recognized and described (Bourinet et al., 2004; Yunker & McEnery, 2003).
VGCCs are heteromultimeric protein complexes. The three-dimensional structure
of the bovine cardiac L-type calcium channel has recently been resolved (van der Heyden
et al., 2005;Wang et al., 2004c). The largest subunit (-490—240 kDa) is the pore-forming
ai subunit, which is associated with an intracellularly located f3 subunit (-55 kDa) and a
mostly extracellularly located disulfide-linked Œ26 subunit (-170 kDa). Several Œi
subunits have been identified to date (alA-alI, aiS, now termed Cavl.l- Cav3.3), and
the aic isoform is the one that is expressed at high levels in cardiac muscle, but also in
smooth muscle and in the brain (Catterall, 2000; Keef et al., 2001; Jiang et al., 2000a;
Striessnig, 1999).
The ŒIC subunit interacting with accessoiy subunits and especially the f3 subunit is
required to form fully functional Ca2 channels andJor to alter certain channel properties.
Accessoiy subunits determine the activation and inactivation kinetics of the channels. The
f3 subunit also controls targeting of the ŒiC subunit to the membrane. A highly conserved
1 8-amino acid sequence in the cytoplasmic loop connecting DI and DII has been
identified as the interaction domain of the ai c subunit for the f3 subunit. The a26 complex,
which is less tightly associated with the Œ1C subunit, consists of an extracellularly located
a2 subunit linked to a hydrophobic membrane-spanning 6 subunit. The a2 subunit and
6 subunit are encoded by a single gene. The mature forms ofthese subunits are derived by
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post-translational proteolytic processing, but they remain associated through a disulfide
bond. The extracellular Œ2 subunit interacts with the $5—S6 linker in DIII of the cxiC
subunit (Norman & Leach, 1994; Striessnig, 1999).
I-3-1-3 Pacemaker Channels (f-Channels)
In 1979, a current named as fuimy current (Ii-, f for “funny” because of its peculiar
features) was recorded from small voltage-clamped SAN preparations (Brown et al.,
1979). I was inwardly activated on hyperpolarization in the appropriate (diastolic) range
ofpotentials, and increased by adrenaline. Following the original report, the I current was
described in several cardiac and noncardiac ceils, but the most detailed analysis was
conducted in SAN celis. I plays an important roles both in initiating normal rhythmic
activity and in mediating the responses to adrenergic and muscarinic neurotransmitters
(Baruscotti & DiFrancesco, 2004; DiFrancesco, 1995; Difrancesco & Tromba, 198$).
Unlike the majority of other voltage-gated channels in which the permeability is
normally selective for a single ion species, f-channels have a mixed permeability to both
Na and K cations (Difrancesco, 1981). The voltage range of current activation is highly
variable and depends on structural and modulatory factors. In SAN myocytes, the I is
time- and voltage dependent inward cunent upon hyperpolarization, activation threshold
can be as positive as -40/-45 mV and being fully activated at -100 mV, and the V112 for
activation is --80mV, which ensures the current contribution within the whole of the
pacemaker phase (Cerbai et al., 1999; Difrancesco & Mangoni, 1994; van Ginneken &
Giles, 1991).
Despite the importance of f-channels to functional properties of cardiac myocytes,
its cloning was only achieved nearly three decades afier its original description and was
accomplished by chance (Santoro et al., 1997). The newly identified sequence bore the
hallmarks of a voltage-dependent Ktpermeable ion channel: six putative transmembrane
domains and an S4-charged Œ-helix, plus the expected cyclic nucleotide binding domains
at the intracellular C-terminus. Following this first sequence, other isoforms were
identified (Gauss et al., 1998; Ishii et al., 1999; Ludwig et aï., 199$; Seifert et al., 1999),
this group of channels, known as the hyperpolarization-activated cyclic nucleotide-gated
family (Pachucki et al., 1999), comprises four members (HCNY to HCN4) and belongs to
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the superfamily of voltage-gated potassium (Kv) channels, with which they share many
similarities. The four isoforms share a homology of -60% in amino acid (Wang et al.,
1996) sequence identity and express in heart except for HCN3 that only in brain (Kaupp
& Seifert, 2001). The firnctional expression ofthese channelsresulted in currents with the
hallmarks of the cardiac I or of its neuronal equivalent (termed ‘h). Although the
properties of different HCN isoforms differ quantitatively, ail isoforms yield cunents that
+ + +.
are activated by hyperpolarization, carry K and Na , are blocked by Cs in a voltage
dependent manner, and are modulated by a direct action of cAMP on the cytoplasmic side
ofthe channel (Santoro et aÏ., 1997).
There is surprisingiy littie direct evidence implicating I in either acquired or
inherited disease. Perhaps the best-studied case is in cardiac ventricular muscle, where
increases in I magnitude or shifis in voltage dependence have been associated with
certain cardiovascular diseases such as spontaneous hypertension in rats (Cerbai et aï.,
1994), human failing hearts (Cerbai et al., 1997; Cerbai et al., 2001). It was also reported
that HCN2 message level varies with thyroid hormone andlor thyroid hormone receptor
level, perhaps contributing to the rapid heart rate associated with hyperthyroidism (Gloss
et al., 2001; Pachucki et al., 1999). In addition to these acquired diseases, a recent report
describes the first known human mutation in an HCN4 gene. The mutation, identified by
genotyping a patient with sinus bradycardia and atrial ventricular fibrillation, results in
truncation of the terminal portion of the HCN4 C-terminal, including the CNBD, which
leads to a pronounced reduction in the magnitude ofI ($chulze-Bahr et al., 2003).
I-3-1-4 Potassium (K) Channels
Cardiac K currents (IK) are a large family of a variety of K channels with
different characteristics. ‘K can be distinguished on the basis of differences in their
functional and pharmacological properties. In mammalian cardiac cells, K channels can
be categorized as voltage-gated (Kv) and ligand-gated channels. The first category
includes the rap idly activating and inactivating transient outward current (Ito) (Wang et al.,
1999), the ultrarapid-activated delayed rectifier (IKur) (Wang et al., 1993), rapid-activated
delayed rectifier (Iy) and slow-activated delayed rectifier (Iy) (Volders et aï., 1999;
Wang et al., 1994) and the inward rectifier (‘ici) (Wang et al., 1998b), whereas the ligand
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gated channels include those activated by a decrease in the intraceliular concentration of
ATP (KATp) (Wilde et al., 1989), activated by acetylcholine (KAh) (Koumi &
Wasserstrom, 1994; Yang et aÏ., 1996), Na-activated K cunents (JKNa) (Kameyama et
al., 1984; Luk & Carmeliet, 1990; Noda et al., 1984), arachidonic acid-activated K
currents (Iyj,jj (Kim & Duff, 1990), and Ca2- Activated K Channels (Ka) (Cao et al.,
2005; Xu et al., 2002).
Cardiac K channeis play a pivotai role in defining resting potential, ceil
excitability and membrane repolarization and thereby the iikeiihood of arrhythmias. The
configuration and duration of the cardiac APs vary considerabiy among species and
different cardiac regions (atria vs. ventricle) and specific areas within those regions
(epicardium vs. endocardium) (Figure 2). This heterogeneity mainiy reflects differences
in the type andlor expression pattems of the K channeis that participate in the genesis of
the cardiac AP. Changes in the expression of K channeis explain the regional variations
in the morphology and duration of the cardiac AP among different cardiac regions and are
influenced by heart rate, intracellular signaiing pathways, drugs and cardiovascuiar
disorders (Coetzee et al., 1999; Nerbonne, 2000; Snyders, 1999). Moreover, the
expression and properties of K channels are flot static but are influenced by heart rate,
neurohumoral state, phanriacologicai agents, cardiovascular diseases (cardiac
hypertrophy and failure, myocardial ischemia and infarction) and arrhythmias.
I-3-1-4-1 Transient Outward K Current (Ito)
Cardiac is responsibie for early rapid repoiarization (Smith et aÏ., 1995) and
determines the height of the eariy plateau, thus influencing activation of other cunents
that control repolarization, mainiy ‘L-Ca and the delayed rectifier K current (IK).
Furthermore, variations in cardiac repolarization associated with ‘to differences strongiy
influence intracellular Ca2 transient by modulating Ca2 entry via ‘L-Ca and
sodiumlcalcium exchange (NCX), potentialiy exacerbating impaired Ca2 cyciing in heart
disease (Sah et aÏ., 2003).
It density is 4- to 6-fold higher in atrial tissue, Purkinje fibers, epicardiai and
midmyocardiai (M) ceils than in the endocardial ceiis ÇNabauer et al., 1996; Yan &
Antzelevitch, 1996). The prominent epicardial ‘to contributes to the selective electncai
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depression of the epicardium during ischemia and to the development of a marked
dispersion of repolarization between normal and ischemic epicardium and between
epicardium and endocardium, thereby providing the substrate for reentrant anhytbmias
(Lukas & Antzelevitch, 1993; Yan et aÏ., 2004). CMI and infarction are associated with
prolongation of the APD, an effect that lias been attributed, in part, to a downregulation of
Ii., (Oudit et aÏ., 2001; Pinto & Boyden, 1999; Tomaselli & Marban, 1999). However,
there is also an evidence of the up-regulation of I in cardiac myocytes afier induced
myocardial infarction (Pinto & Boyden, 1999; Yao et aÏ., 1999). Paradoxically, using the
dynamic clamp technique whicli allows quantitative ‘insertion’ of simulated conductance
in real, biological celis, bridging pure computer modeling and experimental
electrophysiology, it lias been verified that ‘to does not significantly affect the APD of
canine ventricular myocytes, and that the ‘to gradient is not a significant contributor to the
transmural APD dispersion in the canine ventricle (Sun & Wang, 2005).
Kv4.3 channels are the leading candidate for encodirig ‘to in human and dog (Kaab
et aÏ., 1998; Wang et aÏ., 1999), although a number of Kv Œ-subunits, such as Kvl.4,
K3.4, K4.2, and K4.3 known for generating I0-like current when heterologously
expressed, have become primaiy candidates for cardiac It. Potassium channel interacting
proteins (KCMP) are Ca2tbinding proteins that act as f3-subunits interacting with the
cytoplasmic amino termini ofKv4 Œ-subunits and modify ‘to features (Sanguinetti, 2002).
For instance, KChIP2, when coexpressed with hKv4.3, increases surface channel density
and cunent amplitude, slows the inactivation, accelerates the recovery from inactivation
and shifts the half-maximal inactivation to more positive potentials (An et aÏ., 2000;
Pounier et al., 2003a). Thus, feamres of K4.3/KCMP2 currents closely resemble those
of I. In human ventricle KCMP2 mRNA is 25-fold more abundant in the epicardium
than in the endocardium, and this gradient parallels the gradient in expression, while
K4.3 mRNA is expressed at equal levels across the ventricular wall. Thus,
transcriptional regulation of the KCMP2 gene is the primary determinant ofI expression
across the ventricular wall (Rosati et aL, 2001).
I-3-1-4-2 Ultra-rapid Delayed Rectifier K Current (IKur)
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Iv is present in human and dog atrium and throughout rat and mouse heart. Its
density is similar in ceils isolated from different regions of the canine right atrium
(Brouillette et al., 2004; Feng et al., 1998; Nattel et al., 1999; Roden et al., 2002; Wang
et al., 1993). ‘Kur is the predominant delayed rectifier current responsible for human atrial
repolarization. K1.5 (613 amino acids) encodes the Œ-subunit ofthe ‘Kur channel (10—14
pS). Heterologous expression of Kvl.5 resuits in a delayed rectifier current with the
biophysical and phannacological characteristics of ‘Kur and exposure to Kvl .5 antisense
oligodeoxynucleotides-AsODN specifically inhibits ‘Kur density in human atrial myocytes
(Nattel et aL, 1999; Wang et al., 1993). Cyclic adenosine 3’, 5’-monophosphate (cAMP),
mechanical stretch and hyperthyroidism increase, whereas extracellular acidosis,
phenyÏephrine, and hypothyroidism decrease Kvl.5 expression (Guo et al., 1998; Le
Bouter et al., 2003; Nattel et aÏ., 1999). K1.5 mRNA levels decrease in hypertensive
liypertrophied rat ventricle (Matsubara et al., 1993) and in the epicardial border zone of
the infracted canine ventricle (Pinto & Boyden, 1999).
‘Kur is a substantial current in human atrial myocytes (Wang et al., 1993). Kinetic
analysis in human atrial celis indicates that ‘Kur has amplitude that is at least as large, and
ofien larger, than that of Itt, (Schaffer et aÏ., 1998). Selective inhibition of ‘Kur with
pharmacologie probes suggests a significant role for the current in repolarizing human
(Wang et aÏ., 1993), canine (Yue et al., 1996), and mouse (Fiset et al., 1997)
cardiomyocytes. Mathematical models of the human atrial AP based on formulations of
directly measured ionic currents also indicate a role for ‘Kur in repolarization
(Courtemanche et al., 1998; Courtemanche et al., 1999; Nygren et al., 1998). In atrial
fibrillation (AF) ‘Kur appears to be downregulated (Van Wagoner et aÏ., 1997), the
morphologic changes associated with tachycardia-induced cellular remodeling (Yue et aï.,
1997) resuit in a clearer AP prolongation from ‘Kur inhibition in AF-type myocytes than in
normal ones (Courtemanche et al., 1999). Thus, inhibition of ‘Kur would be expected to
prolong human atrial refractory period and protect against atrial reentrant anhythmias like
AF. At the same time, ‘Kur is absent in human ventricular myocytes (Li et aÏ., 1996).
Therefore, the development of IK-selective blockers could resuit in atrial-specific
antiarrhythmic drugs. If this proves to be feasible, it would be a major therapeutic
advance, because the most important limitation of AP-prolonging antiarrhythmic therapy
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2003; Roden et al., 2002; Splawski et al., 2000). Whereas gain of function in ly bas been
associated with “short QT-syndrome” (Brugada et al., 2004), a new clinical entity
originally described as an inherited syndrome (Gussak et al., 2000), also leading to the
development of lethai arrhythmia and SCD, although the different phenotypes are
attributed to the alterations in Iy fimction.
Molecrilar Basis and Structure
The human ether a-go-go-related gene (HERG) product constitutes the Œ-subunit
(1159 amino acids) underlying I (Keating & Sanguinetti, 2001; Sanguinetti et al., 1995;
Trudeau et al., 1995) and the KCNE2 gene product minK-related peptide 1 (MiRP 1) (123
amino acids) may contnbute to I as a 3-subunit (Abbott et aÏ., 1999; Tristani-Firouzi &
Sanguinetti, 2003).
HERG was initially isolated by screening a human hippocampal cDNA library
with a mouse homolog of ether-a-go-go, a Drosophila K channel gene (Warmke &
Ganetzky, 1994). The function of HERG was unknown when isolated, but it was strongly
expressed in the heart and was posmlated to play an important role in repolarization of
cardiac APs (Curran et al., 1995). This notion was verified and moreover, following the
discovery HERG lias become one of the liottest targets in electropliysiological and
pharmacologie studies.
HERG channels represent a typical potassium channel protein composed of six (X
helical transmembrane segments, S4 fimctions as a voltage sensor, and a highly selective
ion conduction pathway located in tlie linker between transmembrane segments $5 and S6
(Tseng, 2001). Predicted topologies of potassium cliannels suggest only very small
portions of the tetrameric HERG protein are exposed to the ER lumen, with large N- and
C-terminal domains including the Per, Arnt, and Sim (PAS) and cyclic-nucleotide binding
domains (cNBD) projecting into the cytoplasm (Morais Cabrai et al., 199$). Since native
I and HERG channels expressed in heterologous systems differ in terms of gating,
regulation by extemal K and single channel conductance (Abbott et al., 1999; Tristani
Firouzi & Sanguinetti, 2003; Tseng, 2001; Sanguinetti et al., 1995; Zliou et aÏ., 19985), it
suggests the presence of a modulating -subunit that co-assembles with HERG to
reconstitute native Ic1. A potential candidate is found to be MiRP1 which when
coexpressed with HERG shifis the HERG activation curve in the positive direction,
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accelerates the rate of deactivation, decreases single channel conductance (from 13 to 8
pS) and mediates the direct stimulatory effect of cAMP on HERG/MiRP 1 channels
(Abbott et al., 1999; Cui et al., 2000). MiRP1 reduces channel sensitivity to [Kj0 and
enhances sensitivity to clarithromycin (Abbott et al., 1999) but flot to dofetilide, E-4031
or quinidine (Weerapura et aÏ., 2002). MiRP1 can also modulate KCNQ1, Kv4.2 and
even the distinctly related hyperpolarization-activated cation (HCN) pacemaker channels
(Tristani-Firouzi & Sanguinetti, 2003). However, the specific contribution of MiRP1 to
native Iy,1- is stiil controversial. For instance, currents resulting from coexpression of
HERG and MiRPÎ did not resemble native Iy properties doser when compared with
HERG in the absence ofMiRPl (Ehrlich et al., 2004; Weerapura et aÏ., 2002).
HERG and MiRP 1 have been identified as the Ioci of mutations associated with
LQT2 and LQT6 of the Romano —Ward variant of LQTS, respectively (Kass & Moss,
2003; Roden et aÏ., 2002; Splawski et al., 2000). More than 100 mutations in the HERG
and KCNH2 gene have been described, including frameshifis, insertions, deletions and
missense and nonsense mutations (Kass & Moss, 2003; Splawsld et al., 2000; Zhou et al.,
1 998a; Rajamani et al., 2002). Mutant channels cause a net reduction in outward K
current during repolarization that can result from different mechanïsms, including
generation of nonfunctional channels, altered channel gating and abnormal protein
trafficking (ficker et al., 2003; Rajamani et al., 2002; Zhou et aï., 1998a).
Expression
There is the enonnous variation as to the tissue expression of J}Cj, or HERG and
MiRPÏ, depending on the different species, tissues, and (patho) physiological conditions.
I has been identified in human atrial and ventricular myocytes, rabbit SA and AVN celis
and Purkinje fibers (Nerbonne, 2000; Schram et al., 2002). In rabbit SA myocytes HERG
channels play an important role in the pacemaker activity and Iy blockers decrease the
maximum rate of diastolic depolarization (Verheijck et aï., 1995). In rats Iv density is
higher in atria than in ventricles, while in humans HERG expression is higher in the
ventricles (Pond et al., 2000). MiRP1 expression is rather sparse in ventricular tissue
(Pourrier et al., 2003b). In canine atria I density is larger in the AV ring region and the
lefi atrial wall than in crista terminalis, pectinate muscles, appendage celis and right atrial
wall, which may account for the shorter APD of the lefi atria (Feng et al., 1998; Schram
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et aL, 2002). However, in the canine ventricle Iy is distributed homogeneously (Liu &
Antzelevitch, 1995), while in guinea pig left ventricle, IW.r is smaller in subendocardial
than in midmyocardial or epicardial myocytes (Bryant et al., 1 99$b). In rabbit left
ventricle, Ijc is greater in the apex than in the basal regions and l blockers cause more
significant APD prolongation in the apex than in the base, increasing the regional
dispersion of APD (Cheng et aÏ., 1999). I density is reduced in myocytes from infarcted
canine ventricle (Jiang et al., 2000b). It, however, increases in subendocardial Purldnje
fibers from the 48 h infarcted heart (Pinto & Boyden, 1999), an effect that may increase
the proarrhythmic effects of lc blockers in patients with myocardial infarction.
Modulation
HERG channels can be modulated via the cAMP-PKA (Cui et aÏ., 2000; Kiehn,
2000), PKC, PKB (Zhang et al., 2003b), phosphatidyl 4,5-biphosphate (PIP2) pathways
(Bian et aL, 2001; Bian et al., 2004). Very intriguingly, the channels have been found to
be regulated by a great number of dnigs (Tamargo et aÏ., 2004) as well as a variety of
physiologically or pathophysiologically produced metabolites (Wang et al., 2001; Wang
et aï., 2004b).
Activation of Ç3-adrenergic receptors and elevation of intracellular cAMP levels
regulate HERG channels both through PKA-mediated effects and by direct interaction
with the protein (Cui et al., 2000; Thomas et al., 2004). PKA activation reduces HERG
current amplitude and induces a depolarizing shift in the voltage-dependent activation
curve(Cui et al., 2000; Kiehn, 2000). This shifi is inhibited by specific PKA inhibitors
(H89, KT5720) and in channels missing all PKA phosphorylation sites (S283A, $890A,
T$95A, S1137A), while coexpression ofHERG wiffi KCNE1 or KCNE2 accentuates the
cAMP-induced voltage shifi (Cui et aÏ., 2000). However, isoproterenol increases ly. in
guinea pig ventricular myocytes, an effect that was inhibited by bisindolylmaleimide (Bis)
(Kiehn, 2000). Isoproterenol also increases l and this effect is inhibited by H89, but not
by Bis in rabbit SA ceils (Lei et aÏ., 2000). These resuits suggest that modulation of iKr
may be species-specific and tissue-specific and may depend strongly on the experimental
conditions as well.
HERG channels are modulated by PKC independently of direct phosphorylation of
the channel (Thomas et al., 2003). PMA causes a positive shift of activation and reduces
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I and its effects can still be observed when the PKC-dependent phosphoiylation sites are
deleted by mutagenesis. Changes in PIP2 levels resuit from activation of several
adrenergic and muscarinic receptors. PIP2 increases HERG current and shifts the voltage
dependence of activation in a hyperpolarizing direction (Bian et al., 2001;Bian et al.,
2004). Moreover, in ceils coexpressing the OEIA-receptor and HERG, phenylephrine
reduces HERG currents and this effect is prevented by PIP2 but flot by PKC inhibition,
suggesting that the mechanism is due to G-protein-coupled receptor stimulation of PLC
resulting in the consumption of endogenous PIP2.
I1/HERG channels are the primary targets of class III antiarrhythmic drugs of the
methanesulfonanilide group (almokalant, dofetilide, D-sotalol, E-4031, ibutilide, and
MK-499). These dmgs produce a voltage- and use-dependent block, shorten open times in
a manner consistent with open-channel block and exhibit low affinity for closed and
inactivated states (Busch et aÏ., 1998; Mitcheson et al., 2000; Tristani-Firouzi &
Sanguinetti, 2003; Tseng, 2001). Iy.1. blockers prolong atrial and ventricular APD (QT
prolongation) and refractoriness in the absence of significant changes in conduction
velocity (AH, HV and PR intervals) ($anguinetti & Salata, 1996). In animal models, ‘Kr
blockers suppress ventricular tachycardia induced by programmed electrical stimulation
or a new ischemic insult in dogs with prior infarct (Nattel & Singh, 1999; Sanguinetti &
Salata, 1996). However, these drugs are probably not effective against triggered activity
or increased automaticity (Sanguinetti & Salata, 1996; Tamargo et al., 2004). An
increasing number of drugs with diverse chemical structures block Ic1, delay ventricular
repolarization, prolong the QT interval (acquired LQTS) and induce TdP (Clancy et aï.,
2003; Redfem et aÏ., 2003). There have been extensive efforts to develop Iy channel
blockers as a new antiarrhythmic agent for atrial or ventricular fibri1lation, since it was
demonstrated that selective blockade of Iy in the heart is not deleterious for the total
mortality in fatal ventricular arrhythmia patients (Lee et al., 2003).
+I-3-1-4-4 Slow Delayed Rectifier K Current (I)
Biophysicat features
‘Ks is slowly activated at potentials positive to —30 mV with a linear I—V
relationship, reaching half-maximum activation at +20 mV (Kurokawa et al., 2001;
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Sanguinetti & Jurldewicz, 1990; Tristani-Firouzi & Sanguinetti, 2003). The current only
shows activation and no inactivation. Deactivation is slow in guinea pig but relatively fast
in dog and rabbit (Canneliet, 1992;Gintant, 1996; Liu & Antzelevitch, 1995). Thus, in
guinea pigs, the slow deactivation of Ig results in a reduction of outward current that
contnbutes to the slow diastolic depolarization of SA node celis (Kurokawa et al., 2001).
Function and Tissue Expression
Like I, I contributes to human atrial and ventricular repolarization. It, however,
particularly plays the role during APs of long duration and is a dominant determinant of
the physiological heart rate-dependent shortening of APD. As heart rate increases, Iy
channels have Iess time to deactivate, leading to an accumulation of open chaimels and a
faster rate ofrepolarization (Delpon et al., 1995; Jurldewicz & Sanguinetti, 1993).
Ij density is greater in atrial than in ventricular myocytes and in subepicardiai and
M celis than in subendocardial ceils (Bryant et al., 1998b), but is smaller in apical than in
basal myocytes of the rabbit left ventricle in guinea pigs (Cheng et aÏ., 1999). There are
no differences in Iy density among ceils from different regions of the canine right atria
(Feng et al., 1998), while in the canine ventricle, Iic density is higher in epicardial and
endocardial celis than in the M celis (Liu & AntzeÏevitch, 1995) and in right than in left
ventricular M celis (Volders et al., 1999). The smaller Ig density in M ceils may explain
their steeper APD-rate relations and their greater tendency to display pronounced action
potential prolongation and to develop EAD at slow heart rates or in response to QT
prolonging drugs (Liu & Antzelevitch, 1995). Iy density is downreguiated in ail layers of
the left ventricle of failing canine hearts (Li et aï., 2002a) and a decrease in J and
KCNQ1/KCNE1 mRNA levels is found in myocytes from infarcted canine ventricle
(Jiang et aL, 2000b).
Motecutar Basis
is composed of four pore-forming KvLQT1 (KCNQ1, 676 amino acids) and
two accessory minimal potassium channel (minK) (KCNE1, 129 amino acids) 13-subunits
(Barhanin et al., 1996; Chen et al., 2003a; Sanguinetti et al., 1996; Suessbrich & Busch,
1999). minK exhibits a single transmembrane spanning domain; the N-terminus is
extracellular and the C-terminus intracellular. Heterologous expression of KvLQT1
produces rapidly activating, slowly deactivating currents, while minK, by itself, does not
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form flinctional channels. Coexpression of KvLQT1/minK slows activation and
deactivation kinetics, shifts the voltage dependence of channel activation to more positive
potentials and increases the macroscopic current amplitude, thus reproducing the
biophysical properties ofthe native cardiac Iy (Sanguinetti et al., 1996).
minK is abundant in the SA node, but less abundant although homogeneously
distributed throughout the ventricular wall and in the mouse heart expression is largely
restricted to the conducting system. An altematively spliced variant ofKvLQT1 with a N-
terminal deletion that produces a negative suppression of KvLQTI is preferentially
expressed in the M ceils, which is consistent with the lower ‘Ks density in this region
(Pereon et al., 2000). KvLQT1 and minK expression and I density increases in
ventricular myocytes from hypothyroid rats, but decreases iii hyperthyroidism (Le Bouter
et al., 2003) and in myocytes from infarcted canine ventricle (Jiang et al., 2000b).
Mutations in KvLQTY and minK are associated with types 1 (LQT1) and 5 (LQT5) ofthe
Romano—Ward variant of the LQTS, respectively, and the Jerveli—Lange—Nielsen
syndrome associated with deafness arises in chiidren who inherited abnormal KvLQTI or
minK alleles from both parents (Schulze-Bahr et aï., 1997; Splawsld et al., 2000).
Modulation
‘lCs is upregulated via the PKA pathway (Kaczmarek & Blumenthal, 1997;
Blumenthal & Kaczmarek, 1994). Stimulation of PKA by cAMP, phosphodiesterase
inhibitors and 3-adrenergic agonists increases I1(s density and produces a rate-dependent
shortening of the APD (Lo & Numann, 1998; Marx et aï., 2002). Phosphorylation of the
KvLQT1 subunit by PKA blunts quinidine- and 293B-induced block, probably by
inducing a change in the KvLQT1 conformation that modifies the drug access to the
blocking site (Yang et al., 2003). Thus, 3-adrenergic stimulation, itself a potent
proarrhythmic stimulus, may also decrease the antiarrhythmic effects of Iic blockers.
PKC modulation of I current is complex, suggesting that there are two flinctionally
distinct PKC sites on KvLQTI—minK channels (Lo & Numann, 1998). Moreover,
premodulation by PKC prevents Iy modulation by PKA, and PKC has no effect on ‘Ks
current afier potentiation by PKA. These data indicate that Iy is modulated by PKC and
PKA in a mutually exclusive manner and suggest that multiple interacting
phosphorylation sites are involved. Endothelin- 1 inhibits the Iy enhanced by
23
isoproterenol and forskolin and prolongs APD duration via the endothelin receptor A
pertussis toxin (PTX)-sensitive G protein!PKA pathway (Washizuka et al., 1997).
In guinea pig cardiac myocytes, the stimulation of G protein-coupled ATP receptor
by extracellular ATP markedly enhances I through a mechanism that appears to be
independent of either the activation of PKC or the elevation of intraceliular Ca2
(Matsuura & Ehara, 1997; Matsuura et al., 1996). Moreover, itwas recently demonstrated
in guinea pig ventricular myocytes that the endogenous membrane PLP2 has a potent
inhibitory action on Iy channels (Ding et aÏ., 2004).
Some fatty acids such as docosahexaenoic acid and lauric acid significantly
enhanced ‘Ks. Eicosapentaenoic acid, however, was without significant effect on current
magnitude, although it reduced the rate of activation. These results suggest that flot ail
fatty acids target the channel and produce the same effect. If KvLQT1 was expressed in
Xenopus oocyte alone, docosahexaenoic acid, lauric acid, and oleic acid did flot augment
cun-ent, suggesting that minK confers fatty acid sensitivity to Ii (Doolan et aÏ., 2002).
Lowering [K]0 and [Ca2 ] also increase Iy (Kurokawa et al., 2001; Tristani-Firouzi &
Sanguinetti, 2003).
1-3-1-4-5 Inward Rectifier K Current (IKI)
‘KI is the current responsible for maintaining the negative resting potential in
cardiac cells. The current is strong rectifier that passes K ions over a limited range of
membrane potentials (Lopatin & Nichols, 2001). At negative membrane potentiais ‘KI
conductance is much larger than that of any other cunent, and so it clamps the resting
membrane potential close to the K equilibrium potential (—9OmV). Upon depolarization,
11(1 channels close almost immediately, remain closed throughout the plateau and open
again at potentials negative to —20 mV. Thus, ‘KI contributes to terminal phase 3 of AP.
‘KI density is higher in ventricular than in atrial myocytes, but is similar in epicardial, M
and endocardial ceils in canine and guinea pig hearts (Schram et aÏ., 2002). ‘KI density is
very low in SA and AV pacemaker cells (Irisawa et al., 1993) and, therefore, the
maximum diastolic potential is more depolarized than in atrial and ventricular myocytes.
Kir2.1 subunits (427 amino acids) encoded by the KCNJ2 gene, coassemble to
form tetrameric channels (Lopatin & Nichols, 2001). Several ‘KI channels with
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conductance of 9, 21, 35 and 41 pS are recorded in human atrial myocytes (Wible et al.,
1995). Likewise, different gene families (Kir2.1—2.3) have been found in human heart
encoding ‘ici (Lopatin & Nichols, 2001). Kir2.1 overexpression increases ki density,
shortens the APD and hyperpolarizes the resting membrane potential in guinea pig
myocytes, while genetic suppression of ‘ici resuits in opposite changes and in a
pacemaker phenotype accelerated by isoproterenol (Miake et al., 2003). Reduced ‘ici
density is observed in canine Purkinje celis afier myocardial infarction (Pinto & Boyden,
1999) and in a 3-day-old infarcted rat heart, but this reduction is greater in epicardial than
in endocardial myocytes (Yao et al., 1999). The ventricular myocytes from patients with
idiopathic dilated cardiomyopathy exhibit decreased channel activity, longer APD and
lower resting membrane potenti ais than those from patients with ischemic
cardiomyopathy (Koumi et aÏ., 1995). The downregulation of ‘KI produces membrane
depolarization, prolongation of ffie APD and both early and delayed afterdepolarizations
ÇNabauer & Kaab, 199$; Tomaselli & Marban, 1999).
1-3-1-4-6 Acetylcholine-induced K Current (Ic,Ch)
The heart rate decrease mediated by the parasympathetic branch of the autonomic
nervous system involves the release of acetylcholine (ACh) from post-ganglionic
cholinergic neurons onto SAN and AVN celis as well as atrial myocytes (Wickman &
Clapham, 1995). Ach binds M2 muscarinic receptors on these celis, triggering the
activation of PTX-sensitive G proteins. The activated G and subunits in tum activate
a distinct class of inwardly rectifying potassium channel (IKAch) (Mark & Herlitze, 2000;
Wickman & Clapham, 1995). Activation of IKCh hyperpolarizes the membrane potential,
slows the spontaneous firing rate of the pacemaker ceils of the SAN and AVN and delays
AV conduction (Carmeliet, 1999; Snyders, 1999).
IKACh density is about 6 times greater in the atrium than in the ventricle (Schram et
al., 2002) and results from a heterotetrameric complex formed by the homologous Kir3. 1
(501 amino acids)/GIRK1 and Kir3.4 (419 amino acids)/GIRK4 potassium channel
subunits (Corey & Clapham, 1998; Dascal et al., 1993; Krapivinsky et al., 1995; Kubo et
al., 1993; Silverman et al., 1996). Kir3.1 was proposed initially to constitute anintegral
subunit of both neuronal and cardiac G protein-gated potassium channels (Kofuji et al.,
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1995; Krapivinsky et aï., 1995; Velimirovic et al., 1996). Recent studies, however, have
presented evidence for the existence of native G protein-gated potassium channels that do
flot contain Kir3.1 (Corey & Clapham, 1998; Inanobe et al., 1999; Jelacic et al., 2000).
Indeed, Kir3 .4 homotetrameric complexes have been identified in heart atrial tissue and
were proposed to contribute significantly to macroscopic ‘ch current (Bender et aï.,
2001; Corey & Clapham, 1998).
‘KAch activity can be stimulated by intracellular ATP, PIP2 and ETA endothelin, t
opioid, Œ2-adrenergic and Al adenosine receptor agonists (Carmeliet, 1999; Cho et aï.,
2002; Shieh et al., 2000) and inhibited by intracellular acidification and several
antiarrhythmic drugs (Brandts et aï., 2000; Guillemare et al., 2000; Inomata et al., 1993).
Disopyramide, procainamide and pilsicainide mainly block the muscarinic receptors,
while flecainide and propafenone act as open channel blockers (Guillemare et al., 2000).
Atrial KAch channels are inhibited by membrane stretch, possibly serving as a
mechanoelectrical feedback pathway, a property conferred by the Kir3 .4 subunit (Ji et al.,
1998). Vagal stimulation produces a nonuniform shortening of the atrial APD and
refractoriness mediated by activation of
.4c.pCh, an effect that may contribute to the
perpetuation of AF (Liu & Nattel, 1997). Chronic AF reduces ‘JCh density possibly to
counteract the AF-induced nonuniform shortening of the atrial refractoriness (Dobrev et
al., 2001).
I-3-1-4-7 ATP-sensitive K Current (IiTP)
IKATP is an inwardly rectifying current identified first from isolated guinea pig
ventricular myocyte (Noma, 1983). Afier this landmark finding, ATP-sensitive K
channels (KATp) underlying Ijjjp have also been shown to exist in other tissues and
appear to consist of various subtypes depending on the tissue or organelle studied (Gross
& Peart, 2003; Isomoto & Kurachi, 1997).
Cardiac KATp are inhibited by physiological intracellular ATP levels (ATP) and
activated by ADP, thus coupling celi metabolism (reflected by ADP/ATP ratio) to
membrane potential (Seino & Miki, 2003; Yellen, 2002; Yokoshild et al., 199$). It was
initially demonstrated that opening of the KATp, induced by hypoxia, ischemia, or
pharmacological KATp openers increased K1 efflux (Carmeliet, 1999; Gasser & Vaughan
26
Jones, 1990) and shortened the cardiac APD by accelerating phase 3 repolarization
(Faivre & findlay, 1990; Isenberg et al., 1983), and therefore plays a role in
arrhythmogenesis during the early phase of myocardium ischemia (Cole et al., 1991;
Noma, 1983; Sanguineffi & Salata, 1996). However, the existing data regarding the role
of KATP in ischemic [K]0-t have been conflicting and challenged (see later in details).
Actually, accumulating evidence has revealed that the opening of the myocardial KATp,
especially mitochondrial KATp (mitoKArp) rather than the sarcolemmal KATp (sarcKArp)
channel are mainly responsible for cardioprotective function against various stresses,
including ischemia and hypoxia (Gogelein, 2001; Gross & Peart, 2003; Grover & Garlid,
2000).
In the view of molecular basis, cardiac KI-p channels resuit from the coassembly
of four inwardly rectifying channel a-subunits (Kir6.2) and four regulatory SUR2A
subunits (Seino & Mild, 2003; Yokoshiki et aÏ., 1998). Kir6.2 subunits confer inhibition
by ATP (Tucker et al., 1997). The SUR2A subunit has three transmembrane domains
(TMDO, TMD 1, and TMD2), each of which consists of five, five, and six membrane
spanning regions and two nucleotide binding folds (NBF-1 and NBf-2) located in the
loop between TMD 1 and TMD2 and in the C-terminus, respectively (Conti et al., 2001;
Seino & Miki, 2003). The SUR2A subunit confers sensitivity to MgADP, sulfonylureas
and K channel openers and ATP hydrolysis at each NBF gates the K permeation
through the Kir6.2 (Seino & Miki, 2003; Yokoshiki et al., 1998). There is an endoplasmic
reticulum retention motif in the C-terminal region in Kir6.2 and in an intracellular loop
between TMD1 and NBF-1 in SUR2A that prevents their surface expression in the
absence of the other subunit (Zerangue et al., 1999). Kir6.2—/— mice lack KATp and
present an aberrant regulation of cardiac excitabi]ity, inadequate Ca2 handiing,
ventricular arrhythmias and sudden death following sympathetic stimulation (Zingman et
al., 2002). These resuits suggest that Kir6.2 is required for adaptation to stress.
KATp are blocked by sulfonylureas (i.e. glibenclamide, glicazide, glipizide,
glimepiride, tolbutamide), glinides (repaglinide, nateglinide) and various antiarrhythmic
dnigs (Tamargo et al., 2004). Several factors desensitize KATp to inhibition by ATP,
including nucleotide diphosphates, lactate, oxygen-derived free radicals and adenosine
Al receptor stimulation (Seino & Miki, 2003; Yokoshiki et al., 1998). Cardiac IYTP
27
blockers prevent the shortening of the APD and the incidence of ventricular fibrillation
during the myocardial ischemia, even when in models of ischemia—reperflïsion they are
mainly anhythmogenic (Gogelein, 2001; Grover & Garlid, 2000; Sanguinetti & Salata,
1996). The clinical effects of glibenclamide are also contradictory in type 2 diabetic
patients with coronary artery disease (Brady & Terzic, 1998). Moreover, since KATp are
present in pancreatic -cells and smooth muscle (Seino & Miki, 2003), ‘icp blockers can
produce hypoglycemia and coronary vasoconstriction, effects that may preclude their
interest as antiarrhythmic agents. Cardioselective JÀTp blockers (clamikalant, HMR 1098)
inhibit hypoxia-induced APD shortening and prevent ventricular fibrillation induced by
coronary artery occlusion in post-infarcted conscious dogs at doses that have no effect on
insulin release, blood pressure or coronary blood flow (Gogelein, 2001; Grover & Garlid,
2000). Thus, they may represent a new therapeutic approach to the treatment of
ventricular arrhythmias in patients with coronary heart disease.
KATp cari be activated indirectly by PKA-coupled and other protein kinase-coupled
receptors via phosphorylation of channel proteins or by depleting cellular ATP levels
(Babenko et al., 1999). Both PKC and adenosine Al receptor activation enhance KATp
and these effects are suppressed by chelerythrine or bisindolylmaleimide (Light et aï.,
1996). KATP activated by glucose-free anoxia close immediately upon reoxygenation, but
activation of both novel and conventional PKC isoforms contributes to the persistent
opening of the channels under these circumstances (Ito et al., 2001). Protein tyrosine
kinases (PTKs) are also mediators of ischemic preconditioning (IPC). In guinea pig
ventricular myocytes the PTK inhibitor genistein elicited ‘KATP. Stimulation of receptor
PTKs with epidermal growth factor, nerve growth factor or insulin attenuates, while the
protein tyrosine phosphatase inhibitor orthovanadate prevents the effects of genistein on
Iirp (Stadnicka et al., 2002). These results suggest that the PTK-protein tyrosine
phosphatase signaling pathway may be one of the regulators of cardiac sarcKATp.
PIP2 directly interacts with positively charged residues (R176, R177) at the C-
terminus of Kir6.2 subunit stabilizing the open state of the channel and antagonizes ATP
inhibition of KATp (Fan & Makielski, 1997; Lopatin & Nichols, 2001), whereas
breakdown of PIP2 by PLC enhances the ATP-sensitivity of KATp channels (Xie et aï.,
1999). Moreover, PIP2 mimics ATP in preventing current nindown and in rescuing
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activity afier rundown (Fan & Maldelsld, 1997). It has been also reported that the release
of nitric oxide (NO) and bradykinin during ischemia can play a role in IPC. KATp are
activated via the NO-cGMP-PKG signaling pathway, which phosphoiylates some serine—
threonine residues and this activation is reversed by protein phosphatase 2A (Han et al.,
2002). PKC- and PKC-îi are activated by NO donors in rabbit hearts (Ping et aÏ., 1999)
and their infarct-size limiting effects are abolished by chelerythrine. Interferon-Œ inhibits
‘KATP in rabbit ventricular ceils and this effect is blocked by genistein, but is flot affected
by H-7, an inhibitor of PKC and PKA (Nishio et al., 1999). These findings suggest that
tyrosine kinase-mediated inhibition of Iyp by cytokines may aggravate celi damage
during myocardial ischemia.
I-3-2 Synopsis of Ionic Channels Underlying Cardiac Action Potentials
The normal electrophysiological behavior of the heart is determined by the ordered
propagation of excitatory stimuli resulting in rapid depolarization and slow repolarization,
generating APs in individual myocytes. In a prototypical fast response cardiac celi (i.e.,
from atrium, ventricle, or the Purkinje system), the membrane is highly permeable to K,
as demonstrated by the fact that the reversal potential for K is very close to the resting
membrane potential. This permeability reflects the fact that inward rectifier K charmels
in the membrane are open at rest. A change in the potential across the cdl (due to a
propagating impulse or an experimentalist’s stimulus) is sensed by the Na channel
protein, which alters its conformation to open, allowing a large, rapid Na influx,
producing the typical rapid phase O depolarization (see Figure 2). In some cells, a rapid
phase 1 repolarization then ensues, because of outward movement of K via transient
outward channels. During phase O and phase 1, Ca channels open. Phase 2, the
characteristically long (hundreds of milliseconds) plateau phase of the AP, reflects a
balance between inward current, largely through L-type Ca2 channels, and outward
current, largely tbrough delayed rectifier K channels. The net outward current during
phase 3 repolarization is provided by delayed rectifier K channels, along with
inactivation of Ca2 channels. Final repolarization is accomplished by outward movement
of K through inward rectifier channels. Slow response cells, those in the SAN and in the
AVN, demonstrate slow depolarization during phase 4, a manifestation of pacemaker
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channel activity. furthermore, a rapid phase 1 upstroke is absent, and initial
depolarization is accomplished by opening of L-type (and perhaps T-type) Ca2 channels.
Other electrogenic behaviors (due to exchangers and pumps) are readily demonstrated in
cardiac tissue and are crucial in maintaining intracellular ionic homeostasis in the face of
large ion fluxes accompanying each AP. At the most generic level, abnormalities of
impulse generation, propagation, or the duration and configuration of individual cardiac
APs form the basis of disordered cardiac rhythm.
Ischemic arrhythmias electrically behavior as APD/QT intewal shortening at the
very early stage (< 15 mm) of blood flow occlusion and then manifest as APD/QT
interval prolongation in the late phase and chronic myocardial ischemia. The common
consequence is ventricular tachyarrhythmia and VT, and eventually $CD. During
myocardial ischemia the function of channels involving in the AP is altered in response to
the metabolic stress characterized by a deficient energenic input as well as deficient waste
removal, leading to a cascade of metabolic and electrophysiological events. The cascade
is identified by the reduced availability of oxygen and substrate, by the disturbances of a
variety of ions, and by the intracellular and extracellular accumulation of metabolic by
products, such as the lipid metabolites (including amphiphile like
lysophosphatidylcholine, free fatty acids, and sphingolipid ceramide), lactate, taurine, etc,
as well as by the overproduction of stress signaling molecules, such as radicals and
cytokines (Beresewicz et al., 2002; Carmeliet, 1999; Cui et al., 2004; Fahim & Halim,
2004; Murase et aÏ., 2000). These alterations, with concomitant stimulation of adrenergic,
purinergic, and muscarinic receptors, as well as the genesis of stretch produce the
profound effects on ion channels and exchangers involving in the APs, thereby the
development oflethal ventricular arrhytbmias.
I-4 Disturbances of Ion Concentrations during Myocardial Ischemia
Like other types of mammalian celis, ffie cardiomyocyte is enclosed by an
approximately 80-À-thick bimolecular lipid membrane. This lipid bilayer serves as an
excellent electrical insulator, permitting passage of veiy few ions, allowing the myocyte
to maintain ion concentrations in its cytosol that are different from those in the
extracellular fluid (see Table 1). By generating ionic concentration differences across the
30
lipid bilayer, the sarcolemmal membrane of myocyte is capable of storing potential
energy in the form of electrochemical gradients, which are used to drive various transport
processes, to convey electrical signais like the AP. In myocardial ischemia the typical
alterations in ion concentrations, which are attributable to the anhytbmogenesis are
accumulation of extracellular potassium concentration (Weiss & Shine, 1982b), increase
in intracellular calcium concentration ([Ca2]-t), intra- and extracellular acidosis, as well
as intracellular sodium concentration ([Na]-t) and depletion of intracellular magnesium
([Mg2j1-’.L). In this introduction, oniy the first two alterations are addressed hereafter.
Table 1. Intracellular and Extracellular Ion Concentrations in Cardiocytes
Extracellular Intracellular Equilibrium
Ion Concentration (mM) Concentration (mM) Potential (mV)**
Na 145 10 +71
K 4 135 -94
Ca2 2 10-7M +132
Mg2 1 1 0
W 10-7 M or pH 7.4 10.7.2 M or pH 7.2
CI 120 20 -48
Total [Ca2j is about 2 mM, and total [Na] is about 30 mM. In both cases, most of the ion is sequestered in
intracellular organelles or is bound to proteins. Values given are estimates of the free concentration in the
cytoplasm.
* Like other ceils in mammal, the cardiac myocytes contain equal quantity of positive (+) and negative f-)
charges (that is, be electrically neutral). Thus, in addition of C1, the ceils contain many other anions, such
as HC03, PO4, proteins, nucleic acids, metabolites carrying phosphate and carboxyl groups, etc. f not
listed in this table).
Equilibrium Potentials were calculated from the Nernst equation at 37°C assuming equal intra- and
extracellular activity coefficients.
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I-4-1 Extracellular K Accumulation (IK1]0-t)
Under physiological conditions, [K1]0 is low and [K1] is high (sec Table 1).
Passive K efflux is compensated by active K influx via the Na-K pump. During
myocardial ischemia, this dynamic equilibrium is broken, and extemal K accumulates.
Increase in [Kj0 or net cellular K loss is one of the earliest consequences of myocardial
iscliemia. The extemal K accumulates lias profound electrophysiological effects (Janse
& Wit, 1989). The most deteriorative effect is membrane depolarization, which leads to
slowing of conduction and altered refractoriness, in concert wiffi other factors, triggers
reentrant ventricular arrhythmias causing SCD.
1-4-1-1 The Temporal Course of tK1]0-1’ during Myocardial Ischemia
[K1]0-t in the myocardium following net cellular K loss ([Kj1-1-) is one of the
earliest consequences of myocardial hypoxia and iscliemia, beginning within 15-30s
(Carmeliet, 1999; Gasser & Vaughan-Jones, 1990; HARRIS et al., 1954; Hirche et aï.,
1980; Weiss & Shine, 1982b; Weiss & Shine, 1982a; Weiss & Shine, 1986; Zeng et al.,
1995). During the first 10—15 min of myocardial ischemia, [K1]0 rises 4-5 fold from its
normoxic value (Hirche et aÏ., 1980) to a plateau level of 6—11 mM above its initial value.
During this plateau phase, [K1]0 remains almost constant for several minutes, and, in
some preparations, it may eventually decrease (Knopf et aÏ., 1990; Wilde et al., 1988).
Thereafier, a siower second increase of [K1]0 takes place simultaneously witli the arrest of
glycolytic activity and cdl death (Sakamoto et al., 1998; Sakamoto et aÏ., 1997). This
triphasic pattern is qualitatively similar in hearts of different species, but the time course
is influenced by heart rate (Weiss & $hine, 1982a; Weiss & Shine, 1986; Wilde et aï.,
1990; Wilde & Aksnes, 1995) and experimental conditions (Canneliet, 1999; Wilde &
Aksnes, 1995). APD-- or QT-1- is associated with these changes of [K1]0. It is well
known that [K1]0-t is related to profound modifications of the electrical behavior of
iscliemic cardiomyocytes. In particular, it contributes to depolarization of resting
membrane potential, APD--, decrease in the maximum upstroke velocity of AP, and
decrease in excitability. These electrophysiological alterations are pivotal in the genesis
of ischemic anhythmias and $CD. Noticeably, APD-’.L or QT- favors the reentrant
anhythmias and DADs, a reproducible pattem of dysrhythmic activities during acute
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myocardial ischemia (Wilde et aÏ., 1988). This typical pattem of ischemic electrical
disorders and arrhythmias are therefore tentatively refened as “short QT syndrome”
(“SQTS”).
Because of the importance of [Kj0-t along with “SQTS” during acute myocardial
ischemia, the mechanisms responsible for those disorders have been a subject of intensive
research. It is generally believed that ischemic electrical disorders are a consequence of
interrelated electrolyte disturbance and metabolic stress. In other words, ischemic [K]0-t
and “SQTS” are an event involving the interplay between ionic channels and metabolic
substrates. To aid in the comprehension of the mechanisms underlying those electrical
and metabolic disturbances, it is necessary to depict the ionic mechanisms and metabolic
regulation for ischemic [K]0-t and “SQTS”.
The temporal course of [K]0-t during myocardial ischemia typically occurs in
three phases. [Kj0-t or net cellular K loss begins within 15-30 seconds afier the
occlusion ofa coronary artery, then the increase reaches a plateau after 3-10 min and after
that is followed by a third siower increase starting between 15 and 30 min (Wilde &
Aksnes, 1995) (Figure 3).
As a matter of fact, the temporal course of the actual levels of {K]0 vary widely
among species, the models used, the rate of beating or pacing, and the activation of the
sympathetic nervous system. Plateau level of [K]0 is highest (20 mM) in the isolated
guinea pig heart (Kleber, 1983), 10-11 mM in the in situ pig (Firek & Weingart, 1995)
and the rabbit perfused septum (Weiss & Shine, 1982a), and 8-9 mM in the Langendorff
perfiised rat (Wu & Corr, 1992). The perfiised rabbit papillary muscle shows a broad
range of {Kj0 levels from 8 to 20 mM that depend on the diameter of the preparation. The
difference has been correlated to a much more pronounced acidosis in the center of thick
preparations (Cascio et al., 1992). Rate of stimulation is important between O and 60-90
min’, but not above this value (Harper, Ir. et al., 1993; Weiss & Shine, 1986). In the
absence of stimulation, [Kj0 accumulation starts with a delay and its rate of accumulation
is clearly less rapid; an outspoken plateau is not present. Stimulation of the sympathetic
nervous system on the other hand causes a faster rise in [K410 (Wilde et al., 1988).
During the plateau, [K]0 is constant or slowly changing in the positive or negative
direction (Firek & Weingart, 1995; Fleet et al., 1985). The preparationremains excitable
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Figure 3. Time-courses of [K]0, pH, [Ca2], and plasma LPC during ischemia. A: increase cf
[K]0 during ischemia in Langendorff-perfused quiescent and stimulated (4 Hz) rat hearts, measured with K
sensitive electrodes inserted in mid left myocardium. Note faster tise but lower plateau during stimulation;
effect on plateau has been interpreted as due to activation cf Na-K pump. [Modification from (Wilde &
Aksnes, 1995).] B: falI in intracellular pH f31P-NMR) during ischemia and fast recovery upon reperfusion in
perfused ferret hearts. [Modification from (Matban et at, 1990).1 C: changes in free [Ca2J (NMR with 5F-
BAPTA) in perfused ferret hearts during 20 min cf ischemia followed by reperfusion. Increase in [Ca2j is
delayed compared with changes in [K]0, or pH. [Modification from (Marban et aI., 1990).] D: changes in
coronary sinus concentration cf LPC in patients in response to atrial pacing. Results are shown for patients
with and without coronary heart disease as judged by a positive stress test. [Modification from (Sedis et al.,
1990).]
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or regains its excitability. When stimulation is ceased, [Kj0 falis, suggesting an active
Na-K pump (Weiss & Shine, 1986). It is also reported that catecholamines are
massively released from newe endings and celis (Schomig et al., 1987), glycolysis is
stimulated, and lactate production is increased during the plateau. The plateau level of
[K]0 is dependent on glycolytic activity (Wilde et al., 1988). When the heart is depleted
of glycogen during successive ischemia periods, lactate production (Gwilt et al., 1993)
and acidification (firek & Weingart, 1995) are less, and [K]0 rises faster.
In the late phase of acute ischemia (over 20-30 mm), [K]0 starts to rise again. This
phase is accompanied by inexcitability, an increase of longitudinal resistance, elevation of
the resting tension, and development of rigor contracture (Cascio et al., 1990;Weiss &
Shine, 1982b). Lactate production stops (Fiolet et al., 1984), and extracellular pH (pH0)
remains at a low level. The metabolic changes suggest that anaerobic glycolysis is blocked.
I-4-1-2 Effects of (K]0-t on Ion Channels and Carriers
The effect of the [K]0-t on channels is mainly indirect via the depolarization of
sarcolemma membrane it causes. The extent of depolarization during acute myocardial
• . . . .
. +ischemia 18 responsible for a partial or complete inactivation of the fast Na channel, the
T-type Ca2 channel, and It, and ‘Kur. Recovery from inactivation of these currents is
slowed and is accompanied by a decrease in excitability, prolongation of refractoriness,
and conduction siowing of the AP.
for the mai ority of K channels the conductance is increased when [K]0 rises; ‘KI
is the most sensitive one (Carmeliet, 1987), but the voltage-activatedcurrents such as J
(Scamps & Carmeliet, 1989) and I (Firek & Giles, 1995), as well as the ligand-gated K
channels such as the fatty acid and amphiphile activated K channels (Kpj, the KACh, the
KATp, and the KNa ail increase their conductance and carry more current at elevated [K]0.
In the case of ‘KI and Iy, the mechanism is less pronounced inward rectification,
consequent to a smaller block by intracellular cations (IKI) or smaller inactivation (Iy).
These changes again will stabilize the Em and reduce excitability. Worthwhile to mention
is the enhanced conductance of Iof which the Na-carrying capabiiity is increased (frace
et aÏ., 1992; Ho et al., 1993). Because this current is only activated at hyperpolarized
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levels, the functional implications of this change remain limited, except transiently during
reperfiision.
I-4-1-3 Effects of [KJ0-t on Electrophysiological Properties
At the multicellular level, the changes by [K]0-t will cause the celi to depolarize
and the AP to be reduced in amplitude, rate of rise, and duration. Inactivation of the Na
conductance, concomitant to the depolarization, is responsible for the fali in AP amplitude
and rate of rise and the decrease in excitability. Transiently, however, excitability may be
increased, the reason being that the depolarization, although causing inactivation of the
-[Na, at the same time moves the Em doser to threshold with a resultant reduction in the
current required to reach threshold(Dominguez & Fozzard, 1970). At depolarized levels,
the recovery from inactivation is siower; in the presence of increased [Kj0, the resuit is a
prolongation of the postrepolarization refractoriness (Janse & Wit, 1989). Conduction
velocity is depressed and slowed, especially during the relative refractory period (Kieber,
1987). APD--L is mainly due to an increase of the ‘KI and I conductance and to a lesser
extent to a decrease of Na conductance. The changes in excitability, refractoriness, and
conduction, together with the shortening of the APD, favor the occurrence of reentrant
arrhythmias.
I-4-2 Increase in Intracellular Ca2 Concentration ([Ca2J1-t)
2+I-4-2-1 Ca Distribution
Under normal conditions, concentrations of Ca2 differ in the cytosol, the SR, the
mitochondria, and the nucleus (Piper et al., 1993). Ca2 plays a different role in each
compartment, and modulates the activity of myofilaments in the cytosol and the activity
of ionic chaimels in the plasma membrane. The SR acts as a store for Ca2 and modulates
contraction and relaxation. In the mitochondria, the free [Ca2] regulates the activity of
three dehydrogenases (pynwate dehydrogenase, a-oxoglutarate dehydrogenase, and
NAD-dependent isocitrate dehydrogenase) and adapts in that way energy production to
energy utilization. In the nucleus, Ca2 modulates gene expression.
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During myocardial ischemia, diastolic free [Ca2j rises with some delay. The delay
is variable, and quite important differences in time course have been reported, depending
on the model. In studies of ischemia (friedman et al., 1973), the delay attained 10-20 min
and the rise in [Ca2]1 slightly preceded the development of contracture and uncoupling of
the gap junctions (figure 3) (Marban et al., 1990; Wagner et al., 1990). A much shorter
delay between 2 and 5 min lias been described in other studies (Kihara et al., 1989;
Mohabir et aï., 1991b). A large variation in time course also exists in experiments on
single ceils subjected to liypoxia or metabolic inhibition (Russ et al., 1996). The reasons
for these divergent results are not known but are probably related to the intensity of the
metabolic biockade.
I-4-2-2 Mechanisms underlying tCa2i-t
The [Ca2]-t during myocardial ischemia resuits from a less efficient removal
from the myocytes via the Na/Ca2 exchanger (NCX) and a. reduced Ca2 uptake in the
2+sarcoplasmic reticulum (SR), an increased inward Ca leak through the plasma
membrane, and dispiacement of Ca2 from binding sites in the cytoplasm and in
mitochondria by H (Carmeliet, 1999).
Tlie most important mechanism for removal of Ca2 from the cell is the NCX,
which is responsible for 77% of the Ca2 extrusion (Lamont & Eisner, 1996; Russ et aï.,
1996). During ischemia the NCX is less efficient because of [Naj-t and [H]-t. An
[Naj-t promotes the reversed mode of the NCX wliereby Ca2 is entering the cell and
Na is removed (Haigney et al., 1994; Smith & Allen, 1988; Tani & Neely, 1989). Ail
mechanisms responsible for an [Naj-t thus also contribute to the [Ca2j-t via the NCX.
The efficiency of the exclianger is furthermore reduced by acidosis (Doering & Lederer,
1993; Philipson et al., 1982) and the influence of radicals (Coetzee et al., 1994).
Coincident with metabolic inhibition occurring myocardial ischemia background
channels carrying Ca2 inward become more important as tliey are activated by radicals
(Jabr & Cole, 1995; Wang et aï., 1995c). Tnward leak of Ca2 also occurs via non-specific
cation channels that are activated by [ATP]0 (Friel & Bean, 1988; Hirano et al., 1991),
mechanical stretch (Craelius et al., 1988; Kim, 1993; Sasaki et al., 1992), and a rise in
[Ca2j itself(Colqulioun et al., 1981; Ehara et al., 1988; Matsuda, 1983).
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2+ 4’I-4-2-3 Effects of tCa J- I on Currents and Carriers
An [Ca2j-t modulates multiple currents in cardiac myocytes. IcaL per se is very
sensitive to [Ca2]-t and shows an increased rate of inactivatïon, limiting in this way the
Ca2 load of the ceil (McDonald et aï., 1994). In contrast, the current may also undergo
facilitation for moderate increases of the Ca2 level (Kass et aï., 1978). Some cunents
rely on {Ca2j for their activation, such as ‘NSC (Colquhoun et al., 1981; Ehara et al.,
1988), the Ca2 release channel (Canneli et al., 1995a; fabiato, 1985), and the NCX
(Miura & Kimura, 1989). An [Ca2j-t stimulates the NCX and counteracts the Nat
induced inactivation in this way (Matsuda, 1996). Other currents are modulated; an
increase is seen for the ‘Ca-T (Tseng & Boyden, 1991), Ij< (Nitta et al., 1994; Tohse et al.,
1987), ly (Scamps & Carmeliet, 1989), I (Hagiwara & Irisawa, 1989), theNa-K pump
(Gao et al., 1996). Two currents are inhibited: the ‘KI (Martynyuk et al., 1996; Mazzanti
& Defelice, 1990; Mazzanti & Difrancesco, 1989), a phenomenon comparable to the
block by [Mg2j, and the gap junction channel (De Mello, 1975; Noma & Tsuboi, 1987).
2+I-4-2-4 Electrophysiological Effects of [Ca J.
Enhancement of ‘L-Ca and ‘T-Ca inactivation induced by Ca2, increase of the
transient Ca2tactivated C1 current, and of the l and iY.s will lead to APD4, which jS
prominent at the early phase of acute myocardial ischemia. As the [Ca21i-t is more
pronounced in Ca2 overload, EAD as well as DAD are generated, and may resuit in
arrhythmias (Kihara et aL, 1989; Thandroyen et aï., 1991). One of the mechanisms
underlying EAD is reactivation OflLCa (Ming et al., 1994), but also release of Ca2 from
the SR (Priori & Corr, 1990), followed by activation of the “transient inward cunent” can
cause EAD. The transient inward current is a composite current and is carried through the
CE channel (Papp et al., 1995; Sipido et aï., 1995), the NSC channels (Canneil &
Lederer, 1986; Han & fenier, 1992), and the NCX (Han & Fenier, 1995; Laflamme &
Becker, 1996; Nattel, 2002). Besides cytoplasmic Ca2, the other factors such as ATP (Xu
et al., 1996), the phosphorylation state of the channel (Patel et al., 1995;Valdivia et al.,
1995), and luminal [Ca2j (Sitsapesan & Williams, 1994) are also involved in detennining
the efficiency of the release mechanism (Canneli et al., 1995b). Under conditions of
moderate Ca2 load, the release is linearly related to the luminal [Ca2j concentration and
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is not propagated. With increase of Ca2 load, however, release becomes regenerative and
propagated (Bassani et al., 1995; Han et al., 1994; Janczewski et al., 1995; Satoh et al.,
1997). Under these conditions, release may be spontaneous and occur in the absence of
trigger Ca2. The resuit is EAD during the A? or DAD, following repolarization.
Important to note is that Ca2 overload also increases the tendency of Purkinje fibers to
become spontaneously active; the activation curve of the I current is shified in the
positive direction (Hagiwara & Irisawa, 1989; Zaza et al., 1991), which favors activation
of the current and increases the rate of diastolic depolarization. The fali in gap junction
conductance by [Ca2]1 further enhances the probability for arrhythmias by reducing
conduction (De Meilo, 1975; Noma & Tsuboi, 1987).
I-5 Metabolic Disturbances during Myocardial Ischemia
In concert witli the ionic disturbances a variety of noxious metabolites accumulate
within the ischemic region, impinge on the sarcolemma, and interact with integral
membrane proteins including ion channels and exchangers, and thereby contribute to
electrophysiological derangements. Over the last decade a great mount of experimental
evidence has shed light on understanding of the substances involved, their sites of
synthesis and subcellular distribution, and the factors that modulate their accumulation, as
well as provided insight into the mechanisms by which they contribute to ischemic
arrhythmias. In this introduction, only radicals, LPC, Ceramide, and TNF-Œ are addressed.
This does not exciude the importance of other metabolites but rather supports the notion
that multiple factors interact to contribute to the marked heterogeneous
electrophysiological disturbances during myocardiai ischemia.
I-5-1 Phospholipid Metabolites and Ischemic Arrhythmias
I-5-1-1 Accumulation of Lysophosphatidylcholine during Myocardial Ischemia
The celi surface membrane or sarcolemma is primariiy composed of phosphoiipid,
cholesterol, and proteins which together form a complex dynamic structure which retains
the intracellular contents, regulates ion homeostasis, govems nutrient transport, and
transduces extracellular signais into the celis. The principal classes of sarcolemmal
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phospholipids are, according to their relative abundance, phosphatidylcholine,
phosphatidylethanolamine, sphingomyelin, phosphatidylinositol, and phosphatidylserine
(Table 2).
Table 2. Phospholipïd Composition of Myocardial Sarcolemma
Phospholipid Class Relative Composition (%)
Phosphatidylcholine (PC) 47
Phosphatidylethanolamine (PE) 28
Sphingomylin 11
Phosphatidylinositol (PI) 6
Phosphotidylserine (PS) 5
Lysophosphatidylethanolamine (LPE) 2
Lysophosphatidylcholine (LPC) J
[Adapted from (Corr et al., 1995) with modification]
The sarcolemmal phospholipids are composed of a charged polar headgroup region
and two non-polar covalently bound long-chain aliphatic hydrocarbon moieties. Under
the situation of myocardial iscliemia, the phospholipids (e.g. phosphatidylcholine) are
metabolized to generate lysophosphatidylcholines (LPCs). LPCs are amphiphile
possessing a charged headgroup like phospholipids but only a single aliphatic
hydrocarbon chain as a consequence of the hydrolytic cleavage of one of the two aliphatic
hydrocarbon groups of phosphatidylcholine (Choy et al., 1997; Hatch et al., 1989). The
major species of LPCs produced in ischemic myocardium is 1-palmitoyl-
lysophosphatidylcholine (LPC-16), which possesses 16 hydrocarbons in its aliphatic
chain. As an intennediate of metabolism of phosphatidylcholine, LPC- 16 is present in a
variety of mammalian tissues (Prokazova et al., 1998) and accumulates rapidly in the
heart during myocardial ischemia and in diabetic cardiomyopathy (Corr et al., 1995;
Kinnaird et aï., 198$; Maldno et al., 1987; Saffitz et al., 1984). The time course ofLPCs
release from ischemic human myocardium parallels the time course of early ischemic
ventricular anhythmia (Sedlis et al., 1997). Accumulation of LPC-16 is thought to be a
major contributor to the development of cardiac anhythnias during myocardial ischemia
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(Corr et al., 1987a; Corr et al., 1987b; Fazekas et al., 1992; Man, 1988; Saffitz et al.,
1984).
I-5-1-2 Effects of LPCs on Currents and Carriers and the Mechanisms
In guinea-pig ventricular myocytes, LPC-16 at concentrations over 10 jiM
ineversibly depressed the amplitude of ‘Na within 0.5-3 mm, retarded the time course of
activation and inactivation of INa(Bumashev et al., 1991; Sato et al., 1992; Shander et al.,
1996), and the reduction 0f ‘Na was followed by ceil contracture or ceil death (Sato et al.,
1992). It was further revealed that LPC modulates ‘Na in these ceils by a pathway that
involves both PKC-dependent and tyrosine kinase dependent phosphorylation (Watson &
Gold, 1997). In rat ventricular ceils, applying LPC (9-25 j.tM) to the inner side of the
membrane reduced peak ‘Na and prolonged the time course of ‘Na inactivation (Bumashev
et aÏ., 1991). It has been reported that the JLCa was reduced (Clarkson & ten Eick, 1983;
Wu & Con, 1992; Ziolo et al., 2001), or flot changed (Liu et aL, 1991), or increased
(Sediis et al., 1983; Ver et ai., 1992; Woodley et al., 1991). LPC (10-50 iM) causes a
concentration-dependent decrease in outward K conductance, providing one possible
explanation for the mechanism responsible for the decrease in resting membrane potential
(Clarkson & ten Eick, 1983; Kiyosue & Arita, 1986). It was also reported that exogenous
LPC induces a Ca21 permeable INSC in cardiac myocytes (Magishi et aÏ., 1996), the
mechamsm involved in a G/G0-coupled receptor and Rho-mediated pathway (Li et al.,
2002b). LPC-16 markedly reduces the single-channel conductance of IKI with no change
in P0 (Clarkson & ten Eick, 1983; Kiyosue & Arita, 1986; Sato et al., 1993).
In the whole the different mechanisms have been proposed to explain the effects of
LPCs on channels and carriers based on the experimental data and the chemical properties
of LPCs: (1) Relatively low concentrations (<5tM) of LPCs may interact directly with
the channel protein (Lamers et al., 1984). Because of their charge, they can affect the
permeation pathway or change the local concentrations of the substrate ion or other
important ions or by interfering with the charge of the phospholipids surrounding the
channels, thereby affecting the gating characteristics of channels (moue & Pappano,
1983). (2) High concentrations (>20j.tM) may incorporate in the myocardial sarcolemma
thereby affect membrane fluidity andJor disnipt the cytoskeleton. Incorporation of LPCs
in the membrane has been measured experimentally and results in a significant
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perturbation of the bilayer structure (Gniver & Pappano, 1993). Mechanicai
destabilization and dysfunction of membrane proteins can also be the resuit of disruption
of the cytoskeleton. Such destabilization has been shown to occur with LPCs (Undrovinas
et al., 1995). (3) By activating LPCs receptors anchoring in the ceil membrane, and then
modulating ion channel functions via a variety of intracellular signaling pathways, sucli
as PIP2, PKA, PKB (Thors et al., 2003), PKC, and tyrosine kinase mediated pathways.
I-5-1-3 Electrophysiological Effects of LPCs
APD-.L- by LPC-16 has been documented in rabbit atrial and ventricular ceils
(Fazekas et al., 1992), guinea pig ventricular celis (Liu et al., 1991), and canine
ventricular ceils (Saffitz et aÏ., 1984) and Purkinje fibers (Corr et aÏ., 1995). LPC-16
levels correlate with the occurrence of arrhythmias in ischemic and diabetic hearts (Corr
et aï., 1987b; Kinnaird et aï., 1988; Man, 1988). Intriguingly, the concentrations of LPC
16 required to elicit these effects are decreased three-foid by a reduction in pH to 6.7,
analogous to that in ischemic myocardium in vivo (Corr et al., 1981; Snyder et al., 1981).
Coincidentaliy, it was reported that LPC-16 decreases tissue K content by —15%, an
effect associated with graduai APD shortening and increased K efflux (Goidhaber et al.,
1998). Pretreatment with cromakalim to selectiveiy activate KATp channels shortened
APD and had no effect on net tissue K content during control aerobic perfusion.
However, cromakalim increased net K ioss during exposure to LPC- 16 (Con et al., 1981;
Goldhaber et aÏ., 1998; Snyder et aÏ., 1981). Thus inhibition of LPC-16 production and
accumulation may be a promising therapeutic strategy to attenuate the incidence of lethai
anhythmias associated with ischemic heart disease (Con et al., 1995; Con & Yamada,
1995; Giffin et aÏ., 1988; Man, 1988).
It has been suggested that increased iC efflux dunng myocardial hypoxia and
ischemia may resuit from extrusion of intracellularly generated anions such as lactate and
inorganic phosphate (Pi) as a mechanism of baiancing transsarcolemmai charge
movement (Gaspardone et al., 1986). Particularly, net cellular L-lactate efflux associated
with acceierated anaerobic glycolysis lias been implicated as a potential cause of the
marked ceilular K loss contributing to lethal cardiac anhythmias in ischemic heart.
However, the data against this notion also exist. In isolated arteriaiiy perfiised rabbit
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interventricular septa, selective inhibition of glycolysis caused a marked increase in K1
efflux despite a fali in lactate production and maintenance of normal cellular high-energy
phosphate content (Weiss et aL, 1989). In isolated rat hearts rendered globally ischemic,
no correlation between early lactate and K efflux rates was found (Kantor et al., 1990).
I-5-2 Sphingolipid Metabolites and Myocardial Ischemia
Although sphingolipid is an abundant component in myocardial sarcolemma, it is
only recently that the first evidence was provided in favor of a biomodulatory role of
some sorts of sphingolipid, in particular the sphingomyelin (SM) metabolites (Hannun &
Luberto, 2000; Spiegel & Merriil, Jr., 1996). A wealth of reports has now accumulated,
on a wide variety of celi types of different animal species, supporting an unquestionable
role of sphingolipid in regulating numerous ceil functions and possibly mediating the
effects of extraceilular stimuli (Alewijnse et al., 2004; Levade et al., 2001; Tabas, 2004;
Levade et al., 2001; Tabas, 2004; Alewijnse et al., 2004). Some studies have indicated
that the sphingolipid metabolites are involved in the reduction of myocardial contractility
during ischemia and reperfiision (Oral et al., 1997).
Upon various stimuli, cells metabolize SM from the cellular plasma membrane to
form sphingosylphosphorylcholine (SPC) or ceramide. The latter can be fiirther
metabolized to sphingosine and then sphingosine-1-phosphate (S1P). Ceramide can be
also generated from pamitoyl CoA and serine through de nova synthesis. Once generated
ceramide can serve as a key second messenger molecule that is capable of mediating
multiple physiological effects including regulation of cellular differentiation, proliferation,
and apoptosis by activating a variety of signaling cascades, including those triggered by
cytokines, growth factors, and stress (Kolesnick, 2002; Mathias et aÏ., 1998; Ohanian &
Ohanian, 2001). Ceramide generation can be triggered by diverse stimuli in a wide
variety of cell types during apoptosis induced by TNF-a, senim deprivation, ischemia or
hypoxia, and other insuits (Figure 4) (Kolesnick, 2002; Mathias et al., 1998; Ohanian &
Ohanian, 2001).
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Figure 4. Schematic of agonist induced generation of sphingosine after activation of
sphingomyelinases to cause sphingomyelin hydrolysis and ceramide production. [Adapted
from (Friedrichs et aI., 2002)].
I-5-2-1 Accumulation of Ceramide during Myocardial Ischemia
Unlike phospholipid metabolites such as LPC-16 that accumulates very rapidly
during the early phase myocardial ischemia, accumulation of ceramide is pronounced
progressively during myocardial ischemia. In anesthetized rats, 30 min of ischemia had
no apparent effect on ceramide concentrations in the myocardium, while 30 min of
ischemia followed by 3 h ofreperfusion resulted in a significant increase in ceramide by
4$ % (Zhang et al., 2001). Moreover, different ceramide may play different roles in the
process of ischemic injury as demonstrated that only ceramide containing palmitic, stearic,
oleic, linoleic, and arachidonic acid accumulate significantly in ischemic rat hearts
(Beresewicz et al., 2002). However, it has also been reported that the activation of neutral
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sphingomyelinase (NSMase) and accumulation of ceramide is one of the earliest
responses of cardiac myocytes to hypoxia and reoxygenation. Ceramide increased
abruptly after reoxygenation, peaking at 10 minutes with 225±40% of the control level.
NSMase activity was induced with similar kinetics, and both activities remained elevated
for several hours. c-Jun N-tenuinal kinase (JNK) was also activated within the same time
frame. Treatment of cardiac myocytes with extracellular ceramide also activated INK.
Pretreating ceils with antioxidants quenched sphingomyelinase activation, ceramide
accumulation, and JNK activation (Hemandez et al., 2000a).
I-5--2-2 Effects of Sphingolipid Metabolites on Currents and Carriers
Numerous studies have indicated that SM metabolites can alter intracellular ion
concentrations in the heart by regulating the activity of various ion channels in the
membranes of the sarcoplasmic reticulum andlor in the celi membrane. Sphingosine was
consistently found to reduce free [Ca2j in neonatal rat (McDonald et aÏ., 1994), adult rat
(Amadou et al., 2002; McDonald et al., 1994), guinea-pig (Sugishita et al., 1999b) and
feline cardiomyocytes (Oral et aÏ., 1997). It has been reported that ceramide and SYP can
increase free [Ca2] in cardiomyocytes from aduit (Liu & Kennedy, 2003;Relling et al.,
2003) and neonatal rats (Nakajima et al., 2000).
Sphingosine, SPC and S1P were reported to inhibit rat cardiac Na channels
(MacDoneÏl et aï., 199$; Yasui & Palade, 1996). Interestingly, the S1P effects on the
chaimel were flot PTX-sensitive (MacDonell et al., 1998). Sphingosine-induced decrease
in ‘Ca-L has been reported in cardiomyocytes from neonatal rats (McDonough et al., 1994),
adult rats (McDonough et al., 1994; Yasui & Palade, 1996) and cats (friedrichs et al.,
2002). A reduced L-type Ca2 channel activity was also reported in rat cardiomyocytes
for SPC (Yasui & Palade, 1996) and ceramide (Liu & Kennedy, 2003). In rabbit isolated
sinoatrial node cells, S 1P did flot affect the basal activity of L-type Ca2 channels but
reversed the effects of the t3-adrenergic agonist isoprenaline (Guo et al., 1999). More
recently, it was reported that sphingosine exerts direct inhibitory effects on the AP and
ICa-L in isolated feline myocytes (Friedrichs et al., 2002), consistent with previously
reported sphingosine activity 011 ‘Ca-L in isolated rat myocytes (McDonough et al., 1994;
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Yasui & Palade, 1996). Thus, it appears that ail SM metabolites exert some inhibitory
effect upon cardiac L-type Ca2 channeis.
+In the view of SM metabohtes on cardiac K channeis, it has been consistently
found that S1P activates ‘Ch in guinea-pig atriai myocytes (Bunemann et al., 1995;
Bunemann et al., 1996; Himmel et al., 2000; Liiiom et aï., 2001; van Koppen et al., 1996),
in freshly isoiated myocytes from mouse and human atrium (Himmel et al., 2000) and in
rabbit isolated sinoatrial node ceils (Guo et al., 1999). The SYP effects in the guinea-pig
atrium were inhibited by pre-treatment with PIX (Bunemann et al., 1995) or with
suramin (Himmel et aÏ., 2000). SPC was found to mimic the S1P effects in guinea-pig
atrial myocytes, and the two SMM caused cross-desensitization of each other (Bunemann
et al., 1996; Liliom et al., 2001). Since these studies observed no cross-desensitization
with acetylchoiine acting on muscarinic receptors, it was proposed that S 1P and SPC may
act on the same receptor. It was further proposed that S1P and SPC account for the
piasma-induced activation of I1cJ1ch in guinea-pig atrial myocytes (Liliom et aï., 2001). In
contrast to S 1P, SPC did flot activate Iicc in freshly isolated myocytes from mouse and
human atrium (Himmel et al., 2000). In rabbit isoiated sinoatriai node celis, S1P did flot
alter basal activity of the I channei but reversed the isoprenaline effects (Guo et al.,
1999). In rat ventricular myocardium, S1P did flot significantly affect the inward rectifier
K channel (MacDonell et al., 1998).
The roie of ceramide in modulating non-cardiac K channei function has also
recently been reveaied, inciuding inward rectifier K currents, voltage-gated shaker type
K channels, and the voltage-gated n-IC channels in lymphocyte (Gulbins et al., 1997;
Hida et al., 1998; Wu et aï., 2001; Zhang et al., 2002), indicating that ceramide may be
invoived in reguiating celi excitability and membrane potentiais. Too few data are
avaiiable to determine ceramide effects on cardiac ion homeostasis.
I-5-2-3 Cardiac Effects of Sphingolipid Metabolites
In cat myocytes, sphingosine markediy decreased APD and iowered the plateau of
AP. Afier administration of TNf-Œ, sphingomyelin, C2-ceramide, or sphingosine, oniy
C2-ceramide and sphingosine depressed cardiac flmction in normal rats (Friedrichs et aï.,
2002). NCX activity was studied in transfected Chinese hamster ovary (CHO) ceiis
expressing the wild-type cardiac NCXY .1 or mutants created by site-directed mutagenesis.
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The activity of the wild-type exchanger, but not exchanger mutants deficient in Ca2-
dependent activation, was inhibited by ceramide and sphingosine (Condrescu et al., 2002).
C2 ceramide (1 nM-1 iM) caused a concentration-dependent inhibition of ICa-L and
increased the rate of ‘CaL inactivation without altering its gating properties in aduit rat
ventricular myocytes (Schreur & Liu, 1997). An inactive ceramide analog failed to inhibit
‘Ca-L• At submaximal concentrations, effects of C2 ceramide and IL-1 beta Ofl ICa-L were
additive and saturable. In the presence ofa maximally effective concentration of IL-1 beta,
C2 ceramide had no further effect Ofl ‘Ca-L• These results suggest that ceramide mediates
IL-1 beta-induced suppression of cardiac ‘Ca-L.
Volume-sensitive chloride channels (ICI,voI) are known to play a key role in the
regulation of ceil volume, thereby apoptosis, by a mechanism called apoptotic volume
decrease (AVD). In aduit rabbit ventricular cardiomyocytes, exposure of cardiomyocytes
to 1 tM doxorubicin, a stimulus for generating ceramide, induced a rapid and significant
reduction in celi volume of cardiomyocytes (average of 15%), i.e. AVD as well as
increases in the early markers of apoptosis. The crucial role of ‘Cl,voj during AVD and
apoptosis was confirmed using C2-ceramide, demonstrating that activation of ICI,vol plays
a major role in the mechanism leading to celI shrinkage and apoptosis-induced AVD by
C2-ceramide (d’Anglemont et al., 2004). Using an aduit rat ventricular myocyte culture
2+ .model, it was found that Ca modulates Ceramide-rnduced cardiac myocyte apoptosis
through the coupling of B-type Ca2 channels in mitochondrial membrane (Henaff et aï.,
2002).
The effects of SM metabolites on cardiac rhythm have been investigated using
cultured cardiomyocytes, isolated sinoatrial node cells, isolated hearts and in vivo studies.
These studies support the notion that SM metabolites lower heart rate under most but not
all conditions. It was found that S1P increases SA rate in dogs (Sugiyama et aï., 2000b)
but reduces the basal rate and reverse the effects of the 3-adrenergic agonist isoprenaline
in rabbits (Guo et aï., 1999). Sphingosine reduced the beating rate ofneonatal rat isolated
cardiomyocytes (Benediktsdottir et al., 2002). SPC reduced the rate ofisolated guinea-pig
hearts (Liliom et al., 2001). The systemic administration of S1P reduced heart rate in rats
(Benediktsdottir et al., 2002; Sugiyama et aï., 2000a), but in some studies this effect was
seen only at high doses (Friedrichs et al., 2002) or flot at all (Bischoff et al., 2000;
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Bischoff et aÏ., 2001). Two recent studies in mice also described S1P-induced lowering of
heart rate (forrest et al., 2004; Sanna et al., 2004). Most interestingly, this effect was
aboiished in SIP3 receptor knockout mice (Sanna et al., 2004), and the ability of several
SYP receptor agonists to lower heart rate in wild-type mice correiated better with their
potency at S1P3 than at S1P1 receptors (Forrest et al., 2004). Taken together, it appears
that SM metabolites, particularly $1P, iower heart rate under most conditions, but these
effects may flot be of sufficient magnitude to be detectable in ail cases, particularly in
vivo.
The above signaling studies would also predict $M metabolites to cause negative
inotropic effects. This has been tested at the level of isolated cardiomyocytes, isolated
myocardial strips, isoiated hearts and in vivo. Sphingosine was shown to inhibit
contractions of isoiated cardiomyocytes from both cats (Oral et aÏ., 1997) and guinea-pigs
(Sugishita et al., 1999b). Sphingosine aiso mimicked the negative inotropic effects of
TNf-Œ in rat right ventricular trabecuiae, and this occurred by impairing the economy of
chemo-mechanical energy transduction (Hofhiann et al., 2003). In une with these in vitro
observations, sphingosine caused negative inotropy upon systemic administration in rats
in vivo (Sugiyama et al., 2000b). Moderate negative inotropic effects have also been
reported for S1P in isolated dog heart (Sugiyama et al., 2000b). Studies on inotropic
effects of ceramide are less consistent. Whiie it was found that ceramide increased
contraction of cardiomyocytes and hearts isolated from aduit rats (Liu & Kennedy, 2003;
Relling et al., 2003), another study detected negative inotropic effects of ceramide upon
iv. administration in rats (Friedrichs et al., 2002). Thus, the majority of studies support
the notion that 5M metabolites, particularly sphingosine, will reduce cardiac contractility.
The negative chronotropic and inotropic effects of 5M metabolites make them a
logical candidate to mediate impaired cardiac function under pathophysiological
conditions, particularly in the context of hypoxia and ischemia. Hypoxia and ischemia
lead to the formation and release of ceramide in neonatal rat cardiomyocytes (Bielawska
et al., 1997), and of sphingosine in adult rat isolated cardiomyocytes.(Cavalli et al., 2002),
in Langendorff-perfiised rabbit heart (Cavalli et aÏ., 2002) and in dog heart in vivo
(Thielmann et al., 2002). This is further supported by the detection of hypoxia-induced
activation of NSMase in cardiac myocytes (Hernandez et al., 2000b). HypoxiaJischemia
48
induced ceramide and sphingosine formation appear to primarily have negative effects on
cardiac function.
Taken together, these data demonstrate that ceramide and sphingosine are formed
during cardiac hypoxialischemia, contribute to the myocardial damage under these
conditions and mediate at least some of the adverse effects of TNF-a in this regard. In
contrast, conversion of ceramide and sphingosine to Si P will counteract these effects and
is cardioprotective. Therefore, it has been proposed that manipulation of the relative
balance between ceramide and sphingosine on the one hand and S 1P on the other hand
may be a possible target for the treatment ofmyocardial ischemia.
I-5-3 Cytoldnes and Myocardial Ischemiaflleart Failure
Cytoldnes, including tumor necrosis-a (TNf-a) (Aukrust et al., 1999; Nozaki et
aÏ., 1997; Pudil et al., 1999), interleukin 1-t3 (IL1-f3) (Aukrust et aÏ., 1999; Pudil et al.,
1999), and interleukin 6 (IL-6) (Aukrust et al., 1999; MacGowan et al., 1997; Pudil et al.,
1999; Roig et al., 1998; Tsutamoto et aÏ., 1998), have been shown to be released by the
cardiac myocyte immediately afier onset of ischemia (Edmunds & Woodward, 1998).
The plasma levels of these cytokines are also known to increase in patients with
myocardial ischemia and chronic heart failure (Aukrust et al., 1999; Deswal et aÏ., 2001;
Edmunds & Woodward, 1998; Kawamura et al., 2001; Torre-Amione et al., 1996;
Tsutamoto et al., 1998). Cytoldnes have been implicated in the syndrome of chronic heart
failure for over a decade (Adamopoulos et aÏ., 2001). A growing body of evidence
suggests that the inflammatory cascade triggered by the binding of TNf.-a to TNF-Œ
receptor I and II (p55TNFR, p75TNFR) are directly responsible for the acute deleterious
effects observed in the myocardium (Kapadia et aÏ., 1995; Oral et al., 1997), and are
deeply involved in the development of ventricular dysfiinction and ventricular remodeling
as well (Biyant et al., 1998a; Finkel et al., 1992; Kapadia et al., 1995; Oral et al., 1997;
Zhang et al., 2005).
I-5-3-1 Accumulation of TNF-Œ during Myocardial Ischemia/Heart Failure
In healthy hearts, the TNF-Œ concentration is veiy low (Aker et aÏ., 2003; Arras et
aÏ., 1996). In response to acute myocardial ischemiaJreperfusion, TNF-Œ is released from
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macrophages, monocytes, mast ceils, and cardiomyocytes per se within minutes (Aker et
aÏ., 2003; Arras et al., 1996; Bellisarii et al., 2001; frangogiannis et al., 1998; Schuiz et
aÏ., 2004). Subsequently, the myocardial TNf-Œ concentration increases within the area at
risk (Frangogiannis et al., 1998; Gurevitch et al., 1996; Irwin et al., 1999). With
prolongation of ischemia and deveiopment of cardiomyocyte necrosis, the TNF-Œ
concentration increases aiso in the surrounding viable portions of the myocardium (Dorge
et al., 2002; Ono et al., 1998; Thielmann et al., 2002).
In animais (Aker et aÏ., 2003; Marin-Garcia et al., 2001; Recchia et al., 2000) and
patients with severe heart failure (Aukrust et al., 1999; Ceconi et al., 199$; Levine et al.,
1990; Munger et aÏ., 1996; Testa et aÏ., 1996; Tone-Arnione et aÏ., 1996), the serum
TNf-a concentration is increased, and the increase is an independent predictor of
mortality in patients with advanced heart failure (Deswal et al., 2001; ferrari et al., 1995;
Rauchhaus et al., 2000). Whule increased myocardial TNF-Œ concentration secondary to
ischemia or infarction induces contractile dysfunction, this does flot necessarily imply that
myocardial dysfunction is aiways associated with an increased myocardial TNf-a
concentration. Indeed, in some experirnental (Recchia et al., 2000) and clinical (Munger
et al., 1996) studies, the TNf-a concentrations did not differ in paired arterial and
coronary sinus blood samples, suggesting that TNF-Œ is of peripheral origin. This
conclusion was further supported by results obtained in rabbits with pacing-induced heart
failure, in which the myocardial TNF-cx concentration remained unchanged, but the
increased serum TNf-Œ concentration closeiy correlated to the increased hepatic TNF-Œ
concentration (Aker et aÏ., 2003).
I-5-3-2 Effects of TNF-Œ on Cardiac Channels and Carriers
In the cultured mature ovine oligodendrocytes, brief exposure of TNF-alpha does
not elicit membrane depolarization or consistent changes in cytosolic Ca2 levels.
However, prolonged exposure leads to inhibition of process extension, membrane
depolarization and a decrease in the amplitudes of both inwardly rectifying and outward
K currents (Soliven & Szuchet, 1995).
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TNF-a inhibited cardiac ‘CaL and contractile Ca2 transients in adult rat ventricular
myocytes. Thus, it is possible that the negative inotropic effects of TNf-Œ are the resuit
of TNFRI-mediated blockade of cardiac excitation-contraction coupling (Krown et al.,
1995). In isolated guinea-pig ventricular myocytes, TNF-Œ (500 U/ml) decreased both
peak systolic [Ca2]1 and the amplitude of celi shortening without detectable reductions in
ICa-L within 5 min. TNf-Œ, however, clearly depressed ‘Ca-L and the amplitude of celi
shortening in 3-adrenergic stimulated celis, significantly increased the content of
sphingosine in isolated heart. The effects of low dose sphingosine (5 jiM) mimicked those
of TNF-Œ on cardiac myocytes, indicating TNF-Œ produced an acute negative inotropic
effect via a sphingomyelin-dependent pathway (Sugishita et al., 1999a). In H9c2
cardiomyocytes, TNf-a (10-50 ng/mL) depresses the depolarization effect of 80 mM KC1
on 45Ca uptake; this effect can be attributed to the negative inotropic effect of TNF-a that
reduces cardiac contractility and attenuates Ca2 influx and release by SR. In the same
study, TNF-Œ activates KATp channels, and this effect is blocked by glybenclamide (El
Ani & Zimlichman, 2003).
Overall the data on the modulation of cardiac channels and carriers by TNF-Œ is
sparse, however, it has been speculated that TNF-a does play an important part in the
modulation that is involved in a variety of pathophysiological situations in heart,
especially heart failure (Ceconi et al., 1998; Ferrari et al., 1995; Munger et al., 1996;
Rauchhaus et al., 2000; Testa et al., 1996; Wang et al., 2005).
I-5-3-3 Deleterlous Effects of TNF-Œ on Heart
A growth body of evidence from both animal and human studies have revealed that
TNF are elevated in patients with heart failure (Dutka et al., 1993; Levine et al., 1990;
McMunay et al., 1991; Torre-Amione et al., 1996). The overexpression of TNF may
contribute to disease progression in heart failure, via virtue of the direct toxic effects that
this cytokine exerts on the heart and the peripheral circulation (Packer, 1995;Seta et al.,
1996). In addition to the well-recognized deleterious effects of TNf, including lefi
ventricular dysfirnction (Bozkurt et al., 199$), left ventricular remodeling, cardiac
myocyte apoptosis (Bozkurt et al., 199$; Krown et al., 1996), and endothelial ceil
51
dysfunction (Agnoletti et al., 1999), there were also several intriguing unes of
experimental evidence that suggested that TNF might contribute to depressed rate heart
rate variability in patients with heart failure. For example TNF had been shown to alter 13-
adrenergic signaling in isolated ceil culture models (Chung et al., 1990; Gulick et aï.,
1989). Moreover, mice liarboring cardiac restricted overexpression of TNF were shown to
have blunted responsiveness to isoproterenol (Kubota et al., 1997). Moreover, TNF is an
independent predictor of depressed heart rate variability in patients with heart failure. The
overexpression of TNf and subsequent loss of beta-adrenergic responsiveness contributes
to the decrease in heart rate variability observed in heart failure (Malave et aÏ., 2003).
Using a rat heart ischemia-reperfiision model, it was demonstrated that FR167653,
a newly synthesized cytoldne inhibitor, significantly reduced ischemia-activated
myocardial TNf-a mRNA expression and TNf-a production and as well as inhibited p38
MAPK activation. Its administration improved recovery of cardiac contractile function
during reperfiision. This suggested that cytokine inhibition is significant as a method for
myocardial protection against ischemia-reperfusion injury (Aleshin et al., 2004; Hoshida
et al., 2000).
Very recently it lias been reported that isolated rat hearts from age-matched adult
males and females were perfused (Langendorf, and myocardial contractile function was
continuously recorded. After ischemialreperfiision (TIR), myocardium was assessed for
expression of TNF-Œ, IL-1f3, and IL-6 (RT-PCR, ELISA); IL-1Œ and IL-10 mRNA (RT
PCR); and activation of p38 MAPK (Western blot). Ail indexes of postischemic
myocardial function [lefi ventricular developed pressure, left ventricular end-diastolic
pressure, and maximal positive (+dP/dt) and negative (—dPldt) values of the first
derivative of pressure] were significantly improved in females compared with males.
Compared with males, females had decreased myocardial TNf-a, IL- 1 f3, and IL-6
(mRNA, protein) and decreased activation of p38 MAPK pathway. These data
demonstrate that hearts from age-matched adult females are relatively protected against
TIR injury, possibly due to a diminished inflamrnatory response (Wang et aÏ., 2005).
In sumrnary, a number of investigation have shown that TNf-cx mimics some
aspects of the so-called chronic myocardial ischemia and heart failure phenotypes,
including (but flot limited to) electronic and anatomie remodeling, progressive lefi
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ventricular dysfunction, pulmonaiy edema, fetal gene expression, and cardiomyopathy
(Diwan et al., 2004; Mann, 2002). The mechanisms underlying the deleterious effects of
TNF-Œ on cardiac functions have also been intensively exploited. To date a couple of
hypotheses have been proposed with some support from various experimental resuits. The
most conceivable mechanism is that the cardiac effects of TNF-Œ executive via the
excessive generation ofreactive oxygen species (ROS) (Giordano, 2005).
I-5-4 ROS and Myocardial Ischemia/Heart Failure
A great number of in vitro and in vivo studies have demonstrated the excessive
production ofROS in the cardiovascular system in response to various stressors and in the
failing heart (Cesselli et aÏ., 2001; Sabri et aÏ., 2003; Sawyer et aÏ., 2002; Suematsu et al.,
2003). furthermore, the results from animal studies have also revealed that antioxidants
and ROS defense pathways can ameliorate ROS-mediated cardiac abnormalities (Chen et
al., 1996; Conrad et al., 2004b; Ho et al., 1998; Yen et aÏ., 1996).
I-5-4-l Generation and Counterbalancing of ROS in Heart
Atoms or molecules with unpaired electrons are designated free radicals and are
highly reactive entities that can readily participate in a variety of chemical/biochemical
reactions. In the electron transport chain of oxidative phosphorylation, 4 electrons are
required to the full reduction of oxygen to water (H20) as a terminal event. The sequential
donation of electron to 02 during the process can generate ROS as intermediates, which
including free radicals, peroxides, and singlet oxygen, and “electron leakage” can also
contribute to the generation of ROS (Davies, 1995; Genova et al., 2003; Miwa & Brand,
2003). Donation of a single electron to 02 results in the formation of the superoxide
radical (02). Donation of a second electron yields peroxide, which then undergoes
protonation to produce hydrogen peroxide (H202). Donation of a third electron, such as
occurs in the Fenton reaction (Fe2 + H202 —> Fe3 + 0H + 0W), results in production of
the highly reactive hydroxyl radical (0H). finally, donation of a fourth electron yields
H20. Singlet oxygen (‘02), a very short-lived and reactive fonn of 02 in which the outer
electrons are raised to a higher energy state, can be formed by a variety of mechanisms,
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including the Haber-Weiss reaction (H202 + 02 —* 0H + 0W + ‘02) (Toufektsian et al.,
2001).
ROS can be formed at a very low concentration in the heart as a byproduct of
normal cellular aerobic metabolism (Davies, 1995; Ide et al., 1999). It has been revealed
that the several mechanisms responsible for ROS production; they can be produced by
xanthine oxidase (XO), NADPH oxidases, cytochrome P450; by autooxidation of
catecholamines; and by uncoupling of NO synthase (Griendiing et al., 2000; $awyer et al.,
2002; Seshiah et al., 2002; Xia et aÏ., 1998). The ROS generation in the heart can be
induced by the action of cytokines and growth factors as well. Angiotensin II (Alu),
PDGF, and TNF-a, for example, can induce H202 and O2 formation via activation ofthe
NADPH oxidase (Bendali et al., 2002; Heymes et al., 2003; Sabri et al., 2003; Sauer et
al., 2004; Seshiah et aÏ., 2002; Thannickal & Fanburg, 2000).
In normal heart, there are several cellular mechanisms that counterbalance the
production ofROS, including enzymatic and nonenzymatic pathways (Nordberg & Amer,
2001). Among the best-characterized enzymatic pathways are catalase and glutathione
peroxidase, which coordinate the catalysis of H202 to H20, and the superoxide dismutases
(SODs), which facilitate the formation ofH2O2 from O2 (de Haan et al., 2004; Kirkman
et al., 1999; Ursini et aL, 1995). Thioredoxin and thioredoxin reductase (TR) together
form an additional enzymatic antioxidant and redox regulatory system that has been
implicated in a wide variety of ROS-related processes (Nordberg & Amer, 2001).
Thioredoxin and TR can catalyze the regeneration of many antioxidant molecules,
including ubiquinone (Q 10), lipoic acid, and vitamin C, and as such constitute an
important antioxidant defense against ROS. Deletion ofTR resuits in developmental heart
abnormalities and in cardiac death secondary to a severe dilated cardiomyopathy (Conrad
et al., 2004a). Nonenzymatic mechanisms include intracellular antioxidants such as the
vitamins E, C, and f3-carotene, Q 10, lipoic acid, urate, and glutathione, which acts as a
reducing substrate for the enzymatic activity of glutathione peroxidase (Nordberg &
Amer, 2001).
During myocardial ischemia the generation of ROS is amplified (Carmeliet, 1999;
Kramer et al., 1994; Kukreja & Hess, 1992). It had been widely appreciated that ROS are
produced primarily with the reintroduction of oxygen following ischemia. However, there
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is much literature to support the notion that ROS can be abundantly generated during
myocardial ischemia per se (Becker, 2004; Hess & Manson, 1984; Kevin et aï., 2003;
Nohi & Jordan, 1986). With ischemia the respiratory cytochromes in mitochondria
become redox-reduced allowing them to directly transfer (i.e. “leak”) elecfrons to 02
(Becker et aï., 1999; Nohi & Jordan, 1986). A redox-reduced myocyte in the presence of
02 appears capable of producing large amounts of ROS, mostly superoxide anions (Hess
& Manson, 1984; Kevin et al., 2003; Nohl & Jordan, 1986). Intriguingly, it has been
found very recently that there is a positive feedback loop of “ROS-induced ROS release”
(Zorov et al., 2000). In isolated adult rat cardiomyocytes, “triggering” or “inducing” ROS
can be created via intracellular photoactivation of tetramethylrhodamine compounds.
These triggering ROS were associated with mitochondrial depolarization along with
mitochondrial permeability transition induction. Observed simultaneously with
mitochondrial permeability transition induction was a large burst of ROS from individual
mitochondria. These ischemia-generated ROS may contribute to a variety of direct
cellular oxidant damage and indirect detrimental roles via different signaling pathways
(Carmody & Cotter, 2001).
I-5-4-2 Effects of ROS on Channels and Transporters
The excessive amount of radicals leads to changes in proteins, lipids, and DNA
and RNA molecules (Bhatnagar, 1994). Sulfhydryl groups of proteins are oxidized and
disulfide bridges are formed, resulting in disturbances of the ion permeation or gating of
ionic channels, decrease of transport capacity of carrier molecules, and activation of
enzymes (Tan et al., 1995; Ward & Giles, 1997). Membrane lipids undergo peroxidation
and change indirectly the behavior of channels. These peroxyradicals oxidize proteins,
cholesterol, and other FA especially polyunsaturated FA, thus propagating the reaction in
a chain-type way (Kramer et al., 1994). General membrane damage secondary to ROS
mediated lipid peroxidation is one mechanism by which this can occur; however, more
specific ROS-mediated effects also contribute. The interplay of ROS with proteins and
lipids results in a variety of alterations in cardiac ion channels and transporters. Briefly,
‘Na, ‘Ca, ‘K except for ‘KATP as well as NCX and Na-K pump are inhibited by ROS.
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Information on the effect of free radicais on the Na channel is scarce. In the frog
ventricle, application of tert-butyihydroxyperoxide causes a graduai reduction in ‘Na with
a shift ofthe in the negative direction (Bhatnagar et al., 1990). In rat ventricular ceils,
the most prominent effect of H202 is a siowing of inactivation of the TTX-sensitive
current (Ward & Giles, 1997).
ROS can target L-type calcium channels on the sarcolemma and suppress the ‘CaL
(Guerra et al., 1996). Inhibition ofthe ‘CaL occurs in the guinea pig (Cerbai et al., 1991)
and is accompanied by a fail in Ca2 transient (Goidhaber & Liu, 1994). In the ferret, the
effect depends on the type of radicals; exposure to oxygen free radicals and S
nitrosothiols increases the current. Under the influence of H202, a Ca2tpermeable leak
channel is induced in cultured rat ventricular myocytes (Wang et al., 1995c). A
nonselective cation channel is activated in guinea pig ventricuiar myocytes afier
extraceliular or intracellular exposure of ROS (Jabr & Cole, 1995; Shattock et al., 1991;
Tan et al., 1994). Oxidative stress activates the SR Ca2 channel probably by disulfide
bound formation (Kawakami & Okabe, 1998; Shattock et aÏ., 1990). Binding of
ryanodine is decreased(Holmberg et aÏ., 1991). The Ca2-ATPase ofthe SR is blocked in
a sensitive way by oxidative stress, and ffie inhibition can be neutralized by dithiothreitol
(Eley et aï., 1991; Kukreja et al., 1991). ROS depress the activity ofthe sarcoplasmic
reticulum Ca2 ATPase SERCA2, a membrane calcium pump that has been shown to play
a crucial role in cardiac calcium handiing and as a determinant of myocardial contractility.
SERCA2 expression is concomitantly reduced in cardiomyocytes stimuiated to
hypertrophy via ROS-associated signaling pathways (Kaplan et al., 2003).
Most of ‘K with the exception of IICATp are inhibited by exposure to ROS. The ‘to in
rat atriai myocytes is decreased secondary to a shifi in the inactivation cuiwe to the lefi by
exposure to 1 mM tert-butylhydroperoxide (Pike et al., 1993). A decrease also occurs by
exposure to oxygen radicals for the delayed ‘K (Pike et aÏ., 1993; Tan et aÏ., 1995;
Valenzeno et al., 1993) and the ‘KI (Jabr & Cole, 1993; Nakaya et aÏ., 1992; Shattock et
al., 1991). In contrast to the well-documented decrease in delayed ‘K by exposure to
oxygen radicals, exposure to thimerosal, know to oxidize sulffiydryl groups into disulfide
bridges increases Ii in canine ventricular myocytes (Yao et al., 1997). The Icpjp appears
afier some delay upon exposure to oxidative stress (Jabr & Cole, 1993). Oxidation of
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sulfhydryl groups by thimerosal treatment indeed changes the ATP sensitivity of the
channel and causes faster activation during ischemia (Coetzee et al., 1995). $imilar
effects can be obtained by partial proteolysis in the presence of trypsin (Fan & Makielski,
1993).
Direct measurement of the of the Na/Ca2 exchange current in patch-clamp
experiments with controlled Ca2 and Na concentrations showed a decrease under
oxidative stress (Coetzee et aï., 1994; Goldhaber, 1996). In contrast, stimulatory effects
have been described in flux smdies in cardiac vesicles (Reeves et aÏ., 1986), in hearts
subjected to hypoxia-reoxygenation (Dixon et al., 1987), and in voltage-clamped guinea
pig ventricular myocytes treated with H202 (Goldhaber, 1996). In those cases, Ca2 and
Na concentrations were flot “clamped,” and stimulation may be due to indirect
concentration changes. The NatK pump cunent is reduced (Shattock & Matsuura, 1993).
The inhibition correlates with a decrease in specific ouabain binding and enzyme activity
(Kako et al., 1988; Kim&Akera, 1987).
1-5-4-3 Electrophysiological changes caused by ROS
There are two distinct stages in the development of symptoms in cardiac celis
exposed to ROS. During a first stage, upstroke velocity and conduction of the AP are
reduced; the plateau is prolonged, and EAD may appear on the slow phase of
repolarization (firek & Beresewicz, 1990; Hayashi et al., 1989; Ward & Giles, 1997).
Repolarization is followed by DAD (Firek & Beresewicz, 1990; Hayashi et al., 1989;
Kukreja et al., 1991). Eventually, the celi may depolarize and show continuous
oscillations at the plateau level. In a second stage, extra systoles or spontaneous activity is
stiil present, but the APD is gradually shortened (Beresewicz & Horackova, 1991). When
the APD becomes very short (Jabr & Cole, 1993), the diastolic potential shifis in the
hyperpolarized direction (Banington et aÏ., 1988), and the celi becomes inexcitable and
goes into ineversible contracture.
Although proanhythmic effects of oxygen radicals can be expected (Shattock et al.,
1991) from the occurrence of EAD and DAD and from the fali in upstroke velocity and
gap junction conductance, their role in ischemic anhythmias has been uncertain.
Arguments have been based on the use of antioxidants, but their effect seems to be
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species dependent. In the rat, an antioxygen radical treatment mostly provides protection
against arrhythmias (Bemier et al., 1989; Hagar et aÏ., 1991; Woodward & Zakaria, 1985),
whereas such protection is absent in the dog (Euler, 1995). Antioxygen radical treatment
may provide a better protection against delayed rather than early ventricular arrhythmias
(Coetzee et al., 1990).
I-6 Electrophysiological Mechanisms Underlyïng the Iscliemic Arrliythmias
It is generally appreciated that the occurrence of lethal arrhythmias in human is the
resuit of the interplay between substrate, trigger, and modulating factors (Coumel, 1987;
Nattel, 2002). Substrate factors may be considered to be the fiinctional changes brought
about by ischemia, creating the setting for functional reentry circuits within the ischemic
myocardium or the anatomical arrangement of surviving myocardial fibers within a
healed infarct, which provides an anatomically defined reentrant circuit. The basic
electrophysiological mechanisms underlying the genesis of cardiac arrhytbmias include
automaticity, triggered activity (EAU and DAD), and reentry (Carmeliet, 1999).
It has been well documented that the prominently electrophysiological changes in
cellular and multicellular level during myocardial ischemia are sarcolemmic membrane
depolarization, APD alterations (shortening accompanied with high frequent DAD during
the early phase of acute ischemia and lengthening going with intensified EAD in the
following period), ERP-t, decrease in conduction velocity, change in excitability, and
[Kj0-t (Carmeliet, 1999; Coronel et al., 1989; Coronel et al., 1991; Verkerk et al., 1996;
Watanabe et al., 1997). Furthermore, the basis of the electrophysiological changes relies
upon the interplay between the various ion channels, ion exchangers and the modulators,
which derive either from the electric disturbances such as [K]0-t or from the
accumulation of metabolic substrates like LPC and ROS during myocardial ischemia.
However, the exact mechanisms underlying ischemic arrhytbmias remain obscure. For
instance, in human, phase I arrhythmias during acute ischemia ofien resuits in VF and
SCD. Reentiy and DADs have been proposed as the major mechanisms responsible for
the phase I arrhythmias in ischemic myocardium (Carmeliet, 1999; Pogwizd et aÏ., 1986;
Pogwizd & Corr, 1987). However, the notion has been challenged with the new
experimental evidence upon which EAD and wavebreak leading to wavelet formation
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might be the hallmark in the mechanism of initiation and maintenance of VF (Cao et al.,
1999; Zaitsev et aÏ., 2003). Noticeably, APD4 or QT-.I- favors the reentrant anhythmias
and DADs, a reproducible pattem of dysrhythmic activities during acute myocardial
ischemia (Wilde et al., 1988). In contrast to acute myocardial ischemia in which APD-.L
or QT- is the fundamental electric disturbance responsible for cardiac arrhythmias, in
chronic ischemia the prominent electric disturbance is ffie iengthening of APD (APD-t)
or QT-t, though both acute and chronic myocardial ischemia manifest some
electrophysiological disturbances in common. In this review I only address two themes,
one is about the mechanisms for [K4]0-t and APD-.I- during the acute myocardial
ischemia, the other is the mechanisms underlying the chronic ischemic arrhythmias.
I-6-l Electrophysiologicai Mechanisms for ischemic IKJ0-t and APD-.T
Because of the importance of [K]0-t along with APD4 during the early phase of
acute myocardiai ischemia, the mechanisms responsible for it have been a subject of
intensive research. It is generally believed that [Kj0-t and APD-’.I- are of multifactoriai
nature with 3 major determinants (Canneliet, 1999; Wilde et al., 1988): increased passive
+ . +.K efflux, reduced active K influx, and diminished extracellular space. Increased
passive K efflux is a prerequisite for ischemic [K]—L or [K]0-t and APD4.
Experimentai studies support the hypothesis that K efflux increases rapidiy during acute
myocardial ischemia; this increase is most likely due to a net increase in the conductance
of K channeis. Reduced active K4 influx is a warranty for ischemic [K’10-t. This is
achieved by reduction of the NatK4 pump activity. Ischemic conditions make a moderate
inhibition of the pump plausible: metabolic stresses have been found to reduce pump
activity (Carmeliet, 1999; Kieber, 1983; Shattock & Matsuura, 1993; Shen & Pappano,
1995). Owing to the remarkable capacity of the pump (150 pA or 3 X i0’ moi/sec), smali
reduction of the activity can render dramatic changes of [K4]0. The normal reversai
potentiai (Erev) of the pump is -180 mV. It may however drop to —60 mV which is about
the membrane potential of the ceiis during the plateau of [K4]0-t in ischemic myocardium.
The pump, in other words, wiil stop operating at the potential expected under ischemic
conditions (Carmeliet, 1999; Glitsch & Tappe, 1995). Dimiuished extracellular space
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+ 4’• . +produces a concentrating effect on [K ]- I induced ;ncreased passive K efflux and
+.
reduced active K influx. Shift of water from extracellular to the rntracellular space
occurs as a consequence of increase in osmotically active particles in the celi, such as
lactate and phosphate. It is estimated that the increase in osmotically active particles can
resuits in a restriction of the extracellular space by 15% after 10 min of ischemia
(Carmeliet, 1999; Fiolet et al., 1993; Yan et al., 1996).
Apparently, increased passive K efflux acts as an initiation mechanism for [Kj0-
t and APD—I-, decreased active K influx as a maintenance mechanism for [Kj0-t, and
shrinkage of extracellular space as an amplification mechanism for [K]0-t. However,
despite the key importance of increased passive K efflux, the ionic mechanisms are stili
+
uncertam and our understanding of pathways along winch K leaves the cells have been
controversial for nearly two decades.
Cardiac K channels play a pivotal role in defining resting potential, celi
excitability and membrane repolarization and thereby the iikelihood of arrhythniias. In
view of ail verified cardiac K currents, some of them have been reported to be
downregulated in their function and expression during acute ischemia; such as I and IKJ
(Boyden & Jeck, 1995; Carmeliet, 1999; Pinto & Boyden, 199$). These channels as
carriers of ischemic K efflux can be excluded. KATp as a candidate for ischemic [Kj0-t
has been extensively studied; yet the results are inconsistent. While either ‘cj or Iyjp. has
the potentiai to be a contributor to ischemic [K70-t, the existing studies are sparse and do
not allow us to reach a definite conclusion. The possible role of Iy or Iy has yet to be
investigated.
Since KATp is gated by intracellular ATP and regulated by a variety of cellular
metabolites, KATp channel is considered to be a sensor of the metabolic state of a
myocardial ceil, and activation of these channels to be an indicator of cellular metabolic
compromise (Ashcroft & Ashcrofi, 1990; Findlay, 1994). However, KATp channels do flot
open unless intracellular ATP ievel ([ATP]1) drops down to less than 100 jM; the 1C50 for
KATp inhibition is <100 jM. This implies that KATp channels nonnally stay in the closed
state because the physiological [ATP] is in the order of milliemolar range (5 mM). This
is perhaps why the existing data regarding the role of KATp in ischemic [Kj0-t have been
conflicting. Evidence exists that KATp channels mediate the ischemic K efflux and APD
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- and most of the evidence is from studies using Krp inhibitors or openers; KATp
inhibitors such as glybenclamide have been found to effectively reverse ischemialhypoxia
APD-..I- and the rate of [IC]0-t (Gwilt et aï., 1992; Gwilt et al., 1993; Kantor et aÏ., 1990;
Wilde et al., 1989; Wilde et al., 1990; Yan et al., 1993). In addition, Glybenclamide also
exhibited potent antifibrillatory activity, abolishing irreversible ventricular fibrillation
during regional ischemia and during global ischemia. However, there are also
expenmental fmdings against KATP channels as mediators of [Kj0-t and APD-.i (Allen
& Orchard, 1987; Mitani et al., 1991; Shivkumar et al., 1997; Vanheel & de Hemptinne,
1992; Venkatesh et al., 1992; Wilde & Aksnes, 1995). first, the measured [ATP] at the
time of metabolic blockade of acute ischernia is still in the millimolar range which is
much too high to induce massive KATp (Nichols & Lederer, 1990; Noma, 1983). Second,
the time-course of opening of KATp channels is too slow to explain the start of [K]0-t
within the first minute of ischemia. Third, the results from KATp openers and inhibitors
have been conflicting; Early ischemic [K]0-t and surface acidification are relatively
insensitive to KATP channel inhibition or activation prior to the ischemic insult (Vanheel
& de Hemptinne, 1992) and KTp opener pinacidil (Kanda et aÏ., 1997). And finally, some
blockers of voltage-gated K channels are effective in preventing and reversing ischemic
[Kj0-t and APD%.; these include diltiazem (Sakamoto et aÏ., 1997). The role of KATp
channel in response to myocardial ischemia, therefore, has been questioned. Very recently,
using Kir6.2 knockout (KO) hearts provides evidence that the activation of KA-rp channels
contributes to the shortening of APD, whereas it is flot the primary cause of [K-j0-t
during early myocardial ischemia (Saito et al., 2005). Thus, it is conceivable that other
mechanisms or more specifically other K currents, in addition to KATp, may also
contribute to [Kj0-t and APD-L in ischemic myocardium.
‘U’a and are another two candidate channels for ischemic [Kj0t. ‘IU’4a 5
activated by a rise of intracellular Na (Kameyama et al., 1984; Luk & Carmeliet, 1990),
a characteristic alteration accompanying [K10-t in ischemic myocardium. With respect
to the potential role of Iioa in ischemic [K]0-t, the problem is similar to that of KATp,
being whether [Na]1 can reach sufficiently high levels needed to activate the channel.
Nonetheless, evidence exists that [Na] close to the membrane can be much higher than
in the bulk; gradient and local accumulation are present (Wendt-Gallitelli et al., 1993).
61
is an ATP-insensitive K channel with an outwardly rectifying property, with a
conductance slightly larger than KATp, and its open probability is enhanced in acidosis
and by stretch, two conditions present during ischemia. Since the level of free fatty acids
rises after longer periods of ischemia, it was proposed that Iyp. contributes to the late or
secondary phase of [K]0-t (Kim & Duff, 1990). Thus, either of the two currents has the
potential to be a contributor to ischemic [Ki0-t and APD--. However, it should be noted
that the two durrents remained insufficiently characterized and their function poorly
understood due to the fact that studies on these currents have been sparse.
I-6-2 Electrophysiological Mechanisms for the Arrhythmias during Chronic
Myocardial Ischemia
The chronic ventricular arrhythmias (CVA) that occur in human with IHD have
been studied extensively by clinical electrophysiologists. Patients who survive afier the
acute phases of MI may experience a variety of CVA, ranging from single premature
depolarization to tachycardia and fibrillation. The CVA significantly increases the
mortality in the first year after MI, the greatest risk being within the first 2 month afier
hospital discharge (Moss et aÏ., 1977). The risk is greater when the premature ventricular
depolarization is frequent or complex (multiform QRS morphologies) (Bigger, Jr. et aï.,
1982; Janse, 2004; Moss et al., 1977; Rubennan et aÏ., 1977). Aside from the premature
ventricular depolarization, other factors, including the situations of increased activity of
the sympathetic nervous system, electrolyte disturbances, such as low serum potassium
levels, and metabolic disorders, such as accumulation of cytoldnes and ROS, as well as
impaired left ventricular flrnction due to molecular, electrical and anatomic remodeling,
may all modify both the substrate and the trigger (Marban, 2002; Nattel, 2002).
The electrophysiological remodeling during chronic myocardial ischemia has been
revealed to manifest as extremely APD-t and ERP-t in the cellular level and QT-t as
reflected in ECG, and which provide the substrates for reentry and EAD-dependent
triggered activity, being proposed mechanisms underlying the CVA. It is well established
that APD is determined by the balance between plateau inward and outward currents. The
APD-t can result from either increase in plateau inward cunents, mainly ‘Ca-L, or
decrease in repolarizing currents, which orchestrate by ‘KI, ‘to, Iy and Iy. Moreover, with
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the APD-t the normal smooth trajectory of repoiarization might then be intemipted by
EAD (Marban et al., 1986; Marban, 2002; Nattel, 2002). The EAD may induce an AP and
produce ectopic firing, and then propagate between different zones of ventricles, which
suffer from the chronic ischemia. Along with ERP-t and myocardial fibrosis, the
abnormal impulse will cause re-entry in the forms of single-circuit or multiple-circuit.
The multiple unstable re-entry circuits can coexist simultaneously; render the ischemic
ventricle to the situation of tachycardia and fibrillation. A factor predisposing to reentry is
the increased dispersion in APD and refractoriness, as has been reported in several studies
(Pak et al., 1997; Yan et al., 2001). The majority of ventricular arrhythmias, however, are
substrate-related reentry tachycardia, most commonly based on an infarct scar
(Brunckhorst & Delacretaz, 2004).
Like in the acute myocardial ischemia whiie [Ca2]1 is increased, mainly due to a
less efficient removal from the ceil via the NCX and a reduced Ca2 uptake in the SR
(Carmeliet, 1999; Trafford et al., 199$), whereas in the chronic myocardial ischemia Ca2
efflux is reduced, Ca2 influx is increased because of metabolic inhibition. The Ca2
influx is mediated prominentiy via background channeis and NSC channels that are
activated by ROS (Jabr & Cole, 1995; Wang et al., 1995e). This Ca2 influx may
contribute APD-t. However, some experimental data have flot favored the notion. It was
reported that peak ICa-L density of epicardiai border zone cells from the 5-day infarcted
heart is significantly reduced by 36% compared to control (Aggarwal & Boyden, 1995).
Furthermore, this reduction is flot due to a decrease in steady-state availability or a
prolonged time course of recovery of ‘CaL. Myocytes adjacent to the $-week infarct in
the rabbit heart show a significant decrease in peak ‘CaL density without a change in
current—voltage relations, voltage-dependence or steady-state inactivation kinetics (Litwin
& Bridge, 1997). So, the role 0f ‘CaL in APD-t is still a matter ofdebate.
In contrast to ‘CaL, the experimentai data have consistentiy supported the notion
that the downregulation of potassium currents, ineluding ‘ici, ‘to, J and Iy is the possible
electrophysiological mechanism underiying the APD-t in the chronie myocardial
ischemia. APs recorded from the epicardiai zone eells of infarcted heart usually show no
phase 1 or reduced phase 1 of repolarization suggesting a loss in 1c In contrast and as
predicted, APs recorded from ail ceiis dispersed from the normai noninfarcted epicardium
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show a large and prominent spike and dome morphology. Voltage ciamp studies confirm
that the It flmctions profoundly in the ceils (Lue & Boyden, 1992). Similarly, densities of
Ijc and Iic are reduced significantly in ceils dispersed from the epicardiai border zone of
the 5-day canine infarcted heart (Pinto & Boyden, 1998; Pinto & Boyden, 1999).
It is obvious that the chronic myocardiai ischemia does resuit in the electrical
remodeling with the characteristics of decreased potassium channel fiinction, particularly
reduction of ‘to, Iy and ‘Ks. The possible moiecular mechanisms underiying the deduction
can be the resuit of an acquired (versus genetic) change in structure and function of
normally expressed channeis, a change in the number of functional channeis, or a
combination of both. From a molecular standpoint, a change in the number of functional
channeis could be due to changes in the levels of expressed protein or to alterations in
channel protein trafficking.
A change in expression of functionai channel proteins is most likely due to a
change in gene transcription, translation or post transiational modification. Transcription,
the initial step in protein expression, invoives the production of an mRNA copy from a
DNA template. It was reported that both the suppressed transcription and function of the
native delayed rectifying K currents in myocytes surviving in the infarcted heart. In
particular, by 4$ h post MI, mRNAs for dKvLQT1, dJK and dERG are ail reduced. By
day 5, dKvLQT1 transcripts have recovered, but dIK and dERG remain reduced. These
findings are consistent with loss in function of Iy and Iy in the 5-day border zone
myocytes (Pinto & Boyden, 1999). More interestingiy, in the setting of chronic
myocardial ischemia, several autocrine/paracrine factors are activated and may also
become important regulators of ion channei function. For instance, the elevated
concentrations of TNF-Œ, ceramide, and ROS are ciosely associated with chronic
• . .
. 1-ischemic heart. It was revealed very recently that the inward rectifier K currents and
voitage-gated shaker type of K current are moduiated by ceramide (Koiesnick, 2002;
Ohanian & Ohanian, 2001); HERG currents can be downreguiated by TNF-Œ.
Furthermore the downregulation is mediated via ROS (Wang et aï., 2004a; Zhang et al.,
2003a). However, the published data are too preliminary to shed light on the moiecuiar
mechanisms underiying the ischemic anhythmias. Too many questions remain to be
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addressed and too many aims should be targeted to fight the IHD, the first killer of
humans.
I-7 Questions Raised from Above Review
A tremendous progress has been achieved over the last two decades regarding the
electrical and molecular basis of myocardial ischemic arrhythmias. New insight into the
basic mechanisms may allow for improved therapeutic approaches in the near future. An
improved understanding of the processes leading to the development of the VF substrate
may guide to better strategies for prevention ofischemic arrhythmias. Nevertheless, many
aspects remain unexplained and the myocardial ischemic anhythmias remain a significant
challenge.
More specifically, in the early phase of acute myocardial ischemia, what are the
ionic mechanisms responsible for [K]-t and APD-1-? Among the cardiac potassium
currents, either voltage-gated ones such as Iy and Ig or ligand-gated ones like Icp or
Icp, which is the dominant contributor governing the repolarization of AP thereby
likelihood of cardiac arrhythmias? How is I}Cj, a critical component of repolarizing
currents, modulated in the media of acute ischemia? Is it reasonable to implicate the
HERG enhancement by LPC- 16, the evidence in our previous study, in the situation of
acute ischemia? Furthermore, what are the molecular mechanisms underlying HERG/I
modulation by lysophospholipid metabolites?
With regard to the chronic myocardial ischemia, what are the molecular signals
leading from myocardial ischemia and infarction to metabolic, ionic, electrical, and
anatomic remodeling? What are the characteristics of the remodeling? Do the
sphingolipid metabolite ceramide and TNF-ct that are excessively generated after chronic
ischemia contribute to the late APD prolongation in ischemic myocardium? If so what is
the molecular mechanisms underlying the contribution? Moreover, what are the inter
relationships among metabolic, electrical, and molecular mechanisms?
I-8 Working Hypothesis
1) [K]0-t and APD-1- during the early phase of myocardial ischemia are an event
consequent to combined metabolic stress and ion channel dysfunction.
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CHAPTER II
Modulate of 1HERG/IKI by Phospholipid Metabolites
Contributes to the Arrhythmogenesis during the Early
Phase of Acute Myocardial Iscliemia
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There are three articles in this chapter. In the first article we described our finding
that apart from being a well-recognized target for dmg inhibition, IHERG can also be
enhanced by the natural metabolite lysophosphatidylcholine, which profoundly
accumulates during the early phase of myocardial ischemia. Furthermore, the mechanism
of enhancement involved a substantial positive shift in ‘HERG inactivation voltage
dependence. This finding, to our knowledge, is the first time that a shifi in IHERG
inactivation voltage-dependence has been shown to underlie a potentially significant
endogenous pathophysiological mechanism. In addition to the potential intrinsic
significance of this observation, it may open up new possibilities in exploring the
regulation of HERG properties by membrane lipids.
Following the finding we carried out a series of detailed experiments to investigate
the potential mechanisms for the enhancement of HERG K channel fiinction by
pliospholipid metabolites. Our resuits demonstrate that the enhancement of HERG
function by lysophospholipids is specific to the lipids with 1 6-hydrocarbon chain structure
(LPC-16 and LPG-16) and the pattem of voltage dependence is determined by the polar
headgroups. The increase in IHERG is best described by direct interactions between lipid
molecules and HERG proteins, which are consistent with lack of effects via membrane
destabilization or modulation by intracellular signaling pathways. These results will be
presented in the second article of this chapter.
In the third article we combine in vivo and in vitro electrophysiological and
biochemical approaches to verify that LPC-16 accumulationlHERG enhancement may be
the Iink between metabolic trigger and ionic pathway for ischemic [Ki0-t and QT4.
This represents the first documentation of IcjHERG as the ionic mechanism in ischemic
[K]0-t and QT-I-. Inhibition of LPC-16 production and accumulation andlor of
IcjHERG may be a promising therapeutic strategy to attenuate the incidence of lethal
arrhythmias associated wiffi ischemic heart disease.
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II-1 Pliospliolipid Metabolïte 1-Palmitoyl-
Lysophosphatidylcholine Enliances Human Ether-a-Go-Go
Related Gene (HERG) K Channel Function
This paper was published in Circulation, 2001; 104: 2645-2648.
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II-1-1 ABSTRACT
Background Lysophosphatidylcholine (LPC), a naturally occurring phospholipid
metabolite, accumulates in the ischemic heart and causes extracellular K accumulation
and action potential shortening. LPC has been incriminated as a biochemical trigger of
lethal cardiac arrhythmias, but the underlying mechanisms remain poorly understood.
Methods and Resuits We studied the effect of 1-palmitoyl-LPC (PaI-LPC) on currents
resulting from human ether-a-go-go-related gene (HERG) expression in human
embryonic kidney (HEK) ceils using wliole-celJ patcli-clamp techniques. Bath application
of Pal-LPC consistently and reversibly increased HERG current (IHERG). The effects of
Pal-LPC were apparent as early as 3 minutes afier application of the drug, reached
maximum within 10 minutes, and were reversible on washout. Pal-LPC increased IHERG at
voltages between -20 and +30 mV, with greater effects at stronger depolarization.
However, Pal-LPC did not affect the voltage-dependence of ‘HERG activation. In contrast,
Pal-LPC significantly shifted the inactivation curve toward more positive potentials,
causing a mean 20.0±2.2 mV shifi in half-inactivation voltage relative to control.
Conclusions Our resuits indicate that apart from being a well-recognized target for drug
inhibition, ‘HERO can also be enhanced by natural substances. An increase in IHERG by Pal
LPC may contribute to K loss, abnormal electrophysiology, and anhythmia occurrence in
the ischemic heart.
Key Words: lysophosphatidylcholines • ion channels • patch-clamp techniques
II-1-2 INTRODUCTION
Lysophosphatidylcholine (LPC) is a naturally occurring intracellularphospholipid
metabolite that is present in a variety ofmammaliantissues.1 LPC accumulates rapidly in
the heart during cardiac ischemia and in diabetic cardiomyopathy.2 It lias been
incriminated as a biochemical trigger of lethal cardiac arrhythmias,38 and it promotes
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abnormai rhythmic activity, deiayed afterdepolarizations, triggered activity, and
intramyocardial reentry. Action potential duration (APD) shortening by LPC has been
documented in rabbit atrial and ventricular cells,4 guinea pig ventricular cells,5 and canine
ventricular cells6 and Purkinje fibers.3 LPC leveis correlate with the occurrence of
arrhythmias in ischemic and diabetic hearts.79
Inhibitoiy effects on sodium current1° and inwardiy rectiiring K current (Ii)
expiain the conduction siowing and membrane depolarization produced by LPC, but the
mechanisms underlying APD shortening remain incompieteiy understood. Reduced lici
should, if anything, increase APD. A recent study by Goldhaber et al12 reported that LPC
(20 pmol/L) decreases tissue iC contentby —15%, an effect associated with graduai APD
+ . . . +
shortemng and mcreased K efflux. During acute myocardial ischem;a, increased K
efflux in the face of maintained Na/K pumping resuits in extraceilular K1 accumulation,
a key anhythmogenic factor. Aithougli increased K efflux can account for some of the
important arrhythmogenic effects of LPC, how LPC increases K efflux is essentially
unknown. Increased K conductance couid account for APD abbreviation and couid
contribute to increased K efflux; however, LPC is flot known to increase cardiac K
currents.
The human ether-a-go-go-related gene (HERG) encodes the rapid deiayed rectifier
current (Jic))3 a criticaiiy important cardiac repolarizing current in most animais,
inciuding humans.’4 Apart from being a moiecular target for mutations that generate long
QI syndrome, HERG is also a prime pharmacological target for a wide range of dmgs
that block the HERG current (IHERG) exclusively; this blockade either confers
antianhytbmic efficacy or produces proanhythmic cardiotoxicity.’5 The present studywas
designed to investigate whether LPC can moduiate ‘HIRG and, if so, to characterize the
biophysical components ofthis action.
II-1-3 METHODS
II-1-3-l Ccli Culture
HEK293 celis stably expressing HERG (a kind gift from Drs Zhou and January,
University of Wisconsin, Madison16) were seeded in a 25-cm2, trianguiar, ceil-cuiture
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flasks and grown in Dulbecco’s modified eagle’s medium supplemented with 10% heat
inactivated fetal bovine serum, 200-jimollL G418, 100 U/mL penicillin, and 100 jig/rnL
streptomycin. The ceils subcultured to —85% confluency were harvested by trypsinization
and stored in Tyrode solution containing 0.5% BSA at 4°C. Electrophysiological
recordings were conducted within 10 hours of storage.
II-1-3-2 Whole-Cell Patch-Clamp Recording
Patch-clamp techniques have been described in detail elsewhere.’4 Currents were
recorded by whole-cell voltage-clamp with an Axopatch-200B amplifier (Axon
Instruments). Borosilicate glass electrodes had tip resistances of 1 to 3 Mf when fihled
with (in mmol/L): GTP 0.1, potassium aspartate 110, KC1 20, MgC12 1, Mg-ATP 5,
HEPES 10, and phosphocreatine 5 (pH 7.2). The extracellular solution contained (in
mmol/L): NaC1 136, KC1 5.4, MgCl2 1, HEPES 5, glucose 10, and CaC12 1 (pH 7.4).
Experiments were conducted at 36±1°C. Junction potentials were zeroed before formation
of the membrane-pipette seal. Series resistance and capacitance were compensated, and
leak currents were subtracted. 1-Palmitoyl-LPC (Pal-LPC; Sigma) was dissolved directly
into the bath solution at the desired concentrations immediately before each experiment.
1 -Palmitoyl-lysophosphatidylglycerol (Avanti Polar Lipid) and membrane-permeable
ceramide (Sigma) were used for negative controls.
II-1-3-3 Data Analysis
Group data are expressed as mean±SEM. Comparisons among groups were made
by ANOVA (F test), Bonferroni-adjusted t tests were used for multiple group
comparisons, and paired t tests were used for single comparisons. A 2-tailed F<0.05
indicated statistically-significant difference. Nonlinear least-square curve-fitting was
performed with CLAMPFIT in pCLAMP 8.0 or Graphpad Prism.
II-1-4 RESULIS
Bath application of Pal-LPC reversibly increased IHERG (figures lA and lB) in a
concentration-dependent manner (Figure 1D). Pal-LPC increased ‘HERG at voltages
between -20 and +30 mV (figure lB), and the F-test indicated the effect was voltage-
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dependent (F<0.0 1, Figure 1 C). However, the haif-maximum activation voltage, which
was determined by the tau currents, was flot affected by Pal-LPC (from control to LPC: -
26±3 to -24±3 mV, P>O.05), nor was the siope factor k (from control to Pal-LPC: 8±1 to
9±1 mV, F>O.05). The effects ofPal-LPC were apparent (-37% the maximum) as early as
3 minutes after application of the drug, and they reached maximum within 10 minutes
(Figure lE). Under our experimental conditions, -2.5 minutes are required for the
solution to circulate into the bathing chamber, and this implies that Pal-LPC effects took
place within 0.5 to 1 minute of exposure. Neither 1 -pahnitoyl-lysophosphatidylglycerol (5
jimol/L) nor membrane-permeable ceramide (50 jimol/L) produced significant effects on
‘HERO (Figures 1F and 1G).
Pal-LPC significantly shifted the inactivation curve toward more positive
potentials (Figures 2A and 2B), causing a mean 20.0±2.2 mV shift in haif-maximum
activation voltage for inactivation relative to control. figure 2C shows Pal-LPC-induced
percent change in currents at +20 mV after prepulses to different voltages, and it indicates
that Pal-LPC did not alter cunents when inactivation was fully removed by prepulses to
more negative voltages but it sigmficantly increased current at prepulse voltages allowing
for inactivation. The inactivation time constants determined by monoexponential fit to the
decaying currents recorded at +20 mV (Figure 2A) were 4.8±0.4 and 6.9±0.9 ms for
control and PaJ-LPC, respectively (F<0.05). The recovery time constants measured by the
inward currents during the hyperpolarizing prepulses were not significantly altered by
Pal-LPC (from 1.9±0.1 to 1.7±0.2 ms, F>0.05).
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Figure 1. A, IHERG recordings in control conditions, 10 minutes aftet LPC application, and after 10
minutes of LPC washout. B, IHERG step current-voltage relations in control conditions (Ctl, C), 10
minutes after LPC (5 pmol/L; <>) application, and after 10 minutes of LPC washout (W/O; À).
*p<005 P<0.01, and ***P<o 001 LPC versus control (n=10 ceNs). C, Ratio of IHERG in the
presence of LPC over control (P<0.05 by ANOVA for the voltage-dependence of current increase
between -30 and +20 mv). D, Concentration-dependence of LPC on IHERG at O mV (n=12). E, Time
course (time after LPC application) of LPC effects (n=10), expressed as ratios of LPC/control,
normalized to 15 minutes. F and G, Raw and mean data of IHERG before and after application of 1-
palmitoyl-lysophosphatidylglycerol (LPG; n=6) or membrane-permeable ceramide (C2; nz6).
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Figure 2. A, IHERG recordings (with voltage protocol in inset) before and 10 minutes after LPC
application. B, inactivation voltage-dependence. Ihe tail current (Itaii) during the test pulse to
+20 mV at various prepulse potentials was normalized to the value for a prepulse to -120 mV.
Symbols are mean±SEM of 13 experiments, and curves are Boltzmann fits. HaIf-maximum
activation voltage for inactivation was shifted by LPC from -40.9±3.4 to -21.2±1.8 mV (P<0.00l). C,
Ratio of /HERG with LPC over control (P<0.001 for voltage-dependence by ANOVA). *p<005
P<001 and P<0.001 for LPC versus control.
II-l5 DISCUSSION
In this study, we demonstrated that Pal-LPC increases ‘HERG in HEK293 ceils. The
Pal-LPC-induced increase in ‘HERG is reversible and occurs within minutes ofextracellular
application. The current-enhancing effect is in large measure due to a substantial
depolanzing shift in ‘HERG inactivation, such that more current is available at any given
voltage within the activation range.
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Intracellular K loss and accompanying extracellular K accumulation impairs
cardiac electrical activity and can also promote celi deaffi through apoptosis,’7 thereby
contributing to the pathophysiology of the ischemic myocardium. ATP-sensitive K
current (Iixrp) contributes significantly to the rapid increase in cellular K efflux and
APD shortening during myocardial ischemia and hypoxia. However, during the first 10
minutes of ischemia in intact hearts, cytosolic ATP concentrations remain —2 orders of
magnitude greater than the ATP concentration, thus causing haif-maximal blockade of
IKM’P in excised membrane patches.18 It is conceivable that membrane conductance other
than ‘KATP may contribute to APD abbreviation and loss of intracellular K.
LPC, a class of lysophospholipids that accumulate in the ceil membrane during
acute myocardial ischemia, decreases peak but enhances sustained Na current, resulting
in a noninactivated component in ventricular myocytes of various species.’°”9’2° LPC also
reduces ‘KI, the major determinant of the membrane resting potential in cardiac ceils.
These findings can account for the conduction siowing and membrane depolarization
caused by LPC, but they do flot explain how LPC produces APD shortening and K
loss.’2 Our observation regarding Pal-LPC effects on IHERG may explain, at least in part,
the latter observations. Because Pal-LPC increased IHERG signiflcantly in the range of
plateau voltages (-10 to +10 mV), it is quite possible that Pal-LPC promotes the
repolarization of cardiac action potentials or APD shortening during acute ischemia and
that Pal-LPC-induced ‘HERG enhancement could also contribute to K-efflux.
Many class III drugs produce their antianhythmic effects by acting on HERGII1<1
currents. In addition, a wide spectrum of non-antianhythmic agents can cause
proarrhythmic effects (acquired long-QT syndrome) by inhibiting ‘HERO. In the present
study, we found that 4IERG can also be enhanced. furthermore, the mechanism of
enhancement involved a substantial positive shift in ‘HERG inactivation voltage
dependence. The rapid inactivation mechanism of IHERG is a distinct property and, to our
knowledge, this is the first time that a shifi in ‘HERO inactivation voltage-dependence has
been shown to underlie a potentially significant endogenous pathophysiological
mechanism. In addition to the potential intrinsic significance of this observation, it may
open up new possibilities in exploring the regulation of HERG properties by membrane
lipids.
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Under ischemic conditions, LPC (normally present at 0.5% to 3.5% of total
membrane phospholipids), increases to an extent that varies among different species and
different tissue compartments. The typical LPC concentration range is 100 to 200 iimol/L.
21 Assuming that —90% ofLPC protein-bound, the ftee concentrationofLPC is lOto 20
iimol/L. LPC, mainly Pal-LPC,223 accumulation during cardiac ischemia is thought to
occur predominantly in the extracellular space.24 Thus, the concentration of PaI-LPC (5
jimol/L) used in this study is likely relevant to pathophysiological situations.
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II-2-1 ABSTRACT
1. Phospholipid metabolite Iysophospholipids cause extracellular K accumulation and
action potential shortening with increased risk of arrhythmias during myocardial ischemia.
Here we studied effects of several lysophospholipids with different lengths of
hydrocarbon chains and charged headgroups on HERG K currents (IHERG) expressed in
HEK293 ceils and the potential mechanisms using whole-cell patch-clamp techniques.
2. Only the lipids with 16 hydrocarbons such as 1-palmitoyl-lysophosphatidylcholine
(LPC- 16) and 1 -palmitoyl-lysophosphatidylglycerol (LPG- 16) were found to produce
significant enhancement of ‘HERG and negative shifts of HERG activation, although the
voltage dependence ofthe effects was different between LPC-16 and LPG-16 which have
differently charged headgroups. The lipid with 18 hydrocarbons modestly increased ‘HERG.
The lipids with 6 or 24 hydrocarbons had no effect or slightly decreased ‘HERG•
3. Inhibition or activation of protein kinase C did not alter the effects of LPC-16 and
LPG- 16. Participation of phosphatidylinositol-4, 5-bisphosphate in ‘HERG enhancement by
LPC- 1 6/LPG- 16 was also excluded.
4. Vitamin E augmented the effects of LPC- 1 6/LPG- 16 whereas xanthine/xanthine
oxidase reduced IHERG: indicating that LPC-16/LPG-16 produced dual effects on IHERG:
direct enhancement of ‘HERG and indirect suppression via production of superoxide anion.
5. We conclude that enhancement of HERG fiinction by lysophospholipids is specific to
the lipids with 1 6-hydrocarbon chain structure and the pattem of voltage dependence is
determined by the polar headgroups. The increase in ‘HERG is best described by direct
interactions between lipid molecules and HERG proteins, which is consistent with lack of
effects via membrane destabilization or modulation by intracellular signaling pathways.
Keywords: HERG; lysophospholipids; l-palmitoyl-lysophosphatidsylcholine; 1-
palmitoyl-lysophosphatidylglycerol; protein kinase C; phosphatidylinositol-4,5-
bisphosphate; oxidative stress; vitamin E
Abbreviations: Bis, bisindolylmaleimide;
‘JjRG, current carried by HERG K channels;
LPC, lysophosphatidylcholine; LPC-6, 1 -caproyl- lysophosphatidylcholine; LPC- 16, 1-
palmitoyl-lysophosphatidylcholine; LPC- 18:1, 1 -oleoyl-lysophosphatidylcholine; LPC-24,
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1 -lignoceroyl-lysophosphatidylcholine; LPG- 16, 1 -palmitoyl-lysophosphatidylglycerol;
PDD, phorbol ester 12,13-didecanoate; PIP2, phosphatidylinositol-4,5-bisphosphate; PIP2-
Ah, inhibitory antibody against phosphatidylinositol-4,5-bisphosphate; PMA, phorbol 12-
myristate 1 3-acetate; VitE, vitamin E; XIXO, xanthine/xanthine oxidase.
II-2-2 INTRODUCTION
The ceil surface membrane or sarcolemma is primarily composed of phospholipid,
cholesterol, and proteins, which together form a complex dynamic structure that retains
the intracellular contents, regulates ion homeostasis, govems nutrient transports, and
tansduces extracellular signais into the ceils. The principal classes of sarcolemmal
phospholipids are, according to their relative abundance, phosphatidylcholine,
phosphatidylethanolamine, phosphatidylinositol, and phosphatidylserine (Corr et al.,
1995). The sarcolemmal phospholipids are composed ofa charged polar headgroup region
and two nonpolar covalently bound long-chain aliphatic hydrocarbon moieties. Under
certain situations, for example, in ischemic tissues, the phospholipids (e.g.
phosphatidylcholine) can be metabolized to generate lysophosphatidylcholine (LPC),
known as a biochemical trigger of ischemic anhythmias in the heart. LPC is an
amphiphile possessing a charged headgroup like phospholipids but only a single aliphatic
hydrocarbon chain as a consequence of the hydrolytic cleavage of one of the two aliphatic
hydrocarbon groups ofphosphatidylcholine (Hatch etal., 1989; Choy et al., 1997). As an
intermediate of metabolism of phosphatidylcholine, LPC is present in a variety of
mammalian tissues (Prokazova et aÏ., 1998) and accumulates rapidly in the heart during
cardiac ischemia and in diabetic cardiomyopathy(Saffitz et al., 1984; Makino et al., 1987;
Kinnaird et al., 1988; Corr et al., 1995). Accumulation of LPC is thought to be a major
contnbutor to the development of cardiac arrhythmias during myocardial ischemia
(fazekas et al., 1992; Man 1988; Corr et aÏ., 1987; Saffitz et al., 1984), such as abnormal
rhythmic activity, delayed aflerdepolarizations (DAD), triggered activity, and
intramyocardial re-entry. Action potential duration (APD) shortening by LPC has been
documented in rabbit atrial and ventricular ceils (fazekas et al., 1992), guinea pig
ventricular ceils (Liu et aÏ., 1991), and canine ventricular celis (Saffitz et al., 1984) and
Purkinje fibers (Corr et al., 1995). LPC levels correlate with the occurrence of
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arrhythmias in ischemic and diabetichearts (Con et al., 1987; Kinnaird et al., 1988; Man,
1988). The most profound alterations associated with electrical activities in ischemic
myocardium are extracellular K accumulation and shortening of APD. This extraceliular
K accumulation in the face of maintained Nat’IC pumping and unaltered ATP-sensitive
K cunent is a key arrhythmogenic factor during myocardial ischemia. Coincidentally, a
recent study by Goldhaber et al. (1998) reported that LPC (20 jtM) decreases tissue K
content by 15%, an effect associated with graduai APD shortening and increased K
efflux.
The abiiity of LPC to induce arrhythmias is likely accounted at least partly by its
ability to affect ion channel functions. Indeed, LPC at concentrations between 5 and 50
M was found to inhibit ‘KI in several studies (Ciarkson & TenEick, 1983; Kiyosue et al.,
1984; Sato et al., 1993) and 5 jM LPC caused about 30% decrease in the single-channel
conductance of ‘KI without altering the open probability. LPC inhibits the peak sodium
cunent (‘Na) but increases the sustained component of ‘Na fl cardiac celis (Bumashev et
aÏ., 1991; Undrovinas et al., 1992). The inhibitory effects of LPC on sodium cunent and
‘Ici explain LPC-induced conduction siowing and membrane depolarization but do flot
account for APD shortening. Instead, inhibition of ‘Ki and enhancement of slowly
inactivating ‘Na should, if anything, prolong APD. In our recent study (Wang et al., 2001 a),
we revealed that LPC significantly enhances the K cunent expressed by HERG (the
human ether-a-go-go-related gene), which encodes the rapid delayed rectifier K cunent
(Ic) (Sanguinetti et al., 1995), one of the key cardiac repolarizing cunents in most
animals, including man (Wang et al., 1993). LPC increases HERG conductance (IHERG),
accelerates ‘HERG activation and slows IHERG inactivation (Wang et aÏ., 200 la), effects
deemed to augment K efflux through HERG channels. These observations provide an
explanation for LPC-induced extracellular K accumulation and APD shortening
occuning in iscliemic myocardium. Yet how LPC modulates ‘HERG, or how the
biochemical substrate (LPC) and the electricai substrate (HERG) for the altered electrical
activities in ischemic myocardium interact with each other, remained unclear.
In theory, LPC can act on ion channels through at least three different mechanisms.
First, LPC can readily incorporate into the sarcolemma, and incorporation of LPC into the
membrane phospholipid bilayer results in significant perturbation of the orderly packed
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phospholipid molecules and alteration of normal conformation of integral membrane
proteins such as ion channels (Corr et aï., 1995). Second, LPC may interact directly with
ion channel proteins. LPC has an easy assess to both the intracellular and extracellular
sides of membrane and may bind to channel proteins so as to alter the conductance of the
channels. And third, HERG modulation by LPC may be mediated through intracellular
signaling pathways.
The present study was designed to clarify which of the above three potential
mechanisms account for LPC enhancement of HERG K channel function. b this end,
we carried out the following experiments: (1) to compare the effects of lysophospholipids
with varying lengths of aliphatic hydrocarbon chain on IHERG stably expressed in HEK293
ceils; (2) to compare the effects of lysophospholipids with different charged headgroups;
(3) to investigate possible participation of some related intracellular signaling pathways in
HERG regulation by the lysophospholipids.
II-2-3 METHOUS
II-2-3-1 Cell Culture
HEK293 ceils stably expressing HERG (a ldnd gifi from Drs Z Zhou and C
Januaiy) (Zhou et al., 1998) were seeded in a 25 cm2 triangular cell-culture flask and
grown in Dulbecco’s modified Eagle’s medium supplemented with 10% heat-inactivated
FBS, 200 jiM G418, 100 U mF’ penicillin, and 100 jtg m11 streptomycin. The cells
subcultured to -85% confluency were harvested by trypsinization and stored in Tyrode
solution containing 0.5% BSA at 4°C. Electrophysiological recordings were conducted
within 10 h ofstorage.
II-2-3-2 Whole-Cell Patch-Clamp Recording
Patch-clamp techniques have been described in detail elsewhere (Wang et al.,
2001a, 2001b). Currents were recorded by whole-cell voltage clamp with an Axopatch
200B amplifier (Axon Instruments). Borosilicate glass electrodes had tip resistances of 1—
3 M when filled with the intemal solution containing (mM): 110 potassium aspartate, 20
KC1, 1 MgC12, 5 Mg-ATP, 10 HEPES (pH 7.2). The extracellular solution contained
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(mM): 136 NaC1, 5.4 KC1, 1 CaCI2, 1 MgCl2, 10 glucose and 5 HEPES (pH 7.4).
Experiments were conducted at 36±1°C. Junction potentials were zeroed before formation
of the membrane-pipette seal. Series resistance and capacitance were compensated and
leak currents were subtracted.
Ail phospholipids were purchased from Avanti Polar Lipid Inc. (Alabaster, AL,
U.S.A.) except for phosphatidylinositoi-4, 5-bisphosphate (PIP2), which was purchased
from Calbiochem-Novobiochem International (La Joua, CA, U.S.A.). To simplify the
terminology, the following abbreviations are used in this manuscript: LPC-6 for 1-
caproyl- lysophosphatidylcholine, LPC- 16 for 1 -palmitoyl-lysophosphatidylcholine, LPC
18:1 for 1 -oleoyl-lysophosphatidylcholine which contains one double bond, LPC-24 for
I -iignoceroyl-lysophosphatidyicholine, and LPG- 16 for 1 -paimitoyl
lysophosphatidylglycerol. The numbers indicate the number of carbon atoms in the
aliphatic chain. LPC-6, PLC-16, and LPG-16 were dissolved directly into the bath
solution at the desired concentrations immediately before each experiment. LPC- 18 and
LPC-24 were dissolved in 100% chloroform as 1000 X stock solutions. Preparation of
PIP2 solution followed the procedures described by Bian et al. (2001). Briefly, PW2 was
dispersed by sonication in water (0.5 mM) for 30 min on ice and then divided into aliquots
and keep at -80°C. Before each experiment, an aliquot was thawed and diluted to 10 M in
the pipette solution and sonicated again for 20 min. PIP2-specific antibody (Assay
Designs Inc., Ann Arbor, MI, U.S.A.) was diluted to 60 nM in the pipette solution. To
minimize binding of PIP2 antibody to the pipette wall, 100 M BSA was included to the
pipette solution. The protein kinase C (PKC)-stimulatingphorbol ester 12, 13-didecanoate
(PDD), phorbol 12-myristate 13-acetate (PMA), bisindolylmaleimide (Bis; PKC inhibitor),
xanthine (X), xanthine oxidase (X0), and vitamin E (VitE) were ail purchased from
Sigma. PDD, PMA, and Bis were prepared as 1000 X final concentration stock solutions
in Me2SO and diluted into patch-clamp recording Tyrode solution at the time of
experiments. X was dissolved in 2 N NaOH and diluted in Tyrode solution by 800 times
with pH adjusted to 7.4 with HC1. X0 was added to the X preparation to form the XJXO
superoxide anion (02) generating system. VitE was dissolved in ethanol and diluted by
1000 times to reach the final concentration. AIl the solvents other than the Tyrode solution,
which was used to dissolve the drugs used in this study, had an experimental
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concentration of 0.1% and for the experiments involving these solvents, the control
recordings were made in the presence of 0.1% of such solvents.
II-2-3-3 Data Analysis
Group data are expressed as mean±s.e.m. Comparisons among groups were made
by ANOVA (F-test), and Bonferroni-adjusted t-tests were used for multiple group
comparisons and paired t-test was used for single comparison. A two-tailed P<O.05 was
taken to indicate a statistically significant difference. Nonlinear least-square curve fiuing
was performed with CLAMPFII in pCLAMP 8.0 or Graphpad Prism 3.0.
II-2-4 RESULTS
II-2-4-l Enhancement of IHERG — an Effect Specific to the Lysophospholipids with 16
Aliphatïc flydrocarbon Chains
This part of the studies was designed to test the possibility that lysophospholipids
modulate HERG K channel fiinction by altering biophysical properties of membrane
owing to their ability to incorporate into the cytoplasmic membrane. This was assessed
indirectly from two different aspects. first, effects of lysophospholipids with different
lengths of aliphatic hydrocarbon chains (figure 1) on ‘RG were investigated. One would
expect that lysophospholipids with longer aliphatic hydrocarbon chains, and thereby
greater hydrophobicity and accessibility to the lipid bilayer, should have greater effects on
IHERG, if membrane incorporation is indeed required for the actions. Second, since the
incorporation of lysophospholipids into sarcolemma can alter sarcolemmal ultrastructure
and destabilize the lipid bilayer, the effects induced by LPC would be expected to persist
even afler the lipids would have been withdrawn from the media. Therefore, by assessing
the time course of ‘HERG recovery to baseline from changes induced by the Jipids upon
washout of the drugs, one can deduce if a drug acts directly by interacting with the
chaimels or indirectly requiring long-lasting modifications of the lipid bilayer
environment in which the channels seat.
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Figure 1. Structures of LPCs, LPG-16 and PIP2. The Iength of aliphatic hydrocarbon chain cf
each lipid used in our study is indicated by the dash unes and the numbers following the short
names of the Iipids. Note the neutral headgroup cf LPC-16 and negatively charged headgroups cf
LPG-16 and PIP2.
Depolanzing steps from a holding potential of -80 mV elicited time-dependent
activation of ‘l-IERG that peaked at -10 mV and decreased in amplitude with stronger
depolarization due to the rapid inactivation process of the channels. ‘HERG was monitored
for 10 min after the formation of whole-cell configuration to ensure the stability of the
current under the normal Tyrode solution, and the cells with current nindown >10% its
initial amplitude were excluded from further experiments. Then, the superfusion was
switched to the Tyrode solution containing one of the Iysophospholipids and the same
current recordings were repeated every 5 min up to 20 min. Recordings made at 15 min
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afier drug application were analyzed for dnig effects. As illustrated in Figure 2 with the
averaged data accompanied with the raw data in the insets, LPC-16 (5 jM) and LPG-16
(5 jiM) both substantially increased 4JERG amplitude. A concentration of 5 tM LPC- 16
was chosen because it is within the range of free concentration of LPC (from 5 to 20 jiM)
in the extracellular space during cardiac ischemia (Liu et al., 1997), and for beller
comparison the concentration of other lysophospholipids studied was also set to 5 jiM
unless otherwise specified.
In contrast, LPC-6 (5 tM) and LPC-24 (5 j.iM) produced some but not statistically
significant decreases fl ‘HERG. Since LPC-6 may have weaker accessibility to the ceil
through the membrane because of its lower hydrophobicity, intracellular application was
performed with LPC-6 (5 j.tM) included in the pipette solution. Yet LPC-6 stiil failed to
increase IIIERG but actually slightly reduced the current under such a condition. Moreover,
no IHERG enhancement was observed even when extracellular LPC-6 concentration was
doubled to 10 jiM. LPC-24 at a concentration of 5 jiM might form micelles because this
concentration is above the critical micelle concentration (1 jiM), which might affect its
effect on IHERG. Thus, effects of 1 jiM LPC-24 were also investigated. However, no
changes of ‘HERG were found (data not shown). By comparison, LPC-18:1 which has
similar chain length as LPC-16 produced a slight increase in ‘HERG amplitude. For
example, at O mV, ‘HERO amplitude was 63.7±9.1 pA before and 70.0±11.5 pA (F>0.05,
n=8) 10 min after LPC-18 (5 tM) application, an increase by 13.4±3.9%. When the
concentration of LPC- 18 was elevated to 10 iM, the effects were also conespondingly
augmented to 20.3±3.5% increase in ‘HERG compared with control.
Alterations of ‘HERG with time before and afier LPC-16 or LPG-16 and afier
washout of the drugs were monitored (Figure 3). ‘HERG generally demonstrated an initial
transient and slight run-up within the first 5 min following whole-cell access and a
subsequent also transient and slight rundown within the next 5 min. Addition of LPC- 16
or LPG-16 produced rapid increases in IHERG and the increases reached maximum levels
within 10 min following drug application. Virtually complete recovery of ‘HERG was
achieved upon washout of the drugs 10 min afier switch back to the drug-free solution.
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Figure 2. Current density—voltage relationships 0f IHERG showing the effects of varlous
lysophospholipids on IRERG at various potentials tested. IHERG was eiicited by the voltage
protocol shown in the inset. Raw traces of 1HERG recorded at O mV are shown in the insets. Ctl —
controi data recorded 10 min after the formation of whole-celi configuration; LPC-16, LPC-6,
LPCJ8:1, and LPC-24 — currents recorded 10 min aftersuperfusion with LPCswith 16-, 6-, 18-, and
24- hydrocarbon chains, respectively (LPG-16, iysophosphatidylgiyceroi with a 16—hydrocarbon
chain). Data are means±s.e. from 13 ceils for LPC-16, 13 for LPG-16, 10 for LPC-6, 11 for LPC
18:1, and 12 for LPC-24. Note that oniy LPC-J6 and LPG-16 produced marked enhancement of
IHERG. P<0.05 vs contrai (Cti).
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Figure 3. Time course of IHERG before (CtI) and after application of LPC-16 (a) or LPG-16 (b)
and afterwashout of the drugs. P<O.05 vs. control (CtI) 10 min.
II-2-4-2 Lack of Influence of PKC on Lysophospholipid-Induced ‘HERG
Enhancement
LPC lias been demonstrated to be able to activate several protein kinases including
PKC (Prokazova et al., 1998; Bassa et al., 1999; Motley et al., 2002) and protein kinase A
(PKA) (Ahumada et al., 1979). Particularly noteworthy is the ability of LPC to activate
PKC because PKC has been importantly implicated in modulation of a variety of ion
channels (Fedida et al., 1993; Prokazova et al., 1998; Bassa et al., 1999; Wang et aï.,
200 lb; Motley et al., 2002). To test this notion, we first looked atwhether PKC inhibitor
Bis could reverse or prevent the increase in ‘HERG induced by LPC-16. The effects of
LPC-16 on ‘HERG were first established by bathmg the celis with the Tyrode solution
containing LPC- 16 (5 pM) alone for 10 mm, followed by addition of Bis (100 nM) to the
LPC-16-containing solution for another 15 min. As illustrated in Figure 4e and 4d, Bis did
not alter the effects of LPC-16 or of LPG-16, as indicated by roughly the same
enhancement of ‘HERG by LPC-16 (Figure 4a) or LPG-16 (Figure 4b) with and without co
application of Bis. In another experiment, the celis were preincubated with Bis (100 nM)
for 30 mm, followed by application of Bis and LPC-16. Under such conditions, LPC-16
maintained the same ability to enhance ‘HERG as without Bis pretreatment (data not
shown). Our data thus indicate that inhibition of PKC does not reverse the effects of LPC
O f0 20
Time (mm)
30 40
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16 on ‘HERO, neither does it prevent the effects of LPC- 16 on IHERG. Likewise, application
of neitherPDD (1 jtM) nor PMA, (1 jiM) to activate PKC increasedlHERG in the absence
of LPC-16 (f igure 4e and 4f). Moreover, PDD or PMA also failed to alter LPC-16- or
LPG- 1 6-induced ‘HERG enhancement.
b ensure that the lack of effects of PKC inhibitors and activators on ‘l-IERG
modulation by LPC-16 is flot due to inappropriate drug concentrations used andlor an
absence of PKC signaling pathway in HEK293 celis, we performed two positive control
experiments. In the first set of experiment, the effects of PKC inhibitors and activators on
transient outward K current (Ito) in isolated canine ventricular myocytes were studied
since we have previously demonstrated the ability of PKC to modulate ‘ta (Wang et aï.,
200 lb). Application ofPDD (1 pM) to the bath suppressedI by —35% and the effect was
completely reversed by co-application of 50 nM Bis. In the second set of experiments,
PKC activities were assayed to verif’ the ability of PDD to stimulate PKC activation in
HEK293 ceils. Consistent with our previous study (Wang et al., 2001b), PDD
significantly increased PKC activities by —47%.
11-2-4-3 Lack of Influence of PIP2 on Lysophosphollpid-Induced ‘HERG
Enhancement
PIP2, a phospholipid to be hydrolyzed to form I ,4,5-inositol trisphosphate (1P3) and
diacyl glycerol (DAG) by phospholipase C, is an intermediate in the Gq protein—
1P3/DAG—PKC signaling pathway. PIP2 has been shown to increase ‘HERG amplitude,
accelerate ‘HERO activation, and slow IHERG inactivation (Bian et al., 2001), effects
resembling those produced by LPC as described in our previous study (Wang et al.,
200 la). This similarityprompted us to hypothesize that PIP2 may be a mediator for LPC
Ï 6-induced ‘HERG enhancement.
b test the hypothesis, we first tested whether inhibition of PIP2 could prevent
LPC-16 from increasing IHERG by studying the effects of LPC-16 in the presence of the
neutralizing monoclonal PIP2-specific antibody (PIP2-Ab). PIP2-Ab (60 nM) was included
in the pipette solution and JHERG was recorded every 5 min after formation of whole-cell
configuration for 10 min to allow completedialysis before addition ofLPC-16 orLPG-16.
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Figure 4. Effects 0f PKC on LPC-16- or LPG-16-induced IHERG enhancement. (a,b) Increases in
IHERG by LPC-16 (n=6) fa) and LPG-16 (n=6) (b). (C) Inhibition of PKC inhibitor Bis 100 nM) fails to
reverse IHERG enhancement induced by LPC-16 (n=8) (c) or LPG-16 (n=5) (d). Bis was added to the
superfusate containing LPC-16 (5 pM) or LPG-16 (5 pM) 10 min after establishment of IHERG
enhancement induced by LPC-16 or LPG-16 alone. (e, f) Lack of effects of PKC activators PDD (1
pM, n=5) (e) and PMA (1 pM, n6) (f) on IHERG. P<0.05 vs. control f Ctl).
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Subsequent addition of LPC-16 (5 pM) or LPG-16 (5 jiM) to the bath increased ‘HERG
amplitude to the same extent as without PIP2-Ab (Figure 5a and b), implyïng that the
presence of PIP2-Ab did not prevent the increase in ‘HERG induced by LPC- 16 or LPG- 16.
To ensure that failure of PIP2-Ab to reverse the effect of LPC-16 or LPG-16 on
‘HERG was flot due to inappropriate use ofthe inhibitor, we performed control studies. PIP2
(10 jiM) was included in the pipette solution and ‘HERG was monitored over a 1 0-min
period right after gaining whole celi access. ‘HERG increased with time and the activation
of ‘HERG shifted towards hyperpolarizing potentials, consistent with the previous finding
reported by Bian et al. (2001). ‘HERG enhancement was abolished when PJP2-Ab (60 nM)
and PIP2 (10 jtM) were co-applied, validating the specificity and effect of PIP2-Ab. Also
noticeable is that the percentage of ‘HERG increase induced by PIP2 is substantially smaller
than that in the presence of LPC- 16 or LPG- 16, despite that the concentration of PIP2
used here is two times higher than that of LPC-16 or LPG-16. For instance, at —20 mV,
JHERG increase was P-50 and —45% by LPC-16 and LPG-16, respectively, but was only
—20% by PIP2.
11-2-4-4 Influence of Antioxidant VitE on Lysopliospholipid-lnduced ‘iwRG
Enhancement
Studies have demonstrated the ability of LPC-16 to enhance reactive oxygen
species (ROS) production, specifically superoxide anion (02), in celis (Ginsburg et al.,
1989; Ohara et al., 1994; Nishioka et al., 1998; Takeshita et al., 2000; moue et al.,2001).
To investigate the possibility of ROS mediation of LPC-16 action on ‘HERG, we assessed
the influence of VitE (100 pM) on LPC-16- or LPG-16-induced 4RG enhancement.
Following a 10-min stabilization period with whole-cell recordings, VitE was co-applied
with PLC-16 or LPG-16. Under such a condition,IHERG was consistently increased, even
to far greater extents than with LPC-16 or LPG-16 alone (Figure 6a-e). The increases in
‘HERG at O mV were —45% for LPC-16 and —20% for LPG-16 in the absence of VitE, and
—70% for LPC- 16 and 110% for LPG- 16 in the presence of, VitE. This increased effect
of LPC- 16 or LPG- 16 by VitE cannot be interpreted as a direct enhancing effect of VitE
on ‘HERG because VitE alone failed to affect the current (Figure 6f). The data are
explainable if we assume that 02 produced by LPC-16 suppresseslHlRG.
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Figure 5. Effects of PIP2 on LPC-16- or LPG-16-induced IHERG enhancement. (a,b) Inhibition of
PIP2 by anti-PIP2 antibody (PIP2-Ab, 60 nM) faits to prevent IHERG enhancement induced by LPC-16
(a) or LPG-16 (b). PIP2-Ab was included in the pipette solution. IHERG was monitored for 10 min
before the addition of LPC-16 (5 IJM) or LPG-16 (5 pM) to ensure complete dialysis of PIP2-Ab into
the cytosol. (c) Effects of PIP2 on IHERG. PIP2 was applied intracellularly through the pipette solution.
IHERG measured at 10 min after membrane rupture was used for analysis (nt6). (d) Effects of co
application of PIP2 and PIP2-Ab on IHERG (n6). Note that PIP2 lost the ability to alter IHERG. P<0.05
vs. control (Ctl).
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Figure 6. Effects of antioxidant VitE on LPC-16- or LPG-16-induced IHERG enhancement. fa, b)
Enhancement of IHERG by LPC-16 fa, n=6) or LPG-16 (b, n6). (c, d) Effects of co-application of
LPC-16 or LPG-16 ami VitE on IHERG. (e) Effects of VitE on IHERG (n=4). (f) Effects of XIXO on IHERG.
Oeils were superfused with X/XO (500 pM/5 mU/mi) for >30 min before patch-clamp recordings. (g)
Comparison of % changes of IHERG with varying drugs over control (Cti). Note the increased effect
of LPC-16 and LPG-16 in the presence of VitE. P<0.05 vs. Ctl.
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The data are explainable if we assume that 02_ produced by LPC- 16 suppresses ‘HERG.
This lias actually been confirmed by our recent studies (Zhang et al., 2003b). Here we
further clarify this issue with an additional experiment using XJXO 02-generating system
(Barringtonet al., 1988; Aiello et al., 1995). Celis were incubated withor without X!XO
(500 jiMJ5 mU/ml) in the Tyrode solution for —40 min before IHERG was recorded. IHERG
density was smaller in XJXO-treated celis than in X./XO-nontreated ceils (figure 6g).
II-2-4-5 Comparison of Effects of Lysophospholipids with Varying Lengths of
Aliphatic Hydrocarbon Chain and Differently Charged Groups on ‘flRG
Lysophospholipids are amphipathic molecules composed of a polar headgroup and
a non-polar aliphatic hydrocarbon chain with varying lengths. b investigate how the
differences in the aliphatic hydrocarbon chain and in the polar headgroup determine the
effects of lysophospholipids on IHERG, we perfonned detailed analyses of voltage- and
time-dependent properties of ‘HERG modulationby various lysophospholipids.
Activation properties
From Figure 2, it appears that the effects ofLPC-16 and LPG-16 are quite different
at different voltages. To clarify this notion in detail, we constructed the normalized 1—V
relationships with various lysophospholipids. As shown in Figure 7, LPG-16 produced a
negative shift of the I—V curve, which resulted in a crossover of I—V curves between
control and LPG-16. This phenomenon was flot seen with LPC-16. This would imply that
while LPC- 16 increases IHERG at the full voltage range tested, LPG- 16 has an effect only
at more negative potentials. This point is better addressed with the percent changes of
‘FIERG, caused by the lysophospholipids, as a firnction of test potentials shown in Figure 8.
LPC-16 produced biphasic voltage-dependent effects on JHERG: between —40 and —10 mV,
LPC- 16 induced greater ‘HERO increment at more negative potentials, whereas between —
10 and +40 mV it produced great effects at more positive potentials. By comparison,
although the effect of LPG- 16 at potentials negative to O mV was similar to that of LPC
16, it was virtually absent at potentials positive to O mV. LPC-18:1 produced similar
patterns of voltage dependence as did LPC-16, but the ‘HERG increase was to a less extent.
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Figure 7. Normalized I—V relationships showing the negative shift of I—V curve by LPG-16 but
flot by other Iysophospholipids. Currents were normalized by dividing step IHERG at varlous
potentials to the corresponding maximum value. Data are means±s.e. from 13 cells for LPC-16, 13
for LPG-16, 10 for LPC-6, 11 for LPC-18:1, and 12 for LPC-24.
To investigate the effects of lysophospholipids on the steady-state voltage
dependent activation property of IHERG, we constructed the activation curves as illustrated
in Figure 9. Both LPC-16 (5 1iM) and LPG-16 (5 jiM) cause significant shifts of
activation curves toward hyperpolarizing potentials. The haif-maximum activation
voltages (V112) were -29.0±3.6 mV with a siope factor (k) of 7.2 mV for control and -
34.6±4.6 mV with siope factor (k) of 7.5 mV for LPC-16 (F<O.05 vs. Ctl), and were -
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28.9±3.4 mV (k6.3 mV) for control and-37.9±4.9 mV (k=5.9 mV) for LPG-16 (F<0.05
vs. CtI), indicating a 5 mV negative shifi for LPC-16 and a 10 mV negative shifi for LPG
16. The difference of Vi,2 shifis between LPC-16 and LPG-16 was statistically significant
(F<0. 05, unpaired t-test), indicating a greater effect of LPG- 16 on the steady-state voltage
dependence of ‘HERG. Other lysophospholipids did flot significantly affect ‘HERG activation
curves.
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Figure 8. Percent changes of IHERG produced by various lysophospholipids over control as a
function of depolarizing voltages. Note the biphasic voltage dependence of IHERG enhancement
induced by LPC-16 and LPC-18:1 but flot other lysophospholipids. Data are means±s.e. from 13
celis for LPC-16, 13 for LPG-16, eight ceNs for PIP2, 10 for LPC-6, 11 for LPC-18:1, and 12 for
LPC-24. -P<O.05 F-test indicating voltage dependence.
a
T LPC-16
150 %Chg
-40 -20 0 20 4
Test Potential (mv)
d
LPc..6
30 %Chg
20
la
-20
Test Potential (mv)
e
LPC-18:1
40
40 -20 0 20 40
Test Potential (mV)
t
LPC-24
- %Chg
Test Potentbl (mV)
153
a b
E
E06f -
Test Potential (mv) Test PoteniaI (mV) Test Potential (mv)
Figure 9. Effects of various Iysophospholipids on the steady-state voltage-dependent
activation curves. The activation curves were constructed by plotting the conductance G as a
function of depolarizing potentials. G was calculated by normalizing the tau currents at -50 mV by
dividing the amplitude of the tau currents measured at various antecedent depolarizing potentials by
that of the tau current at +40 mV. Symbols are mean of experimental data and unes represent the
Boltzmann fit: G/Gmax=l/{l+eXp[fV112V)IkJ}, where Gmax represents the maximal conductance at
+40 mV, V112 is the half-maximal activation voltage, and k is the siope factor. Data are means±s.e.
from 13 cells for LPC-16, 13 for LPG-16, 10 for LPC-6, 11 for LPC-18:1, and 12 for LPC-24.
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Inactivation properties
The steady-state voltage-dependent inactivation was assessed by the voltage
protocol shown in the inset of Figure 10. ‘HERG was first inactivated by a 2 s depolarizing
step to +40 mV and then reactivated to various extents during the hyperpolarizing pulses
to various potentials of a 10 ms duration that allowed for full reactivation with minimal
deactivation, and the decaying outward currents induced by the subsequent 50 ms
depolarizing pulse to +20 mV represent ‘HERG inactivation. As displayed in figure 10,
LPC- 16 caused significant shifi (10 mV) of the inactivation curve to depolarizing voltages
with inactivation V1/2 changed from -54.7±5.6 mV (k=-l8.6 mV) to —44.1±4.8 mV
(F<0.05 vs. Ctl) (k=-l4.8 mV). LPC-18: 1 produced a slight non-significant positive shifi
of IHERG mactivation curve. LPG-16 did flot alter ‘HERO inactivation properties (Figure
lob), nor did LPC-6 and LPC-24. This issue was further addressed bythe data presented
in the insets of Figure 10 where percent changes of IHERG caused by the lysophospholipids
over control are plotted as a function ofhyperpolarizing potentials. Obviously, the degrees
of IHERG increases induced by LPC- 16 and LPC- 18:1 significantly depended on the
antecedent hyperpolarizing voltages (F<0.05, F-test), with greater effects at more positive
potentials (Figure lOa and d). By comparison, the effect of LPG-16 was only weakly
voltage-dependent (Figure lOb, P>0.05, F-test).
Kinetics
Effects of various lysophospholipids on the time-dependent properties of ‘HERO
were analyzed. The apparent activation and deactivationtime courses were determined by
the single exponential fit to the step IHERG during depolarizing pulse to O mV and to the
tail IHERG upon repolarization to —50 mV, respectively. As shown in Figure lia and c, the
apparent activation time constant was significantly decreased by LPC-16, LPG-16, and
LPC 1$: 1, and the apparent deactivation was significantly accelerated only by LPC- 16 but
flot the other lipids studied. Since the apparent activation contains components involving
both activation and inactivation processes, it was flot sure whether the observed effects of
the lipids are truly specific to the activation kinetics. b clarifS’ this point, we performed
experiments using the voltage protocols shown in Figure 1 lb, which allowed data analysis
reflecting true activation with minimal inactivation. The resuits confirmed the ability of
LPC-16 and LPG-16 to accelerate the activation time course.
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Figure 10. Effects of various Iysophospholipids on the steady-state voltage-dependent
inactivation curves. The inactivation curves were constructed by plotting the channel availability
or conductance G as a function of hyperpolarizing potentials. G was calculated by normalizing the
tau currents elicited at +20 mV by dividing the amplitude of the tau currents measured at various
antecedent hyperpolarizing potentials by that of the tail current at -100 mV. Symbols are the mean
cf experimental data and lines represent the Boltzmann fit: G/Gmaxl/{l+eXp[(Vi,V)Ik]}, where
Gmax represents the maximal channel availability at -100 mV, Vu2 is the half-maximal activation
voltage, and k is the siope factor. Data are means±s.e. from 10 cells for LPC-16, fine for LPG-16,
eight for LPC-6, eight for LPC-18:1, and fine for LPC-24. Percent changes of IHERG produced by
various lysophospholipids over control as a function of hyperpolarizing potentials are shown in the
insets. Data are means±s.e. from 10 cells for LPC-16, 9 for LPG-16, 8 for LPC-6, 8 for LPC-18:1,
and nine for LPC-24. +P<0.05 F-test indicating voltage dependence.
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Figure 11. Effects of various Iysophospholipids on the kinetics 0f 1HERG. (a, b) Effects on
activation kinetics. The activation time constants (Tact) in ta) were obtained with the single
exponential fit to the step IHERG evoked at O mV, and ict in (b) was determined by the single
exponential fit to the peak inward currents elicited at —100 mV with antecedent depolarizing steps of
varying durations from 5 to 80 ms in 5-ms increments, as shown in the inset. (c, d) Effects on
deactivation kinetics. The deactivation time constants (Zieact) in (c) were determined by the single
exponential fit to the outward tau IHERG elicited at —50 mV preceded by a depolarizing step to O mV,
and Vdeact in (d) was determined by the single exponential fit to the inward tau IHERG elicited at —100
mV. (e) Effects on inactivation kinetics. The inactivation time constants (tinact) were obtained with
the single exponential fit to the outward decaying currents elicited at +20 mV (as indicated by the
solid arrow in the inset) with the voltage protocol shown. (f) Effects on reactivation kinetics. The
reactivation time constants (Zeact) were determined by the single exponential fit to the inward
currents elicited at —100 mV preceded by a 2 s depolarizing step, as indicated by the dash arrow in
the inset. P<0.05 vs. Ctl.
However, the deactivation process analyzed with the decaying phase of the inward
currents elicited during the brief hyperpolarizing pulse to —100 mV failed to show any
significant alterations in the presence ofLPC-16 or LPG-16.
The inactivation and reactivation ldnetics were analyzed with the voltage protocols
shown in the inset of Figure 10 and current traces in Figure 11e. The resuits in Figure 11e
and f indicate that both LPC- 16 and LPG- 16 significantly slowed the inactivation ldnetics
and none of the lipids tested appreciably altered the reactivation time course. The siowing
of inactivation by LPC-16 and LPG-16 is to a similar extent; the inactivation time
constants were 2.9±0.2 ms for control and 3.8±0.1 ms for LPC-16 (F<0.05, n=7), and
2.8±0.3 ms for control and 3.7±0.3 ms for LPG-16 (F<0.05, n6).
II-2-5 DISCUSSION
We compared in this study the effects of several lysophospholipids with different
aliphatic hydrocarbon tails and polar headgroups on HERG fiinction. It appears that the
enhancement of HERG function is specific to the lysophospholipids with 16 hydrocarbons,
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whereas the voltage dependence of the effects is determined by the charged headgroups.
Enhancement of ‘HERG cannot be weil explained by altered membrane properties as a
resuit of incorporation of the lipids into sarcolemma. Potential involvement of several
intraceliular signaling pathways in the effects of LPC- 1 6/LPG- 16 on ‘HERG seems uniikely
either. Our data point to direct interaction between LPC- 1 6/LPG- 16 and HERG K
channel proteins or some other unidentified signaling pathways related to LPC- 1 6/LPG-
16 as the mechanisms by which these iipids enhance HERG function. Increase in ‘HERG by
the lysophosphoiipids may contribute to iC loss and action potentiai shortening in the
ischemic heart.
HERG is highly susceptible to regulation by various extracellular and intracellular
factors. 0f drugs belonging to various categories that have been shown to modulate
HERG, ail have been reported to inhibit the channel (Tagliaiateia et al., 199$). This
property of HERG channels is responsible for the long QT syndrome induced by drugs or
under pathoiogicai situations associated with aberrant neuronal functions in many of the
clinical cases. However, recent studies from our laboratory (Wang et al., 200 la) and
another group (Bian et aÏ., 2001), as weii as the present smdy, reveaied the other side of
HERG channels: HERG function can also be enhanced. We were the first to report that
HERG function is increasedby a phospholipid metabolite l-LPC-16 (Wang et al., 2001a).
Subsequentiy, Bian et al. (2001) showed that PIP2 produced similar enhancing effects on
‘HERG. More recently, we found that HERG function is largely dependent on the basal
activity of protein kinase B (PKB) in the human embryonic kidney ceii une and activation
of PKB enhances HERG function (Zhang et aï., 2003a). The present study further
revealed that besides LPC-16, other phosphoiipid metabolites also have the potentiai to
enhance HERG function; specificaliy, the lysophosphoiipids with 16 hydrocarbons such
as LPG-16 produces similar effects, as does LPC-16. By comparison, the potency ofLPC
16 and LPG-16 is greater than that of PW2, in terms oftheir effects on IHIRG; extraceiiuiar
application of 5 iM of LPC-16 or LPG-16 increased ‘HERG to a greater extent than
intracelluiar application of 10 jiM PIP2 (see Figure 5) (Bian et al., 2001; Wang et al.,
200 la). Lysophospholipids are metabolic intermediates that are massively produced under
various metaboiic stresses (Hatch et aï., 1989; Choy et aÏ., 1997). In ischemic
myocardium, uniike PIP2 which is decreased (Mouton et aï., 1991; Liu et aï., 1997),
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lysophospholipids particularly LPC-16 are rapidly produced and accumulated both
extracellularly and intracellularly (Corr et aï., 1987; 1995; Man, 1988; Kinnaird et aï.,
1988; Fazekas et al., 1992). LPC-16 is known to be acausative factor for the occurrence
of an-hythmias in the early phase of acute myocardial ischemia. One of the potential
mechanisms for LPC- 1 6’s arrhythmogenic action is its ability to induce cellular K loss or
extracellular K accumulation and shortening of APD, characteristic disorders of cardiac
electrophysiology in ischemic hearts (Goldhaber et al., 1998). LPC- 16 has been shown to
decrease cardiac inward rectifier K cunent (Clarkson & Ten Eick, 1983; Kiyosue et aï.,
+1984; Sato et al., 1993) and to induce a noninactivating component of ;nward Na current
(Bumashev et al., 1991; Undrovinas et al., 1992). While these properties of LPC may
contribute to ischemic arrhythmias, they hardly explain LPC-induced K loss and APD
shortening; instead one would expect to see prevention of K loss and lengthening of APD
with inhibition of inward rectifier K current and induction of noninactivating Na current.
Obviously, some other ion currents may be responsible for LPC’s effects on cardiac
electrophysiology. The present study provides an alternative mechanism by which LPC
could cause cardiac electrical disturbances; LPC increases IHERG, and thereby K efflux,
leading to cellular K loss and APD shortening. Moreover, our data show that besides
LPC- 16, other lysophospholipids such as LPG- 16 and LPC- 18:1 also have the ability to
increase ‘HERO to varying extents, which could also contribute to the increased risk of
ischemic arrhythmias.
A change in the mechanical properties of a bilayer could modify the function of
embedded proteins by changing the free energy difference between different
conformational states of the protein. At concentrations below their critical micelle
concentrations (CMCs), lipids can cause monomer—membrane interaction in which
adsorption of monomer into membrane occurs after disaggregation of micellar lipids.
Above CMC, there exist micellar—membrane interactions in which desorption of intrinsic
membrane phospholipid occurs with formation of mixed micelles in the incubation
medium and associated loss of membrane phospholipid, altered membrane permeability
and electrical distability or micellar—membrane interactions in which the primaiy process
is adsorption of micellar lipids with localized perturbation of the biophysical
characteristics of the membrane bilayer. The effects of amphipathic lipid metabolites on
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membrane protein (such as ion channels) function have traditionaily been ascribed to their
effects on membrane fluidity and membrane deformation energy (DaTorre et al., 1991;
Lundbœk & Andersen, 1994). This interpretation is grounded on the following facts: (1)
effects of the iipid metabolites are nonspecific, or in other words, the different lipid
metabolites produce the same effects on membrane proteins in spite of their different
polar headgroups and different lengths of aliphatic chain; and (2) these lipid metabolites
are readily incorporated into the sarcoiemma. Gross et al. (1982) demonstrated that
electrophysiological abnormalities occurred in Purkinje fibers and ventricular muscles of
canine hearts when only as littie as 1% of cellular phospholipid was supplanted by
exogenous LPCs, which were incorporated into the sarcolemma. Lundbœk & Andersen
(1994) reported that several lysophospholipids affected gramicidin channel function on
planar bilayer by aitering membrane defonnation energy as a result of their incorporation
into the bilayer.
It is expected that the lipids examined in this study could ail readily incorporate
into the sarcolemma. However, our data argue against membrane incorporation as the
major mechanism by which lysophosphoiipids moduiate HERG function. Our argument is
supported by two lines of evidence. First, the effects of the lipids on ‘HERG developed
rapidly with significant increases occurring wiffiin 3 min afier application and are readily
reversible with compiete recovery of IHERG within 5 min afier washout ofthe drugs (see
Figure 3). This rapid recovery is unexpected should the lipids take their effects by
incorporating into sarcoiemma, because once the lipids incorporate into the membrane
they wili become a part of the membrane composition and can cause permanent
destruction of the membrane. Second, the effects of lipids on membrane protein function
will vary as a function of their concentrations in the membrane, which can be estimated
by membrane adsorption coefficients of various iipids: the higher the concentration of a
given lipid in the membrane, the greater the effect. At iow aqueous lipid concentrations
[iipid]o, the mole fraction of the lysophospholipids in the membrane should approximately
be equai to [lipid]0/CMC (Nichois & Pagano, 1981; Lundbœk & Andersen, 1994). The
CMCs for the iysophosphoiipids used in this study are --7 pM for LPC-16, 600 jiM for
LPG-16, >7 jiM for LPC-6, -O.4 iiM for LPC-18:1, and -1 1.tM for LPC-24 and the
concentration is 5 jtM for all of the lysophospholipids examined. Besides, 1 jiM LPC-24
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or 10 iM LPC-18:1 was also tested. Accordingly, LPC-1$:1 and LPC-24 would be
expected to have much higher ratio of membrane incorporation or higher concentrations
in the membrane thanLPC-16, LPG-16, and LPC-6. Furthennore, LPC-18:1 and LPC-24
have bulider structures compared with LPC-16, LPG-16, and LPC-6, and should produce
more severe derangement of sarcolemma. However, the effects of LPC- 18:1 and LPC-24
on IHERO are much smaller or absent relative to LPC-16- or LPG-16. In addition, 5 tM
LPC-16 is quite close to its CMC while 5 pM LPG-16 is far below its CMC; yet the
effects of these two lipids on ‘HERG are quite comparable, indicating that membrane
concentration or incorporation does not play a major role in defining the effects of these
Iipids on ‘HERG.
Lysophospholipids are not simply Jipid metabolites producing toxic effects; instead
they have been implicated in many signal transduction processes and some of them are
acmally signaling molecules. By involving in signaling pathways, these lysophospholipids
can regulate the function of a variety of proteins, presumably including ion channels. One
of the most recognized effects of LPC is its ability to stimulate activation of several
protein kinases, such as PKC (Prokazova et al., 199$; Bassa et aL, 1999; Motley et al.,
2002) and PICA (Ahumada et aÏ., 1979). The potential involvement of PKC in HERG
modulation by LPC-16 orLPG-l6 was excluded on the ground of failure ofthe inhibitor
to affect the enhancement of IHERG by LPC- 16 or LPG- 16 (figure 4) and of failure of PKC
activators to mimic the effects ofLPC-16/LPG-16. Participation of PIP2, a component of
PKC signaling pathway, in ‘HERG modulation by LPC-16 and LPG-16 was also ruled out
because the effect was not significantly altered by the inhibitory antibody against PIP2 and
also because direct application of PJP2 produced much smaller enhancement of ‘HERG than
LPC- 16 or LPG- 16 although the concentration of PIP2 (10 jiM) used was twice as much
as LPC-16 or LPG-16 (Figure 6). In agreement with the present work, most of the
previous studies have also failed to observe modulatory effects of PKC on JHERG (Kiehn et
al., 1998; Bian et al., 2001). Participation of PKA in LPC-16- or LPG-16-induced
‘HERG
enhancement was flot examined because previous work has consistently found that PICA
simulation actually suppresses
‘HERO (Kiehn et al., 1998; Cui et aÏ., 2000).
Effects of LPC on cellular fimctions have also been linked to its ability to enhance
production of superoxide anions (02) (Ginsburg et aÏ., 1989; Ohara et aÏ., 1994; Nishioka
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et al., 1998; Takeshita et al., 2000). There is thus a possibility thatIHERG enhancement by
LPC is mediated by 02.. However, our data do flot support this notion. We have recently
found that 02. impairs HERG fiinction (Zhang et al., 2003b). In the present study, we also
demonstrated that 02 generating system X/X0 (Barrington et al., 1988; Aiello et al.,
1995) depresses ‘HERG. Moreover, the enhancement of ‘HERG induced by LPC-16 or LPG
16 was augmented in the presence of VitE to scavenge 02. (see Figure 7), indicating that
2. produced by LPC- 1 6/LPG- 16 indeed participated in IHERG modulation, but instead of
mediating the enhancing effects it exerts an opposite effect counteracting ‘HERO
enhancement. In other words, LPC-16 and LPG-16 actually produce dual effects on
HERG fiinction: they depress IHERG via production of 02. and increase IHERG by some
other mechanisms with a net increase in ‘HERG. ROS has been implicated in ‘HERG
modulation (Taglialatela et al., 1997; Benibe et al., 2001); intriguingly, ‘HERG was found
increased by hydrogen peroxide (H202) which is supposed to be converted to hydroxyl
group (0W) to become reactive. Together, these data suggest that different species of
ROS may have different effects on ‘HERG.
Comparison of various LPCs and LPG-16 reveals that only the lipids canying 16
hydrocarbons in their aliphatic tails are able to affect HERG function to significant
extents and the lipids with shorter (such as LPC-6) or longer (LPC- 18:1 and LPC-24) tails
merely affect or weakly affect JHERG. As a matter of fact, LPC-6 and LPC-24, which are
drastically different from LPC16/LPG-l6 in terms of their aliphatic chains, virtually
suppress ‘HERG to as much as 20% (Figure 8d and f). Moreover, LPC-16 and LPG-16
caused significant shifis of HERG activation along the voltage axis towards more
negative potentials, so did LPC-18:0 although to a less extent, whereas LPC-6 and LPC
24 produced littie effect. furthermore, the activation time course was significantly
accelerated by LPC-16, LPG-16, and LPC-18:0 as well, but notby LPC-6 and LPC24.
These resuits could hardly be explained by incorporations of the lipids into the
sarcolemma. As estimated based on their CMCs, the membrane incorporation of LPC- 16
and LPC24 are quite comparable and that of LPC-18:0 is around 10—20 times higher than
LPC-16 and LPC-24; by comparison, the membrane incorporation ofLPC-6 and LPG-16
would be at least l00-fold less than LPC-16. The observed effects are quite comparable
between LPC-16 and LPG-16 and between LPC6- and LPC-24, but do not follow the
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expected order of membrane incorporation. If the effects are viewed as consequences of
direct interactions between lipid molecules and HERG proteins and there is a specific
‘binding’ site for the lipids in the HERG sequence, then our data can be well explained.
For example, similar degrees of ‘HERG enhancement by LPC- 16 and LPG- 16 are
presumably aflributable to their identical aliphatic hydrocarbon chain. This implies that
1 6-hydrocarbon chain structure can best fit ffie ‘binding’ site in HERG sequence and that
the hydrocarbon chains shorter than 16 may not satisfy the ‘binding’ requirements whule
the hydrocarbon chains longer thanl6 may flot have an access to the site. The lipids with
similar hydrocarbon chain like LPC-18:0 can also “bind” to the HERG site, but may not
in optimal position. This explains why the LPC with 1 8-hydrocarbon chain is able to
enhance ‘HERG, although the effect is weaker thanthose ofLPC-16/LPG-16. Our data are
therefore best described by direct interactions between lipid molecules and HERG
channel proteins.
On the other hand, although at a concentration of 5 iM, LPC- 16 and LPG- 16
produced similar enhancement of ‘HERG, detailed comparisons reveal that the voltage
dependencies of actions are different. For example, LPC-16 showed biphasic voltage
dependence on the test potentials that set the open probability of the channels (Figure 8);
at potentials negative to —10 mV, the increase was grater at more hyperpolarized voltages,
whereas at potentials positive to —10 mV, the increase was greater at more depolarized
potentials (figure 8a). By comparison, the effect ofLPG-16 was monophasic; the increase
in JHERG was weaker at more positive potentials and was nearly absent at potentials
positive to —10 mV (figure 8b). Similarly, the enhancement of ‘HERG by LPC-16 was also
significantly dependent on the prepulse potentials that set the availability of channels for
opening with greater effects at more positive potentials that render smaller cliannel
availabilities (figure lOa). The effects ofLPG-16 did not significantly depend on prepulse
potentials (f igure lob). This is also reflected by the positive shift of the HERG
inactivation curve, induced by LPC-16 but flot LPG-16 (Figure 10). Noticeably, the
voltage dependence ofLPC-18:O mimickedthat ofLPC-16. The reason for the differences
between LPC-l6and LPG-16 and the similarity of LPG-18:O to LPC-16 is quiteobvious:
the headgroups in LPC-16 and LPC-18:0 are identicaland are neutral with one negatively
charged P04 and one positively charged NH3, while the headgroup in LPG- 16 is
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negativeiy charged with one P04 (Figure 1). The distinction in the headgroups between
LPC- 16 and LPG- 16 confers their different voltage dependence of effects Ofl whule
LPC-16 and LPC-18:0 have the samepattem of voltage dependence because they share
the same headgroup. Intriguingiy, PIP2 lias a negatively charged headgroup and its effects
on IHERG demonstrate characteristic voltage dependence similar to LPG- 16 (Figure $c)
(Bian et aÏ., 2001). It has been proposed that PIP2 may interact with HERG channels by
binding to positiveiy charged amino-acid residues in the HERG sequence. LPG-16 might
act in the same way as PIP2. For LPC-16 and LPC-18:0, since they have both positive and
negative charges, they might be able to bind both negatively and positiveiy charged amino
acids of HERG.
Considering ail these arguments, it appears that enhancement of HERG firnction by
LPC- 16 and LPG- 16 is not mainiy due to membrane incorporation of these lipids or to
intraceliular signaling pathways that are known to be related to the functions of these
iipids. We tend to believe that effects of LPC-16 and LPG-16 on ‘HERO are the
consequence of direct interactions between the lysophosphoiipids molecules and HERG
K channel proteins or of some other signaiing pathways related to LPC-16/LPG16
actions. We shouid admit that our experiments do flot provide any direct evidence for the
hypothesis of direct lipid—channel interactions. Such evidence requires identification of
the binding site(s) for the lipids in HERG sequence by mutagenesis. The possibility that
LPC- 1 6/LPG- 16 modulate HERG function via some unidentified pathways is therefore
flot excluded.
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11-3-1 ABSTRACT
Background The most profound abnormalities during acute myocardiaÏ iscliemia are
extracellular K accumulation ([Kj0-t) and shortening of action potential duration or QT
interval (APD-.1- or QT-.I-), which are pivotal in the genesis of ischemic arrhythmias and
sudden cardiac death. The ionic mechanisms remain obscure.
Methods and Results We performed studies in a rabbit model of acute global myocardial
ischemia in order to explore the potential role of delayed rectifier K current (Iy1-) as an
iconic mechanism for ischemic [K]0-t and QT-».I-. Exogenous LPC-16 mimicked the
low-perfusion ischemia to produce significant [K]0-t and QT4. The [Kj0-t and Q-SI
induced by either LPC- 16 or ischemia were prevented by 1 blocker Dofetilide, but flot
by blockers for other K channels. Consistently, dofetilide efficiently abolished the
ventricular tachy-arrhythmias. At the cellular level, LPC-16 remarkably shortened APD
and enhanced the function ofI and HERG, the pore-forming subunit of Iy. The effects
of LPC-16 were manifested with shorter APD (faster repolarization rate) and at more
negative potential (membrane repolarization). Dofetilide abolished the lKr/HERG
enhancing and APD shortening effects ofLPC-16.
Conclusions Our results suggest that LPC-16 accumulation1HERG enhancement may be
the Iink between metabolic trigger and ionic pathway for ischemic [K]0-t and QT4.
This represents the first documentation of IyJHERG as the ionic mechanism in ischemic
[K]0-t and QT-L. Inhibition of LPC-16 production and accumulation andJor of
IKr/HERG may be a promising therapeutic strategy to attenuate the incidence of lethal
arrhythrnias associated with ischemic heart disease.
Key Words: ischemia• arrhythmias ion channels potassium myocytes
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II-3-2 INTRODUCTION
Myocardial ischemia leads to a cascade of metabolic and electrophysiological
events which are interrelated and are caused by metabolic stress, such as intracellular and
extracellular accumulation of metabolic by-products like lysophosphatidylchoiine (LPC
16), and by extraceilular K accumulation ([Kj0-t).’ The results are failure of contraction,
deterioration of electrical behavior, and eventual death of the celi. At the organisrn level,
the end point may be lethal arrhythmias or mechanical pump failure. The most profound
abnormalities associated with acute myocardiai ischemia are [K]0-t and shortening of
action potential duration or QT interval (APD-I’ or QT-I-).
[K]0-t in the myocardium following net cellular K loss ([K]1-.I) is one of the
earliest consequences of myocardiai hypoxia and ischemia, beginning within 15-30 s.17
Dunng the first 10—15 min ofmyocardial ischemia, [K]0 (or potassium activity) rises 2-3
fold from its normoxic value (5 mmol/L) to a plateau level of 6—11 rnmol/L above its
initial value. [K70-t is related to profound modifications of the electrical behavior of
ischemic cardiomyocytes. In particular, it contributes to depolarization of resting
membrane potentiai, decrease in the maximum upstroke velocity of action potential (AP),
and decrease in excitability. APD-1-/QT-.i- is also tightiy associated with these changes of
[K]0; increase in K1 efflux can resuit in APD4 and [K1]-t as weli. These
electrophysiological alterations are pivotai in the genesis of ischemic arrhythmias and
sudden cardiac death.
Ischemic arrhythmias are generally categorized into three phases based on the tirne
when they appear: phase I arrhythmias occuning during the first 30 min of ischemia,
phase II arrhythmias between S to 72 hours and phase IiI arrhythmias of the chronic stage
after an infarct. The first burst of ventricuiar tachycardia occurs between 2 and 10 min of
ischemia. In human, phase I arrhythmias ofien resuits in ventricular fibrillation and
sudden cardiac death. Reentry1’8 and delayed afierdepolarizations (DADs)1’9 are the major
mechanisms for phase I arrhythniias in ischemic myocardium. Noticeably, APD4/QT-i-
favors the reentrant arrhythmias and DADs, a reproducible pattem of dysrhythmic
activities during acute myocardial ischemia.7 Here we refer this typical pattem of
ischemic electricai disorders and anhythmias to as “short QT syndrome”. Indeed,
pharmacological modulation of [Ki0-t and APD-I- during acute myocardial ischemia has
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been considered as a promising new antiarrhythmic and cardioprotective strategy during
myocardial ischemia and reperfusion. Yet our insufficient knowledge of the mechanisms
for [Kj0-t and APD-I- hinders us from benefiting from the promise.
The ccli surface membrane or sarcolemma is primarily composed ofphosphoiipid,
cholesterol, and proteins which together form a complex dynamic structure which retains
the intracellular contents, regulates ion homeostasis, govems nutrient transports, and
tansduces extracellular signais into the ceils. The principal classes of sarcolemmal
phospholipids are, according to their relative abundance, phosphatidylcholine,
phosphatidylethanolamine, phosphatidylinositol, and phosphatidylserine)° Under certain
situations, for example, in ischemic tissues, the phospholipids (e.g. phosphatidylcholine)
can be metabolized to generate Iysophosphatidylcholines (LPCs). LPCs are amphiphiles
possessing a charged headgroup like phospholipids but oniy a single aliphatic
hydrocarbon chain as a consequence of the hydrolytic cleavage of one of the two aliphatic
hydrocarbon groups of phosphatidylcholines. The major species of LPCs produced in
ischernic myocardium is 1 -palmitoyl-iysophosphatidylcholine (LPC- 16) which possesses
16 hydrocarbons in its aiiphatic chain. As an intenuediate of metaboiism of
phosphatidylcholine, LPC-16 is present in a variety of manmialian tissues and
accumulates rapidly in the heart during cardiac ischernia)°” -12 Accumulation of LPC- 16
is thought to be a major contributor to the development of cardiac arrhythmïas during
myocardiai ischemia,’2’5 such as abnormal rhythmic activity, delayed
afterdepolarizations (DAD), triggered activity and intramyocardial reentry, and is
regarded as a biochemicai trigger of ischemic anhythmias. APD shortening by LPC- 16
has been documented in rabbit atrial and ventricular ceils,’3 guinea pig ventricular ceiis,’6
and canine ventricular cells’ and Purkinje fibers.1° LPC-16 levels correlate with the
occurrence of arrhythmias in ischemic heartsJ”4”5 Coincidentaiiy, a recent study by
Goldhaber et aï’7 reported that LPC-16 decreases tissue K content by —15%, an effect
associated with gradual APD-I and [K]0-t.
The delayed rectifier K current (Iy.), encoded mainly by human ether-a-go-go
related gene (HERG), canes outward K flow which is crucial for repolarizing cardiac
membrane. Ii has the potential of being a contributor to ischemic [IC]0-t and APD-
and the associated arrhythmias, considering the following notes. First, the only two
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existing studies conceming Jyj and ischemia suggest that Iy, is increased during ischemia
and infarction. Shinmura et aï’8 studied the effect of E-4031, a class III antiarrhythmic
drug which specifically inhibits Iy.1, on ischemia- and reperffision-induced arrhythmias.
They found that E-4031 (100 nM) attenuated loss of K from the ischemic myocardium
and concomitant reduction of ischemia-induced arrhythmias. Another study reported by
Pinto and Boyden’9 described an E-4031 -sensitive K current which was increased in
alThythmogenc subendocardial Purkinje myocytes from the infarcted hearts of dogs.
Although the nature of this E-4031 sensitive K current remains to be clarified, it
possesses some characteristics ofIy. Second, HERG is highly susceptible to modulation
by various extracellular and intracellular factors. We have recently found that LPC-16
significantly increased
‘HERG amplitude by shifiing the inactivation of the channels to
more positive potentials and by siowing the inactivation kinetics.20’2’ The effects took
place within 1 min afier LPC-16 reached the celis and were readily reversible upon
removal of the drug. These data are in une with the fact that LPC- 16 causes [K]0-t and
APD-i- and thus suggest that
‘HERG”Kr contribute to the early event of ischemia-induced
alterations of cardiac electrical activities. Finally, HERG conductance is known to
increase with increasing extracellular Kt a typical condition in ischemia. It is thus
conceivable that Iy increases both as a cause and as a consequence of [K’10-t.
We proposed that ischemic electrical disorders are a consequence of interrelated
metabolic stress and electrolyte disturbance. In other words, ischemic [K]0-t and APD-
are an event involving the interplay between ionic channels and metabolic substrates. The
present study was designed to examine this hypothesis. Our resuits provide supporting
evidence for the role of LPC-16 and IyJHERG in ischemic [Kj0-t and APD4, and
suggest that both LPC- 16 and IKjHERG be the pharmacological targets for the treatment
ofischemic cardiac electrical disturbance or arrhythmias.
II-3-3 METHODS
II-3-3-l Global Myocardial Ischemic Model
New Zealand white rabbits weighing 2.2-2.8 kg of either sex were sedated with a
subcutaneous injection of ketamine (50 mg/kg) and xylazine (4mg/kg) and anesthetized to
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a surgical plane with intravenous administration of sodium pentobarbital (30 mg/kg).
Heparin (1 ,000units/kg) was delivered intravenousty. Heart was then rapidly excised afier
thoracotomy and placed in cold heparinized Tyrode’s solution (4°C).
The aorta was imrnediately cannulated in a heated chamber filled with humidified
room air and the hearts was perfused retrograde in the Langendorff perfusion apparatus at
75 imnHg constant perfusion pressure with modified Tyrode’s solution of the following
composition (in mmol/L): NaC1 130, KC1 4, CaC12 1, MgCl2 1, NaHCO3 24, NaH2PO4 1.2,
and glucose 10. Ihe perfusate was maintained at 35-37°C by a temperature transducer
(Physitemp 1H8) and oxygenated with 95% 02 and 5% C02. The cava and pulmonary
veins was sutured closed and the pulmonary artery was cannulated in order to obtain
samples of venous effluent under anaerobic conditions for potassium concentration
measurement. The perfusion rate was continuously monitored with a flow meter
(transonic 1206) and maintained at 30 rnl/min for alt baseline control penods. The
pressure in the aorta was measured with a pressure transducer (WPI BLRP) connected to
a strain gage amplifier (EMKA technologies).
II-3-3-2 Experimental Protocols
To mimic global acute ischemia, the perfusion flow was reduced from 30 ml/min
to 5 ml/min (1/6 or 17% of baseline control) for 15 min under normothermic condition.
The hearts were then subjected to the following experimental procedures.
(1) Baseline recording (30 mm, 30 ml/min) — Ischemia (l5min, 5 ml/min) —
Reperfusion (30 ml/min);
(2) Baseline recording (30 mm, 30 ml/min) — K channel blockers (30 ml/min) —
Blockers + Ischernia (15 mm, 5 ml/min)
— Reperfusion (30 rnl/rnin);
(3) Baseline recording (30 mm, 30 mI/min) LPC-16 (30 ml/min)
— Reperfusion
(30 ml/min);
(4) Baseline recording (30 mm, 30 ml/min)
— K channel blockers (30 mI/min) —
Blockers + LPC (3 imol/L, 15 mm, 30 ml/min)
— Reperfiision (30 ml/rnin).
for experiments involving K channel blockers, dmgs were administrated by a
Harvard apparatus pump at a rate of 3 ml/min (1/10 dilution). Lysophosphatidylcholine
(LPC-16) was purchased from Avanti Polar Lipid Inc (Alabaster, Alabama) and
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glibenclamide (GA) were ail purchased from Sigma. Dofetilide (Dof, IKr/HERG blocker)
is a gift from Pfizer, and chromanol 2933 (293B, ‘Ks blocker) and HMR (3R, 4S)-(+)-N-[-
3 -hydroxy-2,2-dimethyl-6-(4,4,4-trifluorobutoxy) chroman-4-yl]- N-methyl
ethanesulfonamide, ‘K blocker) were generously supplied by Aventis. The concentrations
of the drugs were set based on our previous and preliminaiy experiments, as weII as on
the studies from other laboratories, being around their respective 1C50 values. PLC- 16 was
dissolved directly into the bath solution at the desired concentrations immediately before
cadi experiment.20’2’
II-3-3-3 Measurement of QT Interval
ECG was monitored, on a data acquisition system (EMKA), continuously
tbroughout the experiment and compared to baseline measurements before global
ischemia or LPC- 16 perfusion. QT intervals were measured on lead II (the negative lead
positioned on the base of the right ventricle and the positive lead was inserted at the apex
of the heart) from QRS onset to the end of the T wave; biphasic T waves were rneasured
to the tirne of final baseline retum. These QT measurements and sirnultaneously recorded
RR intervals were used to derive heart rate correctcd QT intervals (QTc) using Bazett’s
formula (QTc=QT/(RRY’0.5).22 ECG was recorded at a sampling rate of 1 KHz and a low
pass filter of 0.5 KHz and a notch filter of 60 Hz. The software ECGauto 1.5.7 was used
to analyze ECG. ECG parameters were averaged from measures of three consecutive
complexes.
II-3-3-4 Measurement of [KJ0
Effluent (8 ml) was collected every 2 min throughout the whole experimental
period. K content was measured by a potassium sensitive electrode (FastFil Combination
Model 44-0001, Lazar Research Laboratory Inc. CA). A standard curve was constructed
with a series of concentrations of standard KC1 solution for each experiment. The
readings (in mV) were obtained with a pH meter (Accumet Basic AB 15, fisher Scientific)
and the corresponding values were converted to mrnol/L concentration in a
semilogarithmic paper as the electrode manual instructed.
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II-3-3-5 Myocyte Isolation
Ceils were isolated from lefi ventricular endocardium, midmyocardium and right
atrium of dogs for collecting action potential (AP) waveforms editing AP-clamp
recordings. Myocytes from left ventricular endocardium of rabbits were isolated for
investigating the effects of LPC-16 on AP parameters. Myocytes from lefi ventricle of
guinea pigs were isolated for studying the effects ofLPC-16 on Iy.
The enzymatic isolation procedures were the same as previously described.2325
The hearts were quickly removed and mounted to a Langendorff perfusion system. The
preparation was perfused with Ca2tcontaining Tyrode solution at 37°C until the effluent
being clear ofblood, and then switched to Ca2-free Tyrode solution (mmol/L: 136 NaC1,
4.7 KC1, 1 MgC12, 0.33 NaH2PO4, 5 HEPES, 10 glucose and 1 CaCI2; pH 7.4) for 20 min
at a constant rate of 12 mllmin, followed by perfusion with the same solution containing
collagenase (110 U/ml CLS II collagenase; Worthington Biochemical) and 0.1% bovine
serum albumin for -30 minutes. The dispersed ceils were stored at 4°C in the medium
containing (mmollL): 20 KC1, 10 KH2PO4, 25 glucose, 70 potassium glutamate, 10 f3-
hydroxybutyric acid, 20 taurine, 10 EGTA, 0.1% albumin and 40 mannitol (pH 7.4).
II-3-3-6 Ceil Culture
HEK293 celis stably expressing HERG (a kind gift from Drs. Z Zhou and C
January)26 were seeded in a 25 cm2 triangular ceil-culture flask and grown in Dulbecco’s
Modified Eagle’s Medium supplemented with 10% heat-inactivated FBS, 200-tmoI/L
G418, 100-U/ml penicillin and 100-g/m1 streptomycin. The ceils subcultured to -85%
confluency were harvested by trypsinization and stored in Tyrode solution containing
0.5% BSA at 4°C. Electrophysiological recordings were conducted within 10 hrs of
storage.
II-3-3-7 Patch-clamp Techniques
The procedure vas the same as described in detail elsewhere.20’21’27 Briefly, a small
aliquot of the solution containing the isolated celis were placed in a 1-ml chamber
mounted on the stage of an inverted microscope. The ceils were perflised at 5 ml/min with
the standard extracellular solution (36°C). Ionic currents and action potentials (APs) were
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recorded with whole-ce1l patch-clamp methods in the voltage-clamp mode and the
cunent-clamp mode, respectively, using an Axopatch-200B amplifier (Axon Instruments).
Borosilicate glass electrodes (1 mm o.d.) had tip resistances of 1-3 M2 when filled with
pipette solution ofthe following composition (mmol/L): 110 potassium aspartate, 20 KCI,
1 MgCI2, 5 Mg-AI?, 0.1 GTP, 10 EGTA, 5 phosphocreatine, 10 HEPE$, pH adjusted to
7.2 with KOH. Command pulses were generated by a 12-bit digital-to-analog converter
controlled by pCLAMP6 software (Axon Instruments). Junction potentials were zeroed
before formations of the membrane-pipette seal in Tyrode solution containing (in
mmol/L): 136 NaC1, 4.7 KC1, 1 CaCl2, 1 MgCl2, 10 glucose and 10 HEPES (pH 7.4). The
capacitance and series resistance were both electrically compensated to minimize the
duration of the capacitive surge on the current recording and the voltage drop across the
clamped celi membrane.
For myocyte experiments, recordings were made under conditions, which
minimized the potentially contaminating currents. Contamination by sodium current was
prevented by holding the ceil at -50 mV. Cadmium chloride (200 rmol/L) was used to
inhibit Ca2 current as well as Ca2tactivated chloride current. KATp, if any, was
suppressed by glibenclamide (10 jimol/L) in the perfusate and by 5 mmol/L Mg-AI? in
the pipette. Acute application of drugs was achieved by bath perfusion. Current
recordings done under control conditions were repeated eveiy 5 minutes up to a total of
15 minutes after drug superfusion. b ensure the purity of Iy, the amplitude was
measured as dofetilide-sensitive currents. For group comparisons, data were expressed as
current density calculated by dividing the current amplitude by the ceil capacitance.
II-3-3-8 Data Analysïs
Group data are expressed as mean ± $.E. Statistical comparisons (perfonned using
ANOVA followed by Dunnett’s method) were carried out, and paired or unpaired t-test
was used, as appropriate, for single comparisons, using Microsoft Excel. A two-tailedp <
0.05 was taken to indicate a statistically significant difference. Nonlinear least square
curve fitting was performed with CLAMPfIT in pCLAMP 8.0 or GraphPad Prism.
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II-3-4 RESULTS
II-3-4-1 Rote of Iicj/HERG in [KJ0-t Induced by Low-perfusion Ischemia or by
Exogenous LPC-16
The K concentration in the perfusate ([Kj0) was 4 mmolJL and the [K]0
measured from the effluent collected 30 min afier stabilization with normal perfusion rate
(30 ml/min) was 3.9 ± 0.1 mmol/L. [K]0 was elevated ([K]0-t) when the perfusion rate
was reduced to mimic global myocardial iscliemia and the elevation was greater with
lower perfusion rate (Figure lA). for instance, with a perfusion rate of 10 ml/min (33%
ofthe normal perfusion rate) for 10 mm, [K]0 was increased to 5.7 mmolIL and when the
perfusion was decreased to 17% (5 ml/min) of the normal perfusion [K]0 was fiirther
increased to 9.3 mmolJL which is similar to the published data.3’7 In the subsequent
experiments, a perfusion rate of 5 mU’min was used as the global acute ischemia model.
{Kj0-t developed rapidly and reached a steady-state (10.5 mmol/L) within 10 min
of ischemia, as shown in figure lB. Administration with dofetilide (20 nmol/L) did not
significantly alter [Kj0 under control conditions, but prevented ischemic [IC]0-t (f igure
IC). By comparison, blockers for I and KTp, 293B (50 tmol/L), HMR (100 nmol/L)
and GA (glibenclamide, 10 tmoIJL), respectively, ah failed to affect the iscliemic {K]0-t.
The efficacies of these blockers were validated in isolated single canine ventricular
myocytes; 293B at 50 tmol/L and HMR at 100 nmolJL produced 92% and 96% reduction
ofIjc, respectively, and GA at 10 imol/L abolished KATP (data not shown).
Coincidently, perfusion with LPC-16 produced concentration-dependent [K-10-t
similar to that seen with ischemia. The EC50 calculated with the Hill equation was 2.3
mol/L (Figure 2A). Hence, 3 p.molIL LPC-16 was used for the rest of the Langendorff
study. LPC- 16 caused a time-dependent [K]0-t with the maximum effect occurring 10
min after perfusion; [K]0 was increased from 4 mmol/L under baseline control to 7.3
mmol/L in the presence of LPC- 16 (figure 2B). Application ofI blocker dofetilide but
not the blockers for I or KATp prevented the [Kj0-t induced byLPC-16 (Figure 2C-2f).
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Figure 1. Increases in extracellular K concentration f[Ky0-t) during global ischemia
and potential role of Iv. [Kj0 was measured with a Kf-sensitive electrode from the effluent of
Langendorff-perfused rabbit hearts. (A) [KJ0-t when perfusion rate was reduced to 33% and 17%
cf the normal perfusion rate (30 mI/min), respectively. (B) [K]0-tas a function of time. Perfusion
rate was 5 ml/min, 17% cf normal control perfusion rate. (C-F) Effects of K channel blockers on
ischemic [K]0-t. Dof: dofetilide (20 nmol/L, IIH ERG inhibitor); 293B: chromanol 293B (50 ijmol/L,
IKs inhibitor); HMR: (100 nmol/L, IKs inhibitor); GA: glibenclamide (10 jmol/L, KATp inhibitor). Note
that [K]0-t was prevented only in the hearts pretreated with Dof but flot with other blockers studied.
*p<005 vs. Control (Ctl); n=3-4 hearts for each group.
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Figure 2. [K]0-t induced by Iysophosphatidylcholine fLPC-16). (A) Concentration
dependent [K÷J0-t induced by LPC-16 with normal perfusion rate. (B) [Kj0-t as a function 0f time
in the presence of LPC-16 (3 pmol/L). (C-F) Effects of K channel blockers on [K10-t induced by
LPC-16. Dof: dofetilide (20 nmol/L); 293B: chromanol 293B (50 pmol/L); HMR: (100 nmol/L); GA:
glibenclamide (10 pmol/L). Note that [K]0-t was prevented only in the hearts pretreated with Dof
but flot with other blockers studied. *p<005 vs. Control (Ctl); n=3-4 hearts for each group.
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II-3-4-2 Role of I/HERG in QTc—I Induced by Low-perfusion Ischemia or by
Exogenous LPC-16
Parallel to the [Kj0-t during ischemia or in the presence of exogenous LPC-16,
QT interval and the heart-rated corrected QT interval (QTc) were consistently shortened
during ischemia or with LPC-16 in the perfusate (figures 3-5). The extent of QTc-’J’
depended upon degree of ischemia or concentration of LPC-16. Intriguingly, QTc—I
failed to reach a steady-state within 15 min low-rate perfusion (5 mL’min, Figure 4B) or
15 min with LPC-16 perfusion (Figure 5B). Perfusion with 20 nmol/L dofetilide
prevented the QTc-’.L induced by either ischemia (Figure 4C) or LPC-16 (fig. 5C). In
contrast, blockers ofIjc or KATp did neither affect the ischemic QTc4 (Figure 4D-4f) nor
LPC-16-induced QTc4 (Figure 5D-5f).
A Baseline CtI
Baseline CtI
lschemia 10 min
1tr Dot 10 min
Baseline I
Dot+It 10 min
LPC-16 loi r- —
Figure 3. Shortening of QT interval (QT4) induced by global ischemia or by LPC-16.
Shown are typical examples of ECG recordings showing Q14 during ischemia (slow perfusion rate,
5 mI/min) or in the presence of LPC-16 (3 pmol/L) and abolition of QT—I- by dofetilide (Dof, 20
nmol/L).
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Figure 4. Shortening of heart rate-corrected QT interval (QTc4) during global
ischemia (IS) and potential role of lKr. (A) QTc4 with 33% and 17% of the normal perfusion rate
(30 ml/min): 10 ml/min and 5 ml/min, respectively. (B) QIc-.L- as a function 0f time under ischemia
(5 ml/min, 17% of the normal perfusion rate). (C-F) Effects of K channel blockers on ischemic QTc
.I. Dof: dofetilide (20 nmol/L, I1/HERG inhibitor); 2938: chromanol 2938 (50 pmol/L, IKs inhibitor);
HMR: (100 nmol/L, IKs inhibitor); GA: glibenclamide (10 pmol/L, KATp inhibitor). Note that QTc-’1-
was prevented only in the hearts pretreated with Dof but flot with other blockers studied. (G) QTc4
during ischemia and recovery upon reperfusion (10 mm), indicating QTc-.1- being reversible. (H)
QTc4 as a function of time under 33% slowing (10 ml/min) of normal control perfusion rate. Note
the initial QTc4 within the first 10 min of ischemia and subsequent pronounced QTc *p<005 vs.
Control (Ctl); n=3-4 hearts for each group.
The ischemic QIc-.!- was reversible upon reperfiision (resuming the normal
perfusion rate of 30 ml/min). When the degree of ischemia was set less severe by
reducing the perfusion rate to 33% (10 ml/min) of the normal rate, QTc demonstrated
biphasic changes with time: initial shortening within the first 10 min followed by
subsequent lengthening up to 40 min.
II-3-4-3 IjHERG Blocker Suppresses Arrhythmias Induced by Low-perfusion
Iscliemia or by Exogenous LPC-16
In our experimental model, either global ischemia (10w perfusion rate of 5 ml/min)
or LPC-16 (3 mo1/L) caused arrhythmias, mainly ventricular tachycardia (VI), defined
as mns of at least five consecutive QRS complexes on ECG. VI was observed in all 4
hearts that underwent global ischemia and in 3 out of 4 hearts treated with LPC- 16
(Figure 6). VT occurred primarily wiffiin the first 10 min after ischemia (average of 10
episodes) or LPC- 16 perfusion (4 episodes), and within the next 10 min VT incidence
considerably decreased with only one episode in ischemic hearts and none in LPC-16-
treated hearts. When pretreated with dofetilide (20 nmol/L), only two out of four ischemic
hearts had an average of one incidence of VI, and none of the five hearts treated LPC- 16
showed any arrhythmias.
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Figure 5. Shortening of QTc interval (QTc4) induced by LPC-16 and potential role of
iKr. (A) QTc4 in the presence of various concentrations of LPC-16. (B) QTc--I- as a function of
time with 3 pmoi/L LPC-16. (C-F) Effects of K channei biockers on LPC-16-induced QTc-.i-. Dof:
dofetilide (20 nmoi/L, IKr/HERG inhibitor); 293B: chromanol 2938 (50 pmoi/L, IKs inhibitor); HMR:
(100 nmoi/L, IKs inhibitor); GA: giibenclamide (10 ijmol/L, KATp inhibitor). Note that QTc4 was
prevented oniy in the hearts pretreated with Dof but flot with other biockers studied. *p<0.05 vs.
Contrai (Cti); n=3-4 hearts for each group.
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Figure 6. Arrhythmias induced by ischemia or LPC-16 (3 pmolIL) and the effects 0f
IKrIHERG blocker dofetilide (20 nmoIIL). Ventricular tachycardia (VT), defined as runs of multiple
extra-excitations of >10 s in duration, occurring within the first 10 min of low rate perfusion (5
ml/min) (A) or LPC-16 application (B). Upper panels are examples of VT during ischemia or in
presence of LPC-16 and lower panels show averaged data of ‘[f episodes. Note that in the hearts
pretreated with dofetilide (Dof), arrhythmias were abolished. *p<005 vs. Control f Ctl); +p<0.05 vs.
ischemia or LPC-16; n3-4 hearts for each group.
II-3-4-4 Enhancement ofI,IHERG by LPC46 Accounts for APD-1-
b investigate the cellular mechanisms for the observed QTc-’.L, we assessed the
effects of LPC-16 on single ceil action potential (AP) in isolated rabbit ventricular
myocytes. As illustrated in Figure 7, LPC-16 (3 tmol!L) applied to the superfiision
solution substantially shortened action potential duration (APD) and the shortening was
prevented by co-application with dofetilide (20 nmoVL) that when applied alone caused
striking prolongation of APD.
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Figure 7. Shortening of action potential duration (APD4) induced by LPC-16 and
potential role of Ig. Action potentials were recorded in isolated single ventricular myocytes from
left endocardial wall of rabbits. (A) APD-..i- induced by LPC-16 (3 pmol/L). Measutements made
under baseline control conditions (Ctl) were repeated 10 min after superfusion with LPC-16. Upper
panels: typical examples of action potentials; lower panels: averaged data from 10 cells. APD50 and
APD90: action potential duration at 50% and 90% repolarization, respectively. (B) Effect of dofetilide
(Dof, 20 nmol/L) on APD-.- induced by LPC-16 (3 pmol/L). Ceils were pretreated with Dof for 10
min before co-application with LPC-16. Note Dof alone prolonged APD and prevented APD--i
induced by LPC-16. Dash unes indicate O mV potential. *p<O.O5 vs. CtI.
The above data suggest that LPC-16 shortens APD by enhancing the function of
IjHERG. To examine this notion, we performed whole-cell action potential-clamp (AP
clamp) experiments in HERG expressing HEK293 celis. AP waveforms, recorded in
myocytes from various regions of the canine heart, including ventricular endocardium,
mid-myocardium and right atrium, were used as command pulses to elicited HERG
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current (IHERG). As depicted in Figure 8A-8C, LPC-16 (3 .imol/L) increased ‘HERG with
various AP wavefonns. Noticeably, however, the effect was to the greatest extent with
atnal AP with an order of atrial AP> endocardial AP> mid-myocardial AP. Intriguingly,
APD is shortest in atrial AP in the order of atrial AP < endocardial AP <mid-myocardial
AP. This implies that the shorter the APD, the greater the enhancement of IHERG by LPC
16. 1f it is twe then more pronounced ‘HERG increase is expected with briefer APD of APs
from the same ceil type. This was indeed verified by applying two endocardial APs in
tandem, one recorded at 2.5 Hz with shorter APD and the other at 0.5 Hz with longer
APD. As shown in figure 8D, ‘HERG enhancement was markedly greater with shorter AP
than with longer AP. This point is further addressed by the data in f igure 8E where
APD50 and APD90 (APD to 50% and 90% full repolarization, respectively) and percent
increases in IHERG are shown. Correlation betveen ‘HERG increase and APD was analyzed
by plotting the former as a function of the latter and by the linear regression. The
goodness of fit was 0.997 for APD50 and 0.992 for APD90, with a 95% confidence range
of4l to 85 for APD50 and of25 to 141 for APD90.
Enhancement of Iy by LPC-16 was verified in native myocytes isolated from
guinea pig ventricle. Guinea pig was used because as it is well known, our cunent
techniques allowed us to record larger Iy. in this species than in any other species, for
more accurate analysis of pharmacological properties. A series of voltage steps ranging
from -40 mV to +60 mV were delivered to inactivate followed by a repolarizing pulse
to -40 mV to reactivate Iy so as to observe Iy tau currents. The dofetilide-sensitive
cunent when plotted as a function of inactivation pulses (depolarizing prepulses) shows
characteristics of Iy (figure 9A and 9B). The current reached a steady-state (maximum)
level from potentials positive to -10 mV. Inclusion of LPC-16 (3 tmoL/L) in the bathing
solution for 10-15 min caused a pronounced increase in the tail current that was reversible
upon subsequent washout of LPC-16. When the Iy tail currents were normalized to the
maximum value to obtain conductance (G) curve, an approximately 5 mV negative shifi
of Iy activation in the presence of LPC-16 was revealed. This negative shifi resulted in
greater increases in Iic at more negative potentials or at the potentials doser to resting
membrane potentials in ischemic myocardium.
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Figure 8. Enhancement of HERG current (IHERG) by LPC-16 in HERG-expressing
HEK293 celis. IHERG was recorded by action potential (AP)-clamp techniques with AP waveforms
obtained from single canine myocytes of different regions. (A-C) Typical examples of APs and the
respective IHERG from endocardium (Endo), mid-myocardium (Mid) and atrium (A), showing
enhancement of IHERG by LPC-16 (5 pimol/L). Note LPC-16 increases IHERG more with AP
waveforms of shorter duration. (D) Direct comparison of LPC-16-induced 1HERG enhancement
between short and long APs. Note LPC-16 increases IHERG more with shorter APD. (E) Comparison
between APD50 and APD90 (Upper) and IHERG enhancement (Lower). *p<O.05 vs. atrium (A); n5
celis. (F) Correlation between IHERG enhancement by LPC-16 and APD50 (Uppet) or APD90 (Lower).
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For example, at -30 mV, LPC-16 produced 136% enhancement of Iy, but the effect
decreased to only 35% at +20 mV. The same pattem of actions of LPC-16 was
consistently seen with the cloned HERG channel expressed in HEK293 ceils (figure 9C):
negative shift of activation and voltage-dependent increase with markedly more
pronounced enhancement at the potentials near the resting potential of iscliemic heart
(145% increase at -40 mV vs. 34% increase at +20 mV).
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Figure 9. Enhancement of native rapid delayed rectifier K current fIKr) in Ieft
ventricular endocardial myocytes isolated from guinea pigs, and cloned IHERG in HEK293
celis, by LPC-16. IKrwas elicited by the voltage protocol shown in the inset. (A) Typical examples
0f IKr traces recorded under control conditions, in presence of LPC-16 (5 iJmolIL), and in presence
of LPC-16 + dofetilide (Dof, 20 nmol/L). The enhancement of I by LPC-16 is revealed by the LPC
1 6-sensitive currents obtained by digital subtraction between the current with and without LPC-16.
Dofetilide, a specific IKrIH ERG blocker was used to verify the native I. (B) Averaged data (n8
ceNs) showing the reversible increase in IKr tau amplitude (left panel), the negative shift of activation
curves (middle panel), and the voltage-dependence of percent increase in IKr (right panel), by LPC
16. The activation curves were constructed by plouing the conductance G as a function 0f
depolarizing potentials. G was calculated by normalizing the tail currents at -40 mV by dividing the
amplitude of the tail currents measured at various antecedent depolarizing potentials by that of the
tail current at +60 mV. Symbols are mean of experimental data and unes represent the Boltzmann
fit: G/Gmax1/{1+exp[(VitVIk]}, where Gmax represents the maximal conductance at +60 mV, Vii
is a haif-maximal activation voltage, and k is a slope factor. W/O: washout. p<O.05 LPC-16 vs. CtI
at potentials from -30 mV to +60 mV. (C) Averaged data (n=6 cells) showing the increase in IHERG
tail amplitude (Ieft panel), the negative shift of activation curves (middle panel), and the voltage
dependence of percent increase in IRERG (right panel), by LPC-16. p<0.05 LPC-16 vs. Ctl at
potentials from -40 mV to +40 mV.
II-3-5 DISCUSSION
II-3-5-l Major Findings ofthe Study
Extracellular K accumulation in myocardium and APD shortening due to
abnormally enhanced K efflux are the critical cause of electrical disturbance, including
the associated ischemÏc arrhythmias, during the early stage of acute myocardial ischemia.
Despite the paramount importance of understanding [Kti0t and APD% for the treatment
of ischemic electrical disorders, the intrinsic pathways through which K1 flows out of the
ceil remained poorly defined and the ionic mechanism for ischemic [Kj0-t and APD4 is
stiil a puzzle to cardiologists and scientists. $imilarly, metabolic perturbation of ischemic
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myocardium is known to have great impact on electrical disturbance. Among the various
metabolic insuits, the rapid accumulation ofphospholipid metabolite LPC in the ischemic
myocardium is of pivotai importance. However, while LPC lias long been recognized as a
biochemical trigger of ischemic arrhythmias, presumabiy due to its ability to cause [Kj0-
t and APD-.1-,’7 how LPC causes [K]0-t and APD-1- remained a mystery. To shed some
iights on these issues, we carried out the present study and made severai important and
novei findings. First, exogenous LPC-16 mimics the [Kj0-t and APD4/QTc-1- seen in
10w-perfusion ischemia and the effects are reversed by specific I1JHERG blocker
dofetilide. Second, dofetiiide is highiy effective in preventing ventricular tachy
anhythmias induced by low-perflision iscliemia or by exogenous LPC-16. Third, LPC-16
enhances Ifcj/IHERG and the effects are greater with shorter action potentiai duration (APD)
and at more negative potentiais. These resuits indicate that enhancement of ‘Ki”HERG by
LPC- 16 contributes to [Kj0-t and APD-L/QTc-’I’ and the associated arrhythmias during
acute myocardiai ischemia. In other words, HERG K channel forms the pathway or one
of the pathways, and LPC-16 acts as a trigger, for abnormal intraceliuiar K loss or K
efflux in ischemic myocardium. Therefore, in addition to the paired ATP depletionfKATp
activation, LPC accumuiation!HERG enhancement forms another link between metabolic
trigger and ionic pathway for ischemic [Kj0-t and QTc—I-.
II-3-5-2 Current Knowledge of Mechanisms for Ischemic tKJ0-t and QTc4
Because of the importance of [K]0-t along with APD-1 to ischemic arrhytbmias,
mechanisms responsible for it have been a subject of intensive research. It is generaily
believed that [KJ0-t and APD-1- are of multifactoriai nature with 3 major
17 . + . +.deternunants: ‘ rncreased passive K efflux, reduced active K influx, and dimimshed
extraceilular space. Increased passive K efflux is a prerequisite for ischemic [K]4 or
[K]0-t and APD-I. Experimental studies support the hypothesis that K efflux increases
rapidly during acute myocardial ischemia; this increase is most likeiy due to a net
increase in the conductance of K channels. Reduced active K influx is a wananty for
ischemic [K]0-t and it is achieved by reduction of the Na-K pump activity. Ischemic
conditions make a moderate inhibition of the pump plausible; metabolic stresses have
been found to reduce pump activity.”283° Owing to the remarkable capacity ofthe pump
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(150 pA or 3 x 1015 mol/sec), small reduction ofthe activity can render dramatic changes
of [Kj. The normal reversai potential (Erev) of the pump is —180 mV. It may however
drop to —60 mV which is about the membrane potential of the celis during the plateau of
[Kj0-t in ischemic myocardium. The pump, in offier words, wiIl stop operating at the
potential expected under ischemic conditions)’3° Diminished extraceliular space produces
+ 4’
.
. +a concentratmg effect on [K 10- I caused by mcreased passive K efflux and reduced
active K4 influx. Shifi of water from extracellular to the intracellular space occurs as a
consequence of increase in osmotically active particles in the celi, such as iactate and
phosphate. It is estimated that the increase in osmotically active particles can resuits in a
restriction of the extraceliular space by 15% afier 10 min of ischemia.”31’32 Apparently,
increased passive K4 efflux acts as an initiation mechanism for [Kj0-t and APD-’I-,
decreased active K influx as a maintenance mechanism for [Kj0-t, and shrinkage of
extracellular space as an amplification mechanism for [Kj0-t. However, despite the key
importance of increased passive K4 efflux, the ionic mechanisms are stiil uncertain and
our understanding of pathways along which K4 leaves the celis have been controversial
for nearly two decades.
Cardiac K4 channels play a pivotai role in defining resting potential, ceil
excitability and membrane repolarization and thereby the likelihood of arrhythmias.
Cardiac ceils possess severai K4 currents: inward rectifier K current (IKI),33 transient
outward K cunent (J10),23’24 rapid delayed rectifier K cunent (JK1),27 slow delayed
rectifier K4 current (Jic),27 uitrarapid delayed rectifier K current (IKur),34 ATP-sensitive
K4 current (KATp),35 Na4-activated K current (Ja),36 arachidonic acid-activated K4
current (Jic&jj,37 etc. Some of these K4 currents have been reported to be downregulated
in their function and expression during acute ischemia; such as I, ‘KI and j1’38 ‘Kur S
believed to be absent in ventricular cells of various species including humans, dogs,
guinea pigs and rabbits. Hence, these channels as carriers of ischemic K4 efflux can be
excïuded. KATp as a candidate for ischemic {Kj0-t has been extensively studied; yet the
results are inconsistent. While either ‘yjja or Iyp has the potential to be a contributor to
ischemic [Kj0-t, the existing studies are sparse and do not allow us to reach a definite
conclusion. The possible role ofI remained yet to be investigated.
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Since KATp is gated by intracellular ATP and regulated by a variety of cellular
metabolites, KATp channel is namrally considered to be a sensor of the metabolic state of a
myocardial ceil, and activation of these channels to be an indicator of cellular metabolic
compromise.39”” However, KA-fp channels do flot open unless intracellular ATP level
([ATP]) drops down to less than 100 tmo1JL; the 1C50 for KATp inhibition is <100 imol/L.
This implies that KATp channels normally stay in closed state because the physiological
[ATP]1 is in the order of millimolar range (5 mmolfL). This is perhaps why the existing
data regarding the role of KATp in ischemic {Kj0-t have been conflicting. Evidence exists
that the KATp channel mediates ischemic K efflux and APD-.1- and most of the evidence
is from studies using KATp inhibitors or openers; KATp inhibitors such as glibenclamide
have been found to effectively reverse ischemia!hypoxia APD-L and the rate of [K]0-
t35,4043 In addition, glibenclamide also exhibits potent antifibrillatory activity, abolishing
irreversible ventricular fibrillation during regional ischemia and during global ischemia.
However, there are also experimental findings against KA-rp channel as a mediator of
ischemic [Kj0-t and APD—L.4’’9 first, the measured [ATP] at the time of metabolic
blockade of acute ischemia is stiil in the millimolar range which is far too high to induce
massive KATp.50’5’ Second, the time-course of KATp channel opening is far too slow to
explain the start of [1(j0-t within the first minute of ischemia. Third, the resuits from
KATp openers and inhibitors have been conflicting; early ischemic [K]0-t and surface
acidification are relatively insensitive to KATp channel inhibition or activation prior to the
ischemic insult48 and KATp opener pinacidil.52 Finally, some blockers of voltage-gated K
channels are effective in preventing and reversing ischemic [K]0-t and APD4; these
include diltiazem.53 Moreover, KATp was found to be inhibited by a variety of lipid
metabolites such as lysophospholipids and arachidonic, linoleic, linolenic, and
eicosatrienoic free fatty acids, which accumulate in ischemic myocardium.38 The role of
KATp channel in response to myocardial ischemia, therefore, has been questioned. It is
thus conceivable that other mechanisms or more specifically other K currents, in
addition to KATp, may also contribute to [K]0-t and APD-1 in ischemic myocardium.
As already described in the introduction, as the major species of
lysophosphatidylcholines that are overproduced and accumulate in ischemic myocardium,
LPC- 16 lias been commonly regarded as a crucial triggering factor for arrhythmogenesis
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of ischemic heart.5456 While the exact mechanisms have flot yet been elucidated, it is
generally accepted that disruption of the cytoplasmic membrane integrity by LPC-16 is
responsible because of the ability of LPC-16 to mcorporate into the membrane lipid bi-
layer. If this is tme then the deleterious effects of LPC-16 would be largely irreversible
and thus many ofthe electrical perturbations ofischemic heart would be inconvertible.
II-3-5-3 I/HERG as an Ionic Determinant and LPC-16 as a Metabolic Trigger
Together Contribute to Ischemic IKJ0-t and “Short QT Syndrome”
Based on the information described above and on our previous studies,24’25 we
propose that ischemic [K]0-t and APD-1- are an event consequent to combined
metabolic stress and ion chaimel dysfiinction. Specifically, IgjIHERG is abnormally
eiihanced during the earïy stage of acute myocardial ischemia and the enhancement is
mainly caused by LPC-16 overproduction and accumulation. The enhancement of
‘Kr/JHERG by LPC-16 is a critical contributor to intracellular K loss/[K]0-t and APD—I
thereby the associated ischemic arrhythmias. In other words, Iyi/’HERG is one of the
important ionic pathways for ischemic K loss and the associated APD shortening. The
present study provides several unes of evidence in support of our hypothesis. First, LPC
16 produced qualitatively the same [K]0-t and QTc-1’ as acute ischemia did. Second, the
[Kj0-t and QTc-’.I’ induced by either ischemia or LPC- 16 were prevented by I/HERG
blocker dofetilide. Third, LPC-16 shortened APD and enhanced I/HERG function,
effects which were again abolished by dofetilide.
One important point to be mentioned here is that the conductance of Ijc/HERG is
known to critically depend upon extracellular K activity; conductance is strikingly
enhanced with increasing extracellular K activity.57’58 It is therefore conceivable that
increase in IKr/IHERG in response to LPC-16 during ischemia results in increase in K
efflux which in conjunction with partial impairment of Nat’IC pump function and
shrinkage of extracellular space leads to [Kj0-t and APD-.I’/QTc-..I’. The increased
extracellular K activity as a result of enhanced IJJHERG in tum promotes ‘Kr”HERG by
enhancing the channel conductance, a positive feedback mechanism.
Another interesting finding of this study concems the mode of LPC- 16 actions on
I/HERG. Our data demonstrate that cardiac membrane repolarization facilitates the
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I/HERG-enhancing effect of LPC-16. This notion is supported by the following data.
first, the I/HERG-enhancing effect of LPC-l6is —2-fold greater with shorter AP or
faster repolarization rate (Figure 8). Considering that APD is shortened during acute
ischemia, or in the presence of LPC-16, relative to control conditions, the I/HERG
enhancing effect of LPC- 16 is expected to be further promoted, another positive feedback
mechanism. Second, also significant is the fact that the IijHERG-enhancing effect of
LPC- 16 is —3-fold greater at negative or repolarized potentials near the resting membrane
potential of the ischemic heart, relative to depolarized potentials positive to O mV (Figure
9). This would imply that LPC-16 can cause increase in K efflux flot only during an
excitation but also during diastolic period. This latter effect might counteract with Na/K
+ . . . +pump so as to weaken the process of K reuptake back into the cell, reinforcing [K ]0
and APD--I-/QTc—L. It is noted that the concentrations of LPC-16 used in this study are
within the range of its level found in ischemic myocardium20’2’ and ifie effects of LPC- 16
are readily reversible upon washout of LPC-16 or by co-application with dofetilide, at
both whole heart level and cellular level. These facts are in favor ofthe idea that LPC-16
acts mainly on HERG channel to produce [IC]0-t and APD-’.I-/QTc-.I- and its potential
penuanent damage to the cytoplasmic membrane does not seem to operate, at least in the
present ischemic model.
The third issue needed to be discussed is that administration with dofetilide
prevents ischemic [Kj0-t but does not alter [K]0 under control conditions (Figure 1C).
On the other hand, dofetilide causes striking prolongation of APD and QTc, regardless of
whether the hearts undergo 10w-perfusion ischemia or whether the superfiision solution
contains LPC- 16. The results suggest that under normal situations HERG channel albeit
+ +
canying K efflux does not cause extracellular K accumulation and only when HERG
function is abnormally enhanced during ischemia or in the presence of LPC-16 does the
excessive K efflux leads to [Kj0-t. This might be one of the explanations for the
selective action ofdofetilide towards diseased state.
We are therefore tempted to propose that there is a quick ionic remodeling process
for ischemic [K]0-t and APD-L/QTc-’1’. Enhanced function of HERG and other ion
channels such as KATp, due to metabolic perturbations (such as accumulation of LPC)
during acute ischemia, causes rapid ischemic [Kj0-t and APD--/QTc-k and the [Kj0-t
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and APD-L/QTc- in tum further enhance the function of HERG channel by directly
increasing HERG conductance and by indirectly increasing the effect of LPC-16 on
HERG amplitude. And this subsequent increase in HERG function will then go on to
amplify [K]0-t and APD4/QTc-1’.
Il-3-5-4 Potential Implication s and Possible Limitations of Our Findings
The present study is, to our knowledge, the first to document the role ofIcjHERG
in ischemic [Kj0-t and QTc-’ and the first to propose the ionic remodeling for ischemic
[Kj0-t and QTc—L with a positive feedback mechanism for abnormal enhancement of
HERG function. Hence, in addition to the paired ATP depletionlKATp activation, LPC
accumulationlHERG enhancement may be considered as another link between metabolic
trigger and ionic pathway, for iscliemic [K1]0-t and QTc-’.I-. This notion provides an
alternative explanation, or one of multiple mechanisms, for ischemic [Kj0-t and QTc-..1-.
Our findings that LPC-16 acts as a metabolic trigger, and HERG as an ionic
pathway, for ischemic [Kj0-t and QTc4 and that ischemic arrhythmias is preventable
and convertible by IK/HERG blocker dofetilide suggest that inhibition of LPC-16
production and accumulation andlor ofIg/HERG may be a promising therapeutic strategy
to attenuate the incidence of Jethal arrhythmias associated with ischemic heart disease.54
56 Nonetheless, it should be mentioned that the initial rapid [K]0-t and APD-i- may be an
adaptive mechanism of cardiac cells to minimize ischemic injuries because [K]0-t may
reduce ceil excitability thereby contractility and energy consumption and APD- can
limit excessive Ca2 entiy so as to prevent intracellular Ca2 overload and celi death.
Unfortunately, this adaptation is at the cost of increased risk of cardiac arrhytbmias, often
lethal arrhythmias. This contradiction creates a difficulty ofhandling [K]0-t and APD-1-.
Obviously, restoration of [Kj0-t and APD4. alone may flot be clearly beneficial to
iscliemic heart. Combination ofIj</HERG blocker and Ca2 channel blocker might be the
way to go because the approach can restore [K]0-t and APD-.I- on one hand and diminish
intracellular Ca2 overload on the other hand. This notion warrants further investigation.
It should also be noted that our study does not provide a definitive link between LPC- 16
and IjHERG due to current lack of LPC-16 inhibitors.
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It is known that inhibition of I/HERG function can generate long QT type of
arrhythmias. Our present study revealed that enhancement of Iy/HERG function can also
be proarrhythmic, causing short QT type of arrhythmias such as reentry and DAD. The
latter concept has actually been proposed by a recent study that describes a form of
inherited malignant ventricular arrhythmias associated with short QT syndrome.59’6° Short
QT syndrome is a genetic syndrome characterized by constantly short QI intervals,
sudden death, short reftactory periods, and inducible ventricular fibrillation. This short
QT syndrome is caused by mutation in HERG gene, which increases HERG function and
can be treated by agents that block IcjHERG. Our data suggest that functional
enhancement of HERG channel activity can produce acquired “short QT syndrome”.
Our experiments with the ‘Ks blockers chromanol 293B and HMR compound
suggest that ‘Ks is unlikely significantly involved in ischemic [K]0-t and QTc-’1-. In
addition, we have also conducted experiments studying the effects of LPC- 16 on ‘Ks in
guinea pig ventricular myocytes and KvLQTY transiently expressed in COS-7 celis and
we found that LPC- 16 did not alter Iy (data not shown). Therefore, contribution of Iy to
ischemic [Kj0-t and QTc4 in our model can be excluded . Nevertheless, in in vivo
system where sympathetic innervation is intact, enhanced adrenergic stimulation during
acute ischemia may well serve to enhance Ix and in this case IKs may also contribute to
ischemic [Kj0-t and QTc-.I-.
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III-1 SUMMARY
Ceramide, a sphingolipid metabolite, has emerged as a key second messenger
molecule that mediates multiple cellular fiinctions. Its de nova synthesis and
accumulation in ischemic myocardium, and congestive heart failure and diabetic
cardiomyopathy have been associated with the pathological processes including the
abnormal QT prolongation (QT-t) and increased risk of arrhythmias. b investigate how
ceramide can be involved in modulating cardiac repolarization, we performed whole-cell
patch-clamp studies on HERG current (IHERG), a critical determinant of cardiac
repolarization, expressed in HEK293 celis. Acute application (bath superfusion for 25
mm) of membrane permeable ceramide (C2, 50 iM) did flot alter ‘HERO. Prolonged
incubation with C2 for 10 hrs caused pronounced ‘HERG inhibition in a concentration
dependent and voltage-independent fashion and positive shifi of voltage-dependent
HERG activation. The 1C50 for IHERG suppression was 19.5 j.iM. C2 did flot affect the
inactivation property and time-dependent ldnetics of IHERG. Similar effects were observed
with production of endogenous ceramide catalyzed by sphingomyelinase. Tyrosine kinase
inhibitors failed to reverse C2-induced suppression of HERG fiinction, and PKA and
PKC inhibitors only slightly reversed the ‘HERO depression. Western blotting and
immunocytochemical analyses indicate that C2 does not alter HERG protein expression
on the cytoplasmic membrane. The inhibitory effect of C2 on JHERG was reversed by
antioxidants vitamin E or MnTBAP. C2 caused considerable production of intracellular
reactive oxygen species (ROS), which was prevented by vitamin E or MnTBAP. We
conclude that ceramide depresses ‘HERG mainly via ROS overproduction and ceramide
induced ‘HERG impairment may contribute to QT-t in prolonged myocardial ischemia,
heart failure and diabetic cardiomyopathy.
Keywords: ceramide, HERG, reactive oxygen species, vitamin E, MnTBAP, QT
prolongation
‘The abbreviations used are: Bis, bisindolylmaleimide; C2, membrane permeable
ceramide; C2, N-acetyl-D-erythro-sphingosine; CM-H2DCFDA, 5-(and-6)-chloromeffiyl-
2’ ,7 ‘-dichlorodihydrofluorescein diacetate; Dihydro-C2, dihydro-, N-acetyl-D-erythro
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sphingosine; Gen, genestein; HA, herbimycin A; MnTBAP, Mn (III) tetrakis (4-benzoic
acid) porphyrin chloride; 02, superoxide anion; OA, okadiac acid; SMase,
sphingomyelinase; VitE, vitamin E.
III-2 INTRODUCTION
Ceramide, a long-chain sphingolipid generated intracellularly on hydrolysis of
sphingomyelin catalyzed by sphingomyelinase (SMase), has emerged as a key second
messenger molecule that is capable of mediating multiple physiological effects including
regulation of cellular differentiation, proliferation, and apoptosis by activating a variety of
signaling cascades, including those triggered by cytoldnes, growth factors, and stress (1-
3). Ceramide generation can be triggered by diverse stimuli and de nova ceramide
synthesis and accumulation takes place in the myocardium under various pathological
conditions such as myocardial ischemia (MI) or hypoxia, congestive heart failure (CHf),
and diabetic cardiomyopathy (DCM) (4-1 1). In these situations, ceramide is involved in
triggering cardiomyocyte apoptosis, cardiac pump failure and cardiac arrhythmias. In
particular, prolongation of action potential duration (APD) and QT interval is a common
feature with regard to cardiac electrical disturbances in chronic MI (12-13), CHF (14-15)
and DCM (16-17).
Upon receiving an incoming impulse, cardiac ceils show a rapid membrane
depolarization followed by a relatively slow repolarization process. Repolarization
disorders, either excessive slowing or accelerating of the rate of repolarization, can cause
cardiac electrical perturbations or arrhythmias. The rate ofrepolarization is determined by
several ion currents, ofwhich the rapid delayed rectifier K current (Iicj) lias a crucial role,
particularly to the plateau phase of action potentials (18-19). The major molecular
component of native I lias been identified as the liuman ether-a-go-go-related gene
(HERG), which generates hc-like current when expressed in heterologous systems (20).
Impairment of Iy.1.IHERG can cause excessive prolongation of APD and QT interval,
which is commonly believed to be a mechanism for both genetic and drug-induced long
QI syndromes. It is important to know whether the sphingolipid metabolite ceramide that
is excessively generated in MI, CHf or DCM can interact with HERG K channels, so as
to have better understanding of the metabolic and ionic mechanisms for the APD/QT
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prolongation in these diseased settings. b this end, we performed studies to investigate
the effects of ceramide on HERG K channel fimction and to elucidate the potential
signaling mechanisms. Our data identified HERG as a target for ceramide action and
intracellular reactive oxygen species (ROS) as a mediator for ceramide-induced
impairment of HERG function.
III-3 EXPERIMENTAL PROCEDURES
III-3-l Celi Culture
HEK293 celis stably expressing HERG (a kind gift from Drs. Zhou and January)
(21) were grown in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with
10% heat-inactivated fetal bovine serum, 200 rM G418, 100 units/ml penicillin, and 100
jig/ml streptomycin, as previously described in detail (22-23).
III-3-2 Whole-CeIl Patch-Clamp Recording
Patch clamp recording of HERG K current (IHERO) has been described in detail
elsewhere (22-23). The Currents were recorded in the whole-cell voltage-clamp mode
with an Axopatch-200B amplifier (Axon Instruments). Borosilicate glass electrodes had
tip resistances of l—3 megohms when fihled with the internai solution containing (mM)
130 KC1, Ï MgC12, 5 Mg-ATP, 10 EGIA, and 10 HEPES (jH 7.2). The extracellular
(Tyrode) solution contained (mM) 136 NaCl, 5.4 KCJ, 1 CaC12, 1 MgCI2, 10 glucose, and
10 HEPES (pH 7.4). Experiments were conducted at 36 ± 1 °C. Junction potentials were
zeroed before formation of the membrane-pipette seal. Series resistance and capacitance
were compensated, and leak currents were subtracted.
III-3-3 Drugs and Treatment
N-acetyl-D-sphingosine, synthetic membrane permeable ceramide (C2),
sphingomyelinase (SMase, the neutral form with long-lasting activity), forskolin (FSK,
PKA activator), H89 (PKA inhibitor), Phorbol 12, 13-Dl-Decanoate (PDD, PKC
activator), bisindolylmaleimide (Bis; PKC inhibitor), okadiac acid (OA), and vitamin E
(VitE) were purchased from Sigma (Oakville, ON). Dihydro-, N-acetyl-D-eiythro
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sphingosine (dihydro-C2, an inactive analogue of C2), herbimycin A (HA, PTK inhibitor)
and genistein (Gen, PTK inhibitor) were purchased from Calbiochem (La joua, CA).
PDD, Bis, C2, dihydro-C2, HA, Gen, and FSK were dissolved in DMSO. OA was
dissolved in phosphate-buffered saline (PBS). SMase was prepared in a worldng solution
of 50% glycerol containing 50 mM Tris-HC1. AIl agents were prepared as 1000 X stock
solutions and stored at —20°C.
for acute exposure, drngs were added to the bathing solution 10 min afier baseline
recording and the current amplitudes before and after drugs were compared. For
prolonged exposure, celis were incubated in normal culture medium containing agents at
the desired final concentrations for 10 hrs prior to patch-clamp recordings and group
comparison between treated and untreated celis (treated with the same vehicles as for
drug treatment groups) was made. Step IRG was defined as the cunent amplitude at the
end of the 2.5-sec depolarizing voltage steps and tail ‘HERG was measured as the peak
value of the decaying tail currents upon repolarization to —50 mV. To have more rational
comparisons between groups, JHERG density was calculated by dividing the current
amplitude by the capacitance of the same ceil. For experiments involving protein kinase
inhïbitors, cells were pre-incubated with the drugs for 2 hrs before exposure to C2.
III-3-4 Western Blot
The procedures for measuring HERG protein levels were essentially the same
as described previously (24). The primary antibody, polyclonal anti-HERG raised in
rabbit against highly purified peptide (CY) EEL PAGAPELPQD GPT, corresponding to
residues 1118-1133 of human HERG was purchased from Alomone Labs (Jerusalem,
Israel). Bound antibodies were detected using the chemiluminescent substrate (Western
Blot Chemiluminescence Reagent Plus, NEN Life Science Products, Boston, USA) and
quantified using a Phosphorimager (Bio-Rad). The presence of HERG channel proteins
was verified by the presence of a prominent band with expected molecular mass in the
range of previous reports and by elimination of the band in preparations preincubated
with the antigenic peptide. Coomassie staining was performed to verify equal protein
loading for each sample.
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III-3-5 Immunocytochemistry
The procedure was the same as previously described in detail (24). The anti HERG
antibody was the same as used for Western blot analysis. The celis were examined under
a Laser scanning confocal microscope (Zeiss LSM 510).
III-3-6 Intracellular Reactive Oxygen Species (ROS) Measurement
The procedures have been described in detail previously (25). CM-H2DFDA from
Molecular Probes was used to detect oxidative activity in living ceils. Ceils were divided
into 5 groups: control group, C2 i0-hrs group, C2 20-min group, C2+VitE, and
C2+MnTBAP group. For experiments involving VitE or MnTBAP, the ceils were
pretreated with VitE (100 jiM) or MnTBAP (5 jM) for 2 hrs and then incubated in the
culture medium containing C2 in the continuai presence of VitE or MnTBAP. The
percentage of positively stained ceils and the fluorescence intensity of staining were
determined by densitometric scanning with LSM software (Zeiss).
III-3-7 Data Analysis
Group data are expressed as mean ± s.e.m. Comparisons among groups were made
by analysis of variance (f-test) and Bonferroni-adjusted t-tests were used for multiple
group comparisons and paired or unpaired t-test was used, as appropriate, for single
comparisons. A two-tailed p < 0.05 was taken to indicate a statistically significant
difference. Nonlinear least square curve fitting was performed with CLAMPFIT in
pCLAMP 8.0 or GraphPad Prism.
III-4 RESULTS
III-4-1 Effects of membrane permeable ceramide on ‘HERG expressed in HEK293
Celis
Depolarizing voltage steps from —60 mV to +40 mV elicited delayed rectifier type
of outward currents with characteristic inward rectification that manifests at stronger
depolarization. Upon repolarization back to —50 mV, slowly decaying tail currents are
recorded. Application of the membrane permeable ceramide (C2) to die superfiisate at a
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concentration of 25 iM for up to 20 min did flot significantly alter the HERG currents
(figure lA), suggesting that ceramide does flot directly act on the HERG channels.
Acute Exposure
A Control C2 (50 jM, 20 mm)
___
.8OmV_j
I sec
Prolonged Exposure
B Control C2 (5 tM, 10 hrs) C2 (25 iM, 10 hrs)
I sec
Figure 1. Analog data showing the effects 0f membrane permeable ceramide fC2) on
HERG current fIHERG) expressed in HEK293 celis. For acute exposure (A), C2 was applied ta the
Tyrade solution for patch-clamp recordings and currents recorded up ta 20 min superfusion with C2
were taken to measure the dwg effect as compared with the befare-drug values. For prolonged
exposure (B), HEK293 cells were preincubated with C2 in the normal culture medium for 10 hrs
before patch-clamp studies and the current amplitude was normalized to celi capacitance ta minimize
the inter-celi variations of celi size for group comparison with untreated celis. IRERG was elicited by 2.5-
s depalarizing pulses ta voltages ranging from —60 ta +40 mV ta record the step current, followed by
2.5-s repalarizatian step ta —50 mV ta record the tail current, as shawn with the voltage protacol
shown in the inset.
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In contrast to the acute exposure, preincubation ofcells with C2 (1-50 j.tM) in the
culture medium for 10 hrs caused consistent changes of IHERG in two different ways. First,
IHERG density was decreased by C2 at a concentration-dependent (Figure lB and Figure 2)
and voltage-independent (Figure 2D) manner. The 1C50 of C2 for IHERG suppression was
calculated by the Hill equation to be 19.5 jiM. Second, the steady-state voltage-dependent
activation of HERG channels was appreciably shified by C2 towards depolarizing
voltages (Figure 2B). for example, the voltage for haif maximum activation (V1,2) was
changed from —27.0 ± 0.5 mV (n=27) to —24.2 ± 1.0 mV (n=13, p<O.05 vs. control) and —
22.0 ± 1.1 mV (n=17, p<O.O5) by 1 and 5 iM C2, respectively, with no changes in the
slope factor (k). Intriguingly, the 1C50 for the V1,2 shifi was around 1.1 tM, some 20-fold
lower than the effect on the current density. Higher concentrations of C2 (10, 25 and 50
tM) did flot produce ffirther shifi of ‘HERG activation. Dihydro-C2 (25 p.M), the inactive
analog of C2, failed to cause any appreciable alterations of ‘HERG (Figure 2A). No effects
of C2 on HERG kinetics and inactivation properties were obsewed (data flot shown).
III-4-2 Effects 0f endogenous ceramide generated by sphingomyelinase on 1RG
To verify the modulation of IHERG by ceramide and the potential
pathophysiological implication, we studied the effects of sphingomyelinase (SMase) that
catalyzes production of endogenous ceramide on ‘HERO. Qualitatively the same effects
were observed with SMase as with exogenously applied C2. SMase significantly
decreased ‘HERG in a concentration-dependent but voltage-independent manner (Figure 3).
SMase also produced positive shifis of ‘HERG activation voltage; Vi12 was changed from -
30.6 ± 0.6 mV (n25) for control to -27.3 ± 0.8 mV (n20, p<O.OS) and -24.4 ± 0.6 mV
(n= 13, p<0.05) in the presence of 0.2 U/ml and 0.6 U/ml SMase, respectively. SMase did
flot affect the activation and deactivation kinetics and inactivation properties of HERG
channels (data not shown).
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-*C2 (1 iM) 1.0 À C2 (1 1.tM)
o -O-C2 (5 i.aM) 0.8 C2 (5 1.M)
-.-C2(10jM) • C2f25M)JF\ -V—C (25 0.6
_________
(25M) 0.4
-60 40 -20 0 20 40 -50 40 -30 -20 -10 0
Test Potential (mv) Prepulse Potential (mv)
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IC=19.5(M) 70
50M
Log10[C2] (j.iM) Test Potential (mv)
Figure 2. Characterization of IHERG with prolonged exposure to ceramide f C2). (A) current
density-voltage relationships. Shown are mean values from n=13 ceils for contrai (Ctl), n=12 for 1
IJM 02, n=14 for 5 pM, 10 pM, 50 pM C2, and 25 pM for dihydro-C2 (the inactive analogue of C2),
respectively. (B) Steady-state voitage-dependent activation curves. The activation curies were
constructed by plotting the conductance G as a function of depolarizing potentials. G was
calculated by normalizing the tau currents at -50 mV by dividing the amplitude of the tau currents
measured at various antecedent depolarizing potentials by that of the tau current at +40 mV.
Symbols are mean of experimental data and unes represent the Boitzmann fit:
G/Gmaxl/{1+exp[(ViV)IkJ}, where Gmax represents the maximal conductance at +40 mV, Vv2 S
a hait-maximal activation voltage, and k is a slope factor. Note that C2 produces positive shift of
HERG activation. (C) Concentration-dependent black of IHERG by 02. Symbols are experimental
data and the curie represents the fit ta the Hill equation: Y=B+(TB)I(1+10hi((LoglCso[C2]o)*n)),
where Y s the percentage of IHERG inhibition, B is the minimum inhibition and T the maximum
inhibition observed, 1050 represents the concentration of C2 [C2J0 for half-maximal inhibition of IHERG,
and n represents the Hill coefficient. (D) Percent decrease in IHERG produced by various
concentrations of C2. *P<005 vs. Ctl.
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Figure 3. Characterization of IHERO depression caused by sphingomyelinase (SMase). (A)
Current density-voltage relationships. Shown are mean values from n=19 ceils for control (Cti), n9
oeils for 0.1 U/mi SMase, n=17 oeils for 0.2 U/mi SMase, n=8 oeils for 0.4 U/mi SMase and n13
oeils for 0.6 UJmi SMase. (B) Steady-state voitage-dependent activation curves. Note that similar to
02, SMase also produces positive shifts of HERG activation. (C) Concentration-dependent block cf
IHERG by SMase. Symbols are experimental data and the curve represents the fit to the Hill equation.
(D) Percent decrease in IHERG produced by various concentrations of SMase. * P<O 05 vs. Ctl.
III-4-3 Effects of inhibitors to PTK, PICA or PKC on ‘HERG modulation by
Ceramide
It has been shown that ceramide inhibits T lymphocyte voltage-gated potassium
channel via tyrosine phosphoiylation of the channel proteins (26). On the contrary, the
IHERG-like current has been found to be enhanced by protein tyrosine kinase (PTK)
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activation in MLS-9 rat microglia celi une (27). b investigate whetlier this mechanism
also applies to HERG modulation by ceramide, we evaluated the effects of two PTK
inhibitors herbimycin A (HA) and genistein (Gen). As illustrated in Figure 4A,
preincubation of celis with FIA (5 j.iM) alone for 2 bis remarkably suppressed IHERG
(—66% at O mV) to a similar extent as the IHERG inhibition caused by 25 tM C2 (—58% at
o mV). Co-incubation of ceils with HA and C2 caused a slightly further decrease in ‘HERG
(by —77%). Similarly, Gen alone also reduced ‘HERG albeit to a less extend compared with
C2. Pretreatment with Gen ($0 tM) did not alter the effects of C2 on IHERG density
(Figure 4B).
Ceramide is characterized by its ability to simulate activation of the atypical
protein kinase C (PKC) (28). PKC can be inhibited by a phospholipase C inhibitor
okadiac acid (OA). Our expenments demonstrated that OA (1 tM) alone significantly
diminished ‘HERG and pretreatrnent of celis with OA failed to prevent ‘HERG reduction
induced by C2; instead, further decreases in ‘HERG were found in the presence ofboth OA
and C2 (Figure 4C).
PKA phosphorylation of HERG channels was shown to cause reduction of current
amplitude due to positive sbift of HERG activation voltages (29-30). To investigate the
potential involvement of PKA pathway in mediating ceramide-induced
‘HERG depression,
we assessed the effects of a PKA inhibitor H89. As illustrated in Figure 5A, incubation of
cells with 1189 (1 jiM) alone for 10 bis produced a marked shift of the HERG I-V
relationship and activation curve towards more negative potentials. The maximum step
JHERG was unaltered despite that because of the positive shift, ‘HERG was increased at
potentials negative to —10 mV and decreased thereafter. The maximum tail ‘HERG,
however, was reduced by approximately 11%. Pretreatment with 1189 only slightly
reduced the degree of C2-induced
‘HERG diminishment (Figure 5A).
PKC is another target of ceramide action. b investigate the possible involvement
of PKC in mediating
‘HERG modulation by ceramide, we evaluated the effects of a PKC
inhibitor bisindolylmaleimide (Bis, 0.1 j.iM) on C2-induced ‘HERG depression. Celis
treated with Bis alone for 10 bis had significantly smaller IHERG density (30.5 ± 2.2 pA/pF,
n=22, p<O.O5) compared with control untreated ceils (39.8 ± 2.8 pAIpf, n=22) (Figure
5B). The ‘HERG activation property was not different between Bis and control groups. Bis
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Figure 4. Effects of inhibitors of tyrosine protein kinases (TPKs) and atypical protein
kinase C (PKC) on IHERG modulation by ceramide (C2). Left panels: current density-voltage
relationships; right panels: steady-state voltage-dependent activation curves. PIK inhibitors
herbimycin A (HA, 5 pM) and genestein (Gen, 80 pM); PKC inhibitot okadiac acid (OA, 1
Comparisons were made among 4 groups: Ctl-control untreated cells (Ctl), C2-cells treated with C2
alone, cells treated with an inhibitor alone, and cells co-incubated with an inhibitor and C2 for 10 hrs
after 2-hrs preincubation with the inhibitor alone. *P<0.05 vs. Ctl.
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pretreatment partially reduced C2-induced ‘HERG depression (figure 6A). Similarly,
pretreatment with another PKC inhibitor cherylethrine (1 iM) partly restored C2-induced
‘HERO reduction and cherylethrine alone also significantly decreased ‘HERO (data not
shown).
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Figure 5. Effects of inhibitors of protein kinase A fPKA) or protein kinase C (PKC) on
IHERG modulation by ceramide (C2). (A) Effects of PKA inhibitor H89 (1 pM) on C2-induced IHERG
depression. Left panels: current density-voltage relationships; right panels: steady-state voltage
dependent activation curves. For experiments involving co-application of H89 and C2, the cells wete
preincubated with H89 for 2 hrs and then incubated with C2 (5 pM) in the presence of H89 for 10 hrs
before patch-clamp recordings. *p<o 05 vs. CtI. (B) Effects of PKC inhibitor bisindotylmaleimide (Bis)
on C2-induced IHERG depression. Left panels: current density-voltage relationships; right panels:
steady-state voltage-dependent activation curves. For experiments involving co-application of Bis and
C2, the celis were preincubated with Bis for 2 hrs and then incubated with C2 (5 pM) in the presence
of Bis for 10 hrs before patch-clamp recordings. *p<0 05 vs. Ctl.
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III-4-4 Lack of effects of ceramide on HERG protein expression Jevel
There is a possibility that the decrease of ‘HERG in presence of ceramide was due to
down-regulation of HERG channel protein expression. To test this notion, we carried out
Western blot analysis with membrane protein samples extracted from HERG-expressing
HEK293 celis to compare the HERG protein levels between control celis and C2-treated
ceils. As shown in Figure 6A, anti-HERG antibody recognized a band of —135 kDa,
consistent with the molecular mass of HERG protem (21, 24), and the band disappeared if
the antibody had been pretreated with its antigenic peptide. HERG protein levels were
comparable between the C2-treated cells and control untreated celis.
This resuit was further reinforced by our immunocytochemical analysis
demonstrating similar pattern and intensity of HERG staining on the surface membrane
between C2-treated cells and control untreated celis (Figure 6B).
111-4-5 Role of reactive oxygen species (ROS) in ‘JiiRG modulation by ceramide
It has been well established by numerous smdies that ceramide can act on
mitochondria and stimulate production of ROS, particularly superoxide anion (02) (2,
3 1-32). We have previously demonstrated that 02 causes impairment of HERG K
channel function (25). It is quite plausible that C2-induced depression of ‘HERG is related
to increased ROS generation. We tested this notion by preincubating the cells with
vitamin E (VitE, 100 .iM) alone for 2 hrs and then incubating the ceils with C2 (25 1iM)
in the continuai presence of VitE for another 10 hrs. As shown in Figure 7A, VitE
substantially weakened the depressing effects of C2, but VitE alone did not produce any
appreciable effects, on ‘HERG. For example, ‘HERG density was —50% smaller in control
than in the celis pretreated with C2 alone, but it was only —24% smaller in the ceils
pretreated with both VitE and C2. In other words, ‘HERG density in the VitE+C2 group
was approximately 52% greater than in the group with C2 alone (48.2 ± 3.2 pAIpF, n=19,
vs. 3L7 ± 2.0 pA/pF, n=16,p-<0.05), at O mV (Figure 7A). Furthermore, Mn (III) tetrakis
(4-benzoic acid) porphyrin chloride (MnTBAP), a superoxide dismutase (SOD) mimic,
resembled the effects ofVitE; it reversed C2-induced ‘HERG reduction (Figure 7B).
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Figure 6. Expression level of HERG protein determined by immunoblotting with
membrane protein preparations extracted from HERG-expressing HEK293 celis. (A) Upper
panel: examples cf immunoblotting bands of —135 kDa, corresponding to the molecular mass of
HERG protein, from 02 treated (02) and untreated ceNs (Ctl). Celis were incubated with C2 (25 pM)
for 10 hrs in the culture medium prior to the procedures for membrane protein extraction. Lower
panel: mean band density from 3 independent protein samples. AP-, without antigenic peptide
pretreatment for anti-HERG antibody; AP+ with antigenic peptide pretreatment for anti-HERG
antibody. (B) Upper panel: examples of immunocytochemical staining of HERG proteins on the
cytoplasmic membrane. Lower panel: averaged data from four independent experiments, showing
% cells with positive staining with anti-HERG antibody and intensity of staining.
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Figure 7. Role of reactive oxygen species (ROS) on IHERG modulation by ceramide (C2).
(A) Effects of vitamin E (VitE) on C2-induced IHERG depression. (B) Effects of MnTBAP, a superoxide
dismutase mimic, on C2-induced IHERG depression. Left panels: current density-voltage relationships;
tight panels: steady-state voltage-dependent activation curves. The celis were preincubated with VitE
(100 pM) or MnTBAP (5 pM) for 2 hrs and then incubated with C2 (25 pM, n=16 cells) in the
presence of VitE (n=16 celis) or MnIBAP (n=16 cells) for 10 hrs before patch-clamp recordings.
*P<005 vs. Ctl (n=14 celis).
To confirm that ROS production was indeed increased by C2 and the C2-induced ROS
was mainly of 02, we proceeded to measure the intracellular ROS levels using CM
H2DCFDA fluorescence dye. The ROS level was measured in ceils incubated with the
culture medium containing 25 p.M C2 for 10 brs. The celis showing fluorescence intensity
5 times the background were defined as positive staining, and the number of celis with
positive staining was pooled from 5 fields for each batch ofcells (a total of 4 independent
batches of ceils for each group were smdied). The intensity of staining by the fluorescent
probe for ROS was analyzed by densitometric scanning using the LSM program, and ceils
with positive staining were taken for analysis, and the data were normalized to the control
values. Under control conditions, ceils with positive staining were sparse. Yet in the ceils
treated with C2, the number of the ceils with positive staining, as well as the intensity of
staining, was consistently higher. If pretreated with VitE or MnTBAP prior to exposure to
C2, the ceils had significantly lower ROS levels, as indicated by the smaller number of
positively stained ceils and the weaker intensity of staining (Figure 8A and $B). Since 20
min superfiision of ceils with C2 failed to affect ‘HERG, we also conducted CM
H2DCFDA experiments with celis treated with C2 for only 20 min. In sharp contrast with
10-hrs exposure, 20 min treatment did flot alter the level ofintracellular ROS.
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Figure 8. Effects of vitamin E (VitE) or MnTBAP (an SOD mimic) on intracellular levels
of ROS measured by CM-H2DCFDA fluorescence dye. (A) and (B) Upper panels: laser
scanning confocal microscopic images of CM-H2DCFDA staining reflecting the intracellular ROS
levels. Lower panels: percentage of positively stained celis (mean ± S.E.), obtained from 5 fields of
4 experiments by counting the cells with staining intensity 5 times the background and averaged
intensity cf CMH-2DCFDA fluorescence measured from the positively stained cells. Data were
obtained from control untreated cells (Ctl), cells treated with C2 (25 pM for 20 min or 10 hrs), and
ceils pretreated with VitE (100 t.JM) or MnTBAP (5 pM). *p.<005 vs. Ctl; +P<0.05 vs. C2.
111-5 DISCUSSION
The present study identifies HERG K channel as a new target for ceramide action.
The major findings of the study are: (1) prolonged exposure (chronic incubation), but flot
brief exposure (acute superfusion), of celis to C2 significantly impairs HERG K1 chaimel
function and (2) stimulation of intracellular reactive oxygen species (ROS) by C2
mediates the depressing effects of C2 on HERG iC channel function. In view of the
critical role of HERG K channel in regulating cardiac repolarization and the fact that
ceramide is overproduced in MI, CHF or DCM, it is possible that HERG impairment by
ceramide contributes to the electrical disturbances in these pathological conditions.
It has been reported that the HERG-equivalent K current in rat microglia MLS-9
ceil (27) is significantly reduced by inhibitors of PTK, indicating the role of PTK in
maintaining HERG flinction. Consistent with these findings, our data demonstrated that
PTK inhibitors herbimycin A and genestein alone both markedly depressed
‘HERG
amplitude, indicating a role of basal PTK activity in maintaining HERG function. Co
application of these inhibitors with ceramide did flot alter ceramide-induced IHERG
depression, or if anything, caused further reduction of ‘HERG. The latter suggests that
ceramide lias the ability to enhance HERG function and partially offsetting its inhibitory
effect by stimulating PTK activities, but failed to do so in the presence ofPTK inhibitors.
Thus, PTKs do not account for ceramide-induced
‘HERG depression. Involvement of PKA
or PKC in ceramide-induced IHERG depression appears to be minimal, if any. This
conclusion was drawn on the basis that neither PKA inhibitor H89 nor PKC inhibitor Bis
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significantly reversed the effects of C2, despite that these compounds themselves when
applied in the absence of C2 produced direct effects on ‘HERG• Obviously, these direct
effects of H89 and Bis are unlikely related to ceramide action on ‘HERG, but the positive
shifi of HERG activation may be caused by PKA because H$9 completely abolished
ceramide-induced shifi.
A growing body of evidence is emerging indicating that oxidative stress and
ceramide generation are intimately connected in celi death signaling. The major source
for ROS in most celi types is probably the electron leakage from the mitochondrial
electron transport chain, which resuits in the formation of superoxide anion (02).
Experimental evidence indicates that celi-permeable ceramide analogs elicit a direct
effect on mitochondria, ranging from inhibition of the respiratory chain and ROS
overproduction to induction of mitochondrial permeability transition in intact celis and
cytoplasts (33-34). Several studies have identified the mitochondrial ubiquinone pool of
complex III (a protein complex that links proton transiocation to electron transfer from
ubiquinone to cytochrome c) as a ceramide target to produce RO$. Indeed, it has been
reported that MnTBAP, an SOD mimic, inhibits ceramide-induced apoptosis in neuronal
celis (35). The present study confirmed that C2 stimulates intracellular production of
ROS as indicated by the increased ROS level and the increase was attenuated by VitE.
Furthermore, our data suggest that C2-induced generation of ROS was mainly of O{
because MnTBAP nearly abolished the ROS increases. These data are consistent with the
electrophysiological resuits that VitE or MnTBAP reversed the C2-induced reduction of
‘HERG amplitude. The fact that 20 min superfusion of the ceils with C2 failed to affect
‘HERG in our experiments (Figure lA) may well be due to failure of C2 to increase ROS
within such a short time frame and this notion is indeed supported by the data shown in
Figure 8A. In other words, the reason why prolonged exposure (>2.5 hrs) was required
for C2 to produce effects on ‘HERG is that sufficient level of ROS needs to be raised with
time in the presence of C2 to affect ‘HERG. The ability of ceramide to induce ROS
production in cultured neonatal rat ventricular myocytes has indeed been recently
confirmed by Suematsu et al (36). Noticeably, neither VitE nor MnTBAP altered C2-
induced positive shifi of HERG activation, indicating that ROS is flot responsible for
ceramide-induced shifi.
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The present study has several important pathophysiological implications. first, it is
known that ischemic myocardium demonstrates characteristic bi-phasic changes of
electrophysiology with APD shortening during early phase of acute ischemia and
subsequent APD lengthening after prolonged ischemic period, which are associated with
different types of arrhythmias (12-13). However, the ionic meclianisms underlying these
sequential alterations ofAPD remained unresolved. This study together with our previous
work seems to provide an explanation. It is well recognized that altered lipid metabolism
is an important deleterious factor in ischemic myocardial injury; some lipid metabolites
such as lysophosphatidylcholines (LPCs) are overproduced rapidly within the first 10 min
of acute myocardial ischemia, while others like ceramide accumulate progressively in the
late phase (30 min afier) of ischemia (1-3, 7). We have recently reported that LPCs
produce pronounced enhancement of HERG fimction (22-23). This finding may explain
in part the APD shortening and the associated arrhythmias occurring in the early phase of
ischemia. On the other hand, in vitro ischemia leads to a progressive accumulation of
ceramide in cardiomyocytes. The content of ceramide in ischemic area was found to be
elevated to 155% baseline levels after 30 mm, and to 330% afier 210 mm, of ischemia.
Ischemia (30 mm) followed by reperfusion (180 mm) increased the ceramide level to
250% in the ischemic area (4). In another study, the total basal ceramide concentration in
the myocardium was 135 nmol/g tissue, and it was increased by 14.1% and 48.4% in 30
min global ischemia and 30 min ischemial30 min reperfusion groups, respectively (5).
Cordis et al (6) showed a 50% decrease of sphingomylein both during ischemia and
subsequent reperfusion with a corresponding increase in ceramide. Another study
suggests that a longer time period (>30 mm) may be needed to alter ceramide mass in
tissues in response to ischemic insuit (7). Intriguingly, the cardiac AP is abnormally
lengthened after prolonged ischemia (12-13). In lieu of the critical role of HERG K
channel in cardiac repolarization and the ability of ceramide to inhibit ‘HERG, it 5 tempting
to speculate that JHERG depression produced by ceramide that accumulates during the late
phase of myocardial ischemia might contribute to the observed prolongation of APD and
the associated arrhythmias.
The second implication of our study is related to arrhythmias in CHf. One
characteristic electrophysiological alteration in CHF is abnormally prolonged APD at the
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cellular level and QI interval as reflected in electrocardiogram (15, 37). This
prolongation provides an electrophysiological substrate for early afterdepolarizations
(EADs) to occur, which can result in ventricular tachycardias that often predispose to
ventricular fibrillation leading to sudden cardiac death (14). Polymorphic ventricular
tachycardias, likely related to arrhythmogenic EADs, are common in CHf (14). The ionic
mechanisms underlying APD prolongation in CHF have flot been precisely defined.
Intriguingly, de novo ceramide synthesis has been found to be increased in heart failure
(8). Increased ceramide level in cardiomyopathy can cause impairment ofHERG function
and resuit in excessive APD prolongation. More importantly, our data demonstrate that
ROS mediates the inhibitory effect of ceramide on IHERG and antioxidants can prevent the
IHERG depression. This explains at Ieast partly the benefits of antioxidants in preventing
and suppressing arrhythmias in ischemic myocardium and failing hearts (3$-39). Indeed,
Tsuji et aÏ. (40) showed Iy, measured as E-4031-sensitive tau current, to be -36%
smaller in rabbits with ventricular tachypacing-induced CFIF than in healthy rabbits.
Lodge and Normandin (41) demonstrated earlier that IiCj, measured as dofetilide-sensitive
tau current, reduced by -45% in the BIO 10-2 strain of cardiomyopathic hamster of 10
months old, derived from the BIO 53.58 animaIs and providing a model of dilated low
output heart failure, compared with the 10-month-old control (BIO F13) hamsters.
Moreover, simulations of cellular electrophysiology predict lvj inhibition to cause EADs
in failing, but not nonfailing, myocytes (42).
finally, the results of this study also have implications in diabetic cardiomyopathy
(DCM). DCM is characterized by electrical remodeling with aberrant electrophysiology,
metabolic remodeling with malignant biochemical processes and anatomical remodeling
with progressive loss of cardiomyocytes, which resuit in impaired cardiac contractile and
increased risk of lethal arrhythmias. QT prolongation and QT dispersion have been
suggested as the predictor of mortality in both type I and type 11(16-17, 43). It has been
documented that de nova synthesis and accumulation of ceramide in diabetic myocardium
contributes to the development of DCM (8, 10-1 1). In addition, oxidative stress is also
known to be a critical deleterious factor for DCM (44-45). Moreover, we have recently
found that L</HERG function is impaired in the rabbit model of DCM (46). Taken
229
together, it seems plausible that ceramide-induced HERG depression may be one of the
multiple determinants for diabetic QT prolongation.
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IV-1 ABSTRACT
Congestive heart failure (CHF) is associated with susceptibility to lethal
arrhythmias and typically increases levels of tumor necrosis factor-Œ (TNf-a) and its
receptor, TNFR1. CHf down-regulates rapid delayed-rectifier K current (Iy) and delays
cardiac repolarization. We studied the effects of TNf-a on cloned HERG K channel
(human ether-a-go-go-related gene) in 11EK293 ceils and native ly.j in canine
cardiomyocytes with whole-cell patch clamp techniques. TNF-o consistently and
reversibly decreased HERG current (IHERG). Effects of TNF-a were concentration
dependent, increased with longer incubation period, and occurred at clinicafly relevant
concentrations. TNf-Œ had similar inhibitory effects on Ig and markedly prolonged
action potential duration (APD) in canine cardiomyocytes. Immunoblotting analysis
demonstrated that HERG protein level was slightly higher in canine hearts with
tachypacing-induced CHF than in healthy hearts, and TNF-a slightly increased HERG
protein level in CHF but not in healthyhearts. In celis pretreated with the inhibitory anti
TNFRÏ antibody, TNf-Œ lost its ability to suppress ‘HERO, indicating a requirement of
TNfRÎ activation for HERG suppression. Vitamin E or MnTBAP (Mn (III) tetrakis (4-
benzoic acid) porphyrin chloride), a superoxide dismutase mimic) prevented, whereas the
superoxide anion generating system xanthine/xanthine oxidase mimicked, TNF-a-induced
IHERG depression. TNF-a caused robust increases in intracellular reactive oxygen species,
and vitamin E and MnTBAP abolished the increases, in both HEK293 ceils and canine
ventricular myocytes. We conclude that the TNF-&TNFR1 system impairs HERG/Iy
firnction mainlyby stimulating reactive oxygen species, particularly superoxide anion, but
not by altering HERG expression; the effect may contribute to APD prolongation by
TNf-u and may be a novel mechanism for electrophysiological abnormalities and sudden
death in CHF.
IV-2 INTRODUCTION
TNF-Œ is a potent inducible cytokine with pleiotropic biological effects (1). Up
regulation of TNf-a is a consistent finding in clinical (2) and experimental CHF (3).
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Circulating concentrations of TNF-Œ and soluble TNfŒ receptors are independent
predictors of mortality in CHF (4).
Patients with CHF are at increased risk of sudden death due to cardiac arrhythmias.
CHf increases action potential duration (APD) (5), leading to early afterdepolarizations
(EADs) and lethal ventricular tachyarrhythmias (6). Polymorphic ventricular tachycardias,
likely related to arrhythmogenic aflerdepolarizations, are common in CHF (6, 7). The
molecular mechanisms underlying APD prolongation in CHF remain incompletely
understood.
The rapid delayed rectifier K current (lys) is crucial in cardiac repolarization. The
human ether-a-go-go-related gene (HERG) encodes the pore-forming Œ-subunit of Iy and
congenital or dnig-induced abnormalities in HERG protein function are a common cause
ofthe long QT syndrome. Simulations of cellular electrophysiology predict I inhibition
to cause EADs in failing, but not nonfailing, myocytes (8). A recent study demonstrated
that transgenic mice overexpressing TNF-a with heart failure had significantly prolonged
APD (9). It is unknown whether TNF-a affects cardiac K channels. We therefore
examined the hypothesis that TNf-Œ might affect HERG/I1, thereby potentially
contributing to CHf-related repolarization abnormalities.
IV-3 EXPERIMENTAL PROCEDURES
IV-3-1 Ccli Disposition
HEK293 celis stably expressing HERG were a kind gift from Drs. Zhou and
January. Ceil culture and handling procedures have been described previously (10).
Cardiomyocytes were isolated from healthy aduit mongrel dogs as described in detail
previously (11, 12). The procedures for animal use were in accordance with institutional
guidelines.
IV-3-2 Whole-cell Patch Clamp Recording
Patch clamp techniques have been described in detail elsewhere (13—16).
Experiments were conducted at 36 ± 1°C. for current recordings in canine cardiomyocyte
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studies, the followings were included in the bath solution to block contaminating currents:
CdCl2 (200-i.imol/liter, L-type Ca2 cunent), 4-aminopyridine (1 mmollliter, transient
outward K currents), glyburide (10 jimolJliter, ATP-sensitive K current), and 293B (10
imoI/liter, slow delayed-rectifier IC current). Action potentials were recorded in the
current clamp mode with Tyrode solution free of ion channel blockers. TNF-a was either
added to the extracellular solution 10 min afier formation of whole-cell configuration
(acute studies), or celis were incubated with TNf-Œ in the medium for 10 h before patch
clamp recording (long term exposure).
IV-3-3 Western Blot
The procedures were similar to those described previously (15). Polyclonal anti
HERG raised in rabbit against highly purified peptide (CY) EEL PAGAPELPQD GPT,
corresponding to residues 1118—1133 of human HERG was purchased from Alomone
Laboratories (Jerusalem, Israel).
IV-3-4 Intracellular Reactive Oxygen Species (ROS) Measurement
5-(and-6)-Chloromethyl-2’,7’-dichlorodihydrofluorescein diacetate (CM-H2DFDA)
from Molecular Probes was used to detect oxidative activity in living ceils as described
details previously (16).
IV-3-5 Data Analysis
Group data are mean ± S.E. Paired t tests were used for single comparisons.
Kinetics was analyzed with CLAMPFIT (pCLAMP 8.0) or Graphpad Prism.
IV-4 RESULTS
IHERG was elicited by 2-s depolarization followed by 2-s repolarizing steps (Figure
1, biset). Cunents were recorded immediately afier formation of whole-cell configuration
and series resistance compensation. Comparisons were made between control celis
(without TNF-Œ) and cells incubated for 10 h with various TNF-Œ concentrations from
0.01 to 10 ng/ml, which are within the pathophysiological range of TNF-Œ levels (‘-0.1
ng/ml) (17—19).
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Figure 1. Impairment of HERG function by TNF-cx. A, effects of 10-h exposure to various
concentrations of INF-cx (in ng/ml) Ofl li- stably expressed in HEK293 celis. Original recordings
are shown in the upper panels, mean current-voltage relations in the lower lefi panel and mean
ratios of IHERG in TNF-a-treated to untreated ceNs in the lowet right panel. n = 15 for control; n = 13,
17, and 15 for TNF-cx 0.01, 0.1, and I ng/ml, respectively. For 0.01 ng/ml TNF-a, p < 0.05 for
voltages from —40 to O mv; for 0.1 ng/ml TNF-a, p <0.01 at 40 and —30 mV and p < 0.05 from —
20 to +20 mV; for 1 ng/ml TNF-cx, p < 0.01 at —40 and —10 mV and p < 0.05 from O to +40 mV. B,
effects of acute exposure to TNF-cx (100 ng/ml) on IHERG in HEK293 cells. Shown are mean data (n
= 5) from the tail IHERG recorded at —50 mV with original recordings (test pulse: O mv) in the inset. C,
effects of bath application of TNF-cx (100 ng/ml) on l in dog striai myocytes, elicited with voltage
protocol shown in the inset. Shown are mean (n = 4) l tail currents elicited at a repolarizing
voltage of —30 mV with original recordings (test pulse: O mV) in the inset. D, effects of TNF-cx (10
ng/ml, 6-h incubation at 4 °C) on action potential duration in canine ventricular cells (n = 15 for
each group). The horizontal lines within the action potential recordings indicate the zero voltage
level. , p < 0.05 and , p <0.01 versus control (CII).
‘HERG density was reduced by TNF-cL, with effects that were concentration
dependent and voltage-dependent, being larger at more negative potentials (Figure lA).
‘HERO kinetics was unaltered by TNF-. Exposure to TNf-cx for 15 min concentration
dependently decreasedllllRG. IHERG amplitude was decreased by 9, 16, and 35% by TNF
cx at 0,01, 0.1, and 1.0 ng/ml, respectively. Resuits at 100 ng/ml are shown in Figure lB.
Depression of Iv.- by TNF-a was reproduced in both dog atrial and ventricular myocytes
(figure 1 C). APD50 and APD90, duration at 50 and 90% repolarization, respectively, were
both significantly longer in single ventricular celis preincubated with TNF-cx at 10 ng/ml
in Tyrode solution for 10 h relative to control celis (Figure 1D).
Western Not analysis of HERG protein levels in the membrane preparations
extracted from HERG-expressing HEK293 cells and from the ventricular myocytes of
healthy dogs or dogs with tachypacing induced CHF was performed. A band of around
135 kDa was identified by anti-HERG antibody, and the band was abolished after the
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antibody had been neutralized by its antigenic peptide. TNF-Œ treatment neither
significantly alter HERG protein level in HEK293 celis nor in healthy dogs. HERG
protein level was slightly higher in CHF than in healthy dogs and was slightly increased
by TNF-a in CHF dogs (Figure 2A).
b clarify whether TNf-a acts on ‘HERG via activation of TNf receptor I (TNFRJ),
we incubated HEK293 ceils with H389 (an inhibitory anti-TNfR1 antibody) for Ï h
before patch clamp recording upon acute exposure to 100 ng!ml TNf-a or beginning 1 h
beforeprolonged (10 h) exposure to I ng/ml TNf-Œ. H389 prevented suppression of 4IERG
by subsequent acute or prolonged application of TNF-Œ. Data from prolonged exposure
experiments are shown in Figure 2B.
Activation of TNFR1 can stimulate overproduction of intracellular ROS (20). b
investigate whether ROS mediates TNF-a-induced HERG depression, we assessed the
effects of TNF-Œ on IHERG in celis pretreated with the antioxidant vitamin E (VitE).
Pretreatmentwith VitE for 2 h prevented ‘HERG reduction by TNF-u (Figure 2C). Another
antioxidant Mn (III) tetrakis (4-benzoic acid) porphyrin chloride (MnTBAP), a superoxide
dismutase mimetic, produced similar preventive effects on TNF-o-induced HERG
impairment (figure 2D). By contrast, preincubation of ceils with superoxide anion
generating system xanthine/xanthine oxidase (X/XO) mimicked the inhibitory effect of
TNF-Œ on IHERG (Figure 2E).
b confirm that intracellular ROS production was indeed stimulatedby TNF-Œ, we
detected ROS level using CM-H2DFDA fluorescence dye to stain the celis. The celis
stained with fluorescence intensity ?5 times the background were defined as positive
staining, and the number of ceils with positive staining was pooled from five fields. The
intensity of staimng was analyzed by densitometric scanning using the LSM program, and
the data were normalized to the control values without TNF-Œ (0.01 and 1 ng/ml)
treatment (16). Under control conditions, ceils stained by CM-H2DCFDA were sparse,
and the staining was weak. Yet with TNF-Œ treatment, the number of the ceils with
positive staining was considerably higher and the ceils were stained evenly throughout the
cytoplasm. Pretreatment with VitE or MnTBAP drastically diminished the number and
the intensity of staining (Figure 2F). Similar resuits were obtained with isolated canine
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ventricular rnyocytes; TNF-a (0.1 ng/rnl) markedly increased ROS level and co
application with VitE (100 tM) or MnTBAP (5 .t1) prevented the effects of TNF-a
(Figure 2G).
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Figure 2. Mechanisms for HERG depression by TNF-a. A, Western blot analysis of HERG
protein leveis. Membrane protein samples wete extracted from left ventricular myocytes isolated
from heaithy dogs and dogs with ventricular tachypacing-induced CHF and from HEK293 ceils.
HEK293 celis were treated with INF-Œ (10 ng/ml) for 10 h in culture medium, and isolated
myocytes were treated with TNF-Œ in Tyrode solution for 10 h. Mean data were calculated from a
total of fout independent samples for each group. MK, protein marker. , p < 0.05 versus control
(Ctl). B, inhibitory anti-INFR1 antibody H389 prevents HERG depression by INF-Œ. Celis were
incubated with H389 (10 t.ig/ml) for I h before ptolonged (10 h) exposure to INF-Œ (10 ng/ml, n =
7). C and D, antioxidants VitE (100 pM, n = 14) or superoxide dismutase mimic MnTBAP (5 pM, n
= 12) prevents HERG depression by TNF-Œ. , p < 0.05 versus TNF-a alone. E, superoxide anion
generating system X!XO (400 pMI5 units/ml, n = 16) mimicked the effects of TNF-Œ on IHERG. F,
alterations of the intracellular level of ROS by TNF-Œ (0.1 or 10 ng/ml) and antioxidants VitE (100
pM) and MnIBAP (5 pM), respectively, determined by CM-H2DFDA fluorescence dye staining
(green) in HERG-expressing HEK293 ceils. The upper panels show examples of confocal
microscopic images, and the lower panels show the percentage of ceils with positive staining (%
Cel[) and the intensity of positive staining (n = 4 batches of celis for each group). , p < 0.05 versus
Ctl; +, p < 0.05 versus TNF-a alone. G, increase in ROS by TNF-Œ (0.1 ng/ml) and reversai by VitE
(100 pM) or MnTBAP (5 pM) in canine ventricular myocytes. The upper panels show exampies of
confocal microscopic images, and the lower panels show the intensity of positive staining (n = 3). ,
p < 0.05 versus Ctl; +, p < 0.05 versus TNF-Œ alone.
IV-5 DISCUSSION
Heart failure is associated with APD and QT interval prolongation, believed to
contribute to the occurrence of sudden cardiac death (6, 7). We show here that TNF-Œ
suppresses JHERG in HEK293 ceils and I in dog cardiomyocytes and prolonged APD.
Depression of IHERG/l, as produced by TNF-Œ in this study, may contribute to delayed
repolarization and associated malignant ventricular tachyarrhythniias with increased TNF
Œ level in patients with CliP.
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Ionic remodeling in CHF has been studied (21). L-type Ca2 current density
appears to be unaltered (20). The inward-rectifier iC current is consistently reduced (5).
The transient outward K current (Ito) is also reduced, potentially causing APD
prolongation (5, 22). However, inhibition of It reduces APD in human atrial ceils (23),
canine atrial ceils (12), and dog Purkinje fibers (24). The effect ofI on the AP depends
largely on the magnitude of ‘K (25). Tsuji et al. (26) showed IK, measured as E-4031-
sensitive tau current, to be —36% smaller in rabbits with ventricular tachypacing-induced
CHF than in healthy rabbits. Lodge and Normandin (27) demonstrated earlier that
measured as dofetilide-sensitive tau current, reduced by —45% in the BIO TO-2 strain of
cardiomyopathic hamster of 10 months oid, derived from the BIO 53.58 animais and
providing a model of diiated low output heart failure, compared with the 10-month-old
control (BIO f13) hamsters. A recent studyby London et al. (9) showed significant APD
prolongation in transgenic mice that overexpressed TNF-Œ and developed heart failure.
Our study suggests that TNf-Œ may be an important mediator of CHF-induced ly
reduction and is the first to demonstrate that TNF-Œ can moduiate cardiac K channels.
We further demonstrated that pretreatment with VitE or MnTBAP prevented,
whereas X!XO mimicked, TNF-Œ-induced IHERG depression. The effects of VitE and
MnTBAP are iikely due to their antioxidant actions because TNF-a increased the
intracellular ROS levei in a concentration-dependent manner in both HEK293 ceils and
canine ventricular myocytes, more specifically 0 level because VitE or MnTBAP
effectively prevented the increase. In une with our finding, a recent study published
during the course of this study cieariy demonstrated the ability of TNF-o to stimulate
mitochondrial production of ROS in cardiomyocytes (20). It has also been shown that
ROS is one of the key deleterious factors in failing heart (28, 29). Our data therefore
indicate that TNF-Œ-induced HERG depression occurs at the functional level, but flot at
the expression levels (TNf-Œ did flot alter HERG protein content), and the fiinctional
impairment of HERG channeis by TNF-cc is mediated by ROS, particuiariy ().
Circulating TNf-u levels predict mortaiity in CHF, and therapies directed against
TNf-a may iimit the pathophysioiogic consequences (1). In healthy human subjects, the
TNF-a level is below 0.01 ng/ml, but in patients with heart failure, it can increase to over
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0.1 ng/ml (17—19). TNF-a significantly inhibited
‘HERG over this concentration range (e.g.
by —35% at plateau voltages from—lO to +10 mV in celis exposed to 0.1 ng/ml TI.W-Œ for
10 h). Our study might have underestimated the effects ofTNf-Œ on APD because the
myocytes were incubated with TNF-Œ at 4 °C to maintain good quality of the celis. Our
observations provide new insights into the potential molecular mechanisms underlying
electrophysiological abnormalities and sudden arrhythmic death in patients with CHf.
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CHAPET V
OVERALL DISCUSSION & CONCLUSIONS
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The aims of this chapter are to summarize the major findings in this study, to
depict the significance and implications of the findings in the research areas, and to
indicate the potential limitations involving in the whole process of study. f inally the
conclusions will be drawn up for the overail research project.
V-1 Novel Findings, Significances and Implications
V-1-1 LPCs Enhance I/HERG: An Additional Mechanism Underlying IKJ0-t and
APD-1. During the Early Phase of Myocardial Ischemia
Ischemic heart disease remains the leading cause of mortality in the Western
World, and is also a significant cause of death worldwide (Association, 2005). A partial
reason is that our cunent insufficient understanding of the contributory factors for the
myocardial ischemic injuries, especially myocardial ischemic arrhythmias, which account
for the mainstream of the death in ischemic heart disease (Brunckhorst et aL, 2004;
Nordlie et al., 2005).
Enormous animal and human studies have revealed that [Kj0-t in myocardium
and APD- resulting from abnormally enhanced K efflux are the cntical causes of the
ischemic arrhythinias during the early stage of acute myocardial ischemia. Cardiac K
channels, obviously, are major factors responsible for determining the [K]0, thereby
resting potential, ceil excitability, membrane repolarization and ultimately the likelihood
of arrhythmias. Among the assortment of cardiac K channels, KATp as a most promising
candidate for ischemic [K1]0-t has been proposed and extensively studied for the decades
(Noma, 1983; Seino et aÏ., 2004; Seino et al., 2003). However, the existing data regarding
the role of KATP in ischemic [K]0-t have been conflicting and the accumulating
evidences have questioned the fiinction of KATp channel in response to myocardial
ischemic insuit (Shivkumar et al., 1997; Vanheel et al., 1992; Venkatesh et aÏ., 1992;
Wilde et aÏ., 1995). It is thus plausible that other mechanisms or more specifically other
K currents, in addition to KATp, may also contribute to [Kj0-t and APD--.I- in ischemic
myocardium.
Correspondingly, metabolic perturbation of ischemic myocardium is known to
have great impact on electrical disturbances. Among the various metabolic insuits, the
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rapid accumulation of phospholipid metabolite LPCs in the eariy stage of ischemic
myocardium is of pivotai importance. However, while LPC has long been recognized as a
biochemicai trigger of ischemic arrhythmias, presumabiy due to its ability to cause [Kj0-
t and APD-I- (Goldhaber et al., 1998), and how LPC causes [K’10-t and APD-J. remains
an anonymity.
In our study we show that LPC-16 remarkably, reversibly and voitage-dependentiy
increases the amplitude ofI’HERGand shortens APD. The effects of LPC-16 on IHERO
are manifested with shorter APD and at more negative potential. Ijr/HERG blocker
dofetiiide abolishes the IjHERG enhancing and APD shortening effects of LPC-16.
Moreover, using the Langendorff heart method, we found that the most evident effects of
LPC-16 are to produce prominent {K]0-t and QT-.I-, which are very paraliel to those
observed under the conditions of iow-flow ischemia. Strikingly, the [Kj0-t and QT-
induced by either LPC-16 or ischemia are prevented by dofetilide, but flot by the biockers
chromanoi 293B and HMR (Iy. biockers), as weii as glibenclamide (IKpjp biocker).
Consistentiy, dofetiiide efficientiy abolishes the ventricular tachy-arrhythmias induced by
LPC-16 or ischemia.
The findings described above are, to our knowledge, the first to decipher the role
of I/HERG in ischemic [K]0-t and QTc-.L and to couple the ionic remodeling for
ischemic [Kj0-t and QTc--J with a positive feedback mechanism for abnormai
enhancement ofI/HERG function. Hence, in addition to the paired ATP depletion/KATP
activation, LPC accumuiationlHERG enhancement may be considered as another
association between metabolic trigger and ionic pathway for ischemic [K]0-t and QTc-’1-.
This notion provides an alternative expianation, or one of multiple mechanisms, for
ischemic [IC]0-t and QTc—1-. It resolves, in a certain extent, the puzzle and advances our
understanding of the ionic and metabolic mechanisms of ischemic electrical disturbances
and of how the interactions between the electrophysiological substrates and the
biochemical substrates determine the ischemic arrhythmogenesis. In particular, it unravels
some novei aspects of I1/HERG K channel function under metabolic stresses and
provides a new guideline for better therapy of ischemic anhythmias associated with
management ofIjHERG K channel and LPC-16 production. Our findings that LPC-16
acts as a metabolic trigger, and HERG as an ionic pathway, for ischemic {K]0-t and
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QTc-.L and that ischemic arrhythmias is preventable and convertible by IKjHERG blocker
dofetilide suggest that inhibition of LPC- 16 production and accumulation andlor of
IjHERG may be a promising therapeutic strategy to attenuate the incidence of lethal
arrhythmias associated with ischemic heart disease.
In addition, we demonstrated in this study that LPCs enhance the IHERG expressed
in HEK293 celis. The current-enhancing effect was in large measure due to the
acceleration of activation kinetics, as well as the substantial depolarizing shifi in HERG
channel inactivation, such that more current would be available at any given voltage
within the activation range. furthermore, we found that only the LPCs with 16
hydrocarbons such as LPC-16 and LPG-16 produced significant enhancement of IHERG
and negative shifis of HERG channel activation.
Given the critical roles of HERG K + channel in the etiology of inherited and
acquired LQTs, the pharmacology of the HERG cardiac K channel has been the subject
of intense study for a decade (Abriel et al., 2004; Kang et al., 2005; Sanguinetti, 1999;
Sanguinetti et al., 1995; Tseng, 2001). It is now clear that a wide variety of drugs from
numerous structural and pharmacological categories act as antagonists of the HERG K
channel (Pearlstein et al., 2003; Redfem et al., 2003). The channel has also been reported
to be modulated by a number of intracellular molecules and pathways, including cAMP
and PKA, as well as adrenergic pathway (Cui et aï., 2000; Kiebn et al., 1998; Thomas et
aÏ., 2004; Thomas et al., 1999; Wei et al., 2002), glucose and Akt (Zhang et al., 2003a;
Zhang et al., 2003b), PKC (Thomas et al., 2003), phospholipase C (Bian et al., 2001;
Bian et al., 2004; Gomez-Varela et al., 2003), and PTK (Cayabyab et al., 2002). Increase
of ‘HERO can be induced by the substrate of phospholipase C, PIP2 (Bian et al., 2001; Bian
et aï., 2004), activation of PTK (Cayabyab et al., 2002), and probably via modulations of
other unknown pathways. However, no natural metabolic substance can increase JHERG
lias been reported before our investigation. Our studies revealed that HERG K channel is
flot oniy a molecular target for long QT syndrome but also a target for “short QT
syndrome”. Thus, our studies also provided the first hint that activation of cardiac
I/HERG could be beneficial in LQTS. It is therefore possible that LPCs, acting as
HERG channel activators by modif’ing the molecular structure, could someday find
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utilization in the treatment of repolarization disorders in the heart, including acquired long
QT syndrome, congenital long QT syndrome, and heart failure.
V-1-2 Impairment of IKt/HERG by Ceramide or INF-Œ in the Prolonged Ischemia
and in Congestive Heart Failure Shares the Common Mechanism:
Overproduction of ROS
The results from our study show that a sphingolipid metabolite ceramide or a
proinflammatory cytoldne TNF-Œ, which are both produced and accumulated drastically
in the prolonged myocardial ischemia and congestive heart failure, impairs HERG K
channel function. Ceramide causes pronounced ‘HERG inhibition in a concentration
dependent and voltage-independent fashion and positive shifi of voltage-dependent
HERG activation in the setting of prolonged incubation. We also demonstrated that TNf
a consistently and reversibly decreases IHERG expressing in HEK293 celis. The Effects of
TNF-Œ are concentration-dependent, increased with longer incubation period, and
occurred at clinically relevant concentrations. Furthermore, TNF-Œ has similar inhibitory
effects on Iy. and markedly prolongs APD in canine cardiomyocytes. Intriguingly, either
ceramide or TNF-Œ causes robust increases in intracellular ROS, and antioxidant VitE or
MnTBAP abolishes the increases, in both HEK293 ceils and canine ventricular myocytes,
indicating the functional impairment of HERG channels and I by ceramide or TNF-Œ is
mediated by overproduction of ROS. b our knowledge tins is the first study to describe
the effects of a sphingolipid metabolite or TNf-Œ on the HERG K channel or ‘1Cr and to
elucidate the underlying mechanisms.
Previously, it has been reported that ceramide regulates a number of potassium
channels (Chik et al., 2001; Ramstrom et al., 2004; Wu et al., 2001). $pecifically, a stout
inhibition within one minute of ceramide application (-70% with 10 iM C2) was shown
and a +10 mV shift of the activation curve in rat pituitary GH3 celis (Wu et al., 2001).
Using HEK293 cells stably expressing HERG we found that acute application (bath
superfusion for 25 mm) of membrane permeable ceramide (C2, 50 jtM) did flot alter
IHERG. However, prolonged incubation with C2 for 10 hrs caused pronounced IHERG
inhibition. These differences probably emanate from the cellular systems used.
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The inhibitory mechanism of ceramide on the K channels was unresolved. It has
been reported that the HERG-equivalent K current in rat microglia MLS-9 ceil is
significantly reduced by inhibitors ofPTK (Cayabyab et aÏ., 2002). Consistent with these
findings, our data demonstrated that PTK inhibitors herbimycin A and genestein alone
both markedly depressed ‘HERG amplitude, indicating a role of basal PTK activity in
maintaining HERG function. However, co-application of these inhibitors with ceramide
did flot alter ceramide-induced ‘HERG depression. This suggests that ceramide has the
ability to enhance HERG channel function and partially offsetting its inhibitory effect by
stimulating PTK activities, but failed to do so in the presence of PTK inhibitors. Thus,
PTKs do not account for ceramide-induced IHERG depression. Involvement of PKA or
PKC in ceramide-induced
‘HERG depression appears to be minimal. This conclusion was
drawn on the basis that neither PKA inhibitor H89 nor PKC inhibitor Bis appreciably
reversed the effects of C2, despite that these compounds themselves when applied in the
absence of C2 produced direct effects on ‘HERG. Obviously, these direct effects of H89
and Bis are unlikely related to ceramide action on ‘HERG. Interestingly, the inhibitory
effect of ceramide on IHERG is reversed by antioxidant VitE or MnTBAP. Consistent with
this was the ceramide-induced inhibition of the ERG current in GH3 cells was abolished
by the reducing agent dithiothreitol (Wu et al., 2001). Thus, ceramide depresses ‘HERG
mainly via ROS overproduction based on our smdy.
TNf-a, as a proinflammatory cytokine, is of important in the pathophysiology of
myocardial ischemialreperfusion injury, myocardial infarction, chronic heart failure and
remodeling, myocarditis, cardiomyopathy (Aker et aÏ., 2003; McTieman et al., 2000;
Meidrum, 1998; Sack, 2002; Schuiz et al., 2004). It has been well documented that
myocardial TNf-Œ production is reinforced during acute myocardial ischemia with or
without reperfusion (Irwin et al., 1999; Meldrum et al., 1998). It has also been
demonstrated that the absence of TNF-a signaling results in enhanced myocardial
apoptosis in response to a prolonged ischemic injury (Kurrelmeyer et al., 2000). TNf-Œ
mediated negative inotropic effect is believed to depend on a sphingosine-signaling
pathway (Oral et al., 1997). TNF-a leads to degradation of cellular sphingomyelin with
the formation of ceramide and its base sphingosine (Lecour et al., 2003). Both have been
demonstrated to be able to deteriorate myocardial force generation (Levade et al., 2001).
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TNF-Œ also seems to play a role in deteriorating mechanical fiinction through nitric oxide
(NO) signaling (finkel et al., 1992). Chronic myocardial ischemia and heart failure are
associated with APD and QT interval prolongation, believed to contribute to the
occurrence of sudden cardiac death (Marban, 2002; Nuss et al., 1999). However, it is
unclear if TNf- u function on any cardiac potassium channels to give rise to APD and QT
interval prolongation, if any, what is the mechanism underlying the function. We show
here that TNf-Œ suppresses ‘HERG in HEK293 ceils and Iy in dog cardiomyocytes and
prolonged APD. TNf-u consistently and reversibly decreases ‘HERG. The Effects of TNF
c are concentration-dependent, increased with longer incubation period, and occurred at
climcally relevant concentrations. Furthennore, TNF-a has similar inhibitory effects on
Iic and markedly prolongs APD in canine cardiomyocytes. Antioxidant VitE or MnTBAP
prevents, whereas the X!XO mimics, TNF-a-induced
‘HERG depression. TNf-Œ causes
robust increases in intracellular ROS, and VitE and MnTBAP abolishes the increases, in
both HEK293 cells and canine ventricular myocytes, indicating the functional impainnent
of HERG channels and Iy± by TNf-Œ is mediated by ROS.
We demonstrated that ceramide and TNf-u act on JHERG in a similar manner with a
similar mechanism: depression of amplitude via overproduction of ROS (Wang et al.,
2004a). Ceramide is known to be a downstream component in the TNf-u/TNF receptor
signaling pathway. Activation of TNF receptors stimulates ceramide generation and
ceramide in tum mediates the cellular function of TNf-Œ (Perry & Hannun, 1998;
Suematsu et al., 2003). The data in this project in conjunction with other previous smdies
seem to provide the link: TNF-Œ enhances ceramide synthesis and ceramide damages
mitochondria leading to ROS overproduction, thereby impairs the function of I/IHERG.
However, it should be noted that there have been controversial reports as to the
ROS modulation of ‘HERG (Berube et al., 2001; Taglialatela et al., 1999). It was shown
that ROS generation enhanced ‘HERO in the manner of voltage dependence of activation
and inactivation (Taglialatela et al., 1997), whereas ROS was demonstrated to accelerate
‘HERG deactivation (Taglialatela et al., 1997). The acceleration of the HERG channel
deactivation rate by ceramide may result from the action of ROS, or other effectors such
as PKC (Thomas et aÏ., 2003). The determination of the components in the signaling
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cascade initiated by ceramide and the resulting loss of surface HERG channels, as well as
the alteration ofdeactivation, requires further investigation.
The cardiac APD is abnormally lengthened after prolonged ischemia (Boyden &
Jeck, 1995; Carmeliet, 1999). In lieu of the critical role of HERG K channel in cardiac
repolarization and the ability of ceramide to inhibit ‘HERG, it is conceivable to speculate
that the depression produced by TNF-Œ/ceramide that accumulate during the late phase of
myocardial ischemia might contribute to the observed prolongation of APD and the
associated arrhythmias. Moreover, one characteristic electrophysiological alteration in
CHF is abnormally prolonged APD at the cellular level and QT interval as reflected in
electrocardiogram (Beuckelmann et al., 1993; Nuss et al., 1999). This prolongation
provides an electrophysiological substrate for early afierdepolarizations (EADs) to occur,
which can result in ventricular tachycardias that often dispose to Vf leading to SCD.
Polymorphic ventricular tachycardias, likely related to arrhythmogenic EADs, are
common in CHF (Marban, 1999; Marban, 2002). More importantly, our data demonstrate
that ROS mediates the inhibitory effect of TNf—Œ/ceramide on ‘BERG and antioxidants
can prevent the IHERG depression. This explains at least partly the benefits of antioxidants
in preventing and suppressing arrhytbmias in ischemic myocardium and failing hearts
(Walker et al., 1998). Overail, the data obtained from this study provides new insights
into the potential molecular mechanisms underlying electrophysiological abnonnalities
and sudden arrhytbmic death in patients with CHF.
In synopsis, the present study has several important pathophysiological implications.
First, it is known that ischemic myocardium demonstrates characteristic bi-phasic
changes of electrophysiology with APD-’.I- during early phase of acute myocardial
ischemia and subsequent APD lengthening afier prolonged ischemic period, which are
associated with different types of arrhythmias (Boyden et al., 1995; Carmeliet, 1999).
However, the ionic mechanisms underlying these sequential alterations of APD remain
unresolved. This study seems to provide an explanation. It is well recognized that altered
lipid metabolism is an important deleterious factor in ischemic myocardial injury; some
lipid metabolites such as LPCs are overproduced rapidly within the first 10 min of acute
myocardial ischemia, while others like ceramide accumulate progressively in the late
phase (30 min after) ofischemia (Kolesnick, 2002; Murase et al., 2000). We have verified
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that LPCs produce pronounced enhancement of HERG fiinction. This may explain in part
the APD—L and the associated arrhythmias occurring in the early phase of ischemia. It is
therefore promising that LPCs, acting as HERG channel activators, could someday find
use in the treatment of repolarization disorders in the heart, including acquired long QT
syndrome, congenital long QI syndrome, and heart failure.
On the other hand, the prolonged ischemia leads to a progressive accumulation of
ceramide in cardiomyocytes. The content of ceramide in ischemic area was found to be
elevated drastically (Beresewicz et al., 2002; Bielawska et al., 1997); Murase et al., 2000).
Intriguingly, the cardiac AP is abnormally lengthened after prolonged ischemia (Boyden
et aï., 1995; Canneliet, 1999). In lieu ofthe decisive role ofHERG IC channel in cardiac
repolarization and the ability of ceramide to inhibit ‘HERG, it is tempting to speculate that
‘HERG depression produced by ceramide that accumulates during the late phase of
myocardial ischemia might contribute to the APD prolongation and the associated
arrhythmias.
The second implication of our study is related to arrhythmias in CHF. One
characteristic electrophysiological alteration in CHF is abnormally prolonged APD at the
cellular level and QT interval as reflected in electrocardiogram (Nuss et al.; 1999;
(Beuckelmann et al., 1993). This prolongation provides an electrophysiological substrate
for EADs to occur, which can result in ventricular tachycardias that ofien predispose to
ventricular fibrillation leading to SCD. Polymorphic ventricular tachycardias, likely
related to arrhythmogenic EADs, are common in CRF (Marban, 2002). The ionic
mechanisms underlying APD prolongation in CHf have flot been precisely defined.
Intriguingly, de novo ceramide synthesis has been found to be increased in CHF
(Listenberger et al., 2002). Increased ceramide level in cardiomyopathy can cause
impairment of HERG function and result in excessive APD prolongation. More
importantly, our data demonstrate that ROS mediates the inhibitory effect of ceramide on
‘HERG and antioxidants can prevent the ‘HERG depression. Ibis explains at least partly the
benefits of antioxidants in preventing and suppressing arrhythmias in ischemic
myocardium and failing hearts (Wallcer et aï., 199$).
Furthermore, the results of this study also have implications in diabetic
cardiomyopathy (DCM). DCM is characterized by electrical remodeling with aberrant
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electrophysiology; metabolic remodeling with malignant biochemical processes; and
anatomical remodeling with progressive loss of cardiomyocytes. Those remodeling
interplay and resuit in impaired cardiac contractile and increased risk of lethal
arrhythmias. The QT prolongation and QT dispersion have been suggested as the
predictor of mortality in both type I and type II (Christensen et aï., 2000; Veglio et al.,
2004). It has been documented that de nova synthesis and accumulation of ceramide in
diabetic myocardium contributes to the development of DCM (Hayat et al., 2005;
Listenberger et aÏ., 2002). In addition, oxidative stress is also known to be a critical
deleterious factor for DCM (Johansen et aÏ., 2005; Maritim et aL, 2003). Moreover, we
have recently found that I/HERG fiinction is impaired in the rabbit model of DCM.
Taken together, it seems plausible that ceramide-induced HERG depression may be one
of the multiple determinants for diabetic QT prolongation.
f inally, correction of the electrical disorders is in no doubt an important step
towards reducing cardiac death of lives suffering from myocardial ischemia, heart failure,
diabetic cardiomyopathy, etc. b achieve the therapeutic goal, sufficient knowledge about
the ionic mechanisms underlying ischemic electrical disorders is essential. Based on our
findings, it appears conceivable that the HERG K channel is a potential therapeutic
target for the treatment ofischemic electrical disorders.
V-2 Limitations of the Study
V-2-1 No direct evidence provided on the direct LPC—INERG interactions
Our findings that LPC-16 acts as a metabolic trigger, and HERG channel as an
ionic pathway, for ischemic [K]0-t and QTc-..I- and that ischemic arrhythmias is
preventable and convertible by I1jHERG channel blocker dofetilide suggest that
inhibition of LPC-16 production and accumulation andlor of Iy/HERG may be a
promising therapeutic strategy to attenuate the incidence of lethal arrhytbmias associated
with ischemic heart disease (Corr & Yamada, 1995; Duan & Moffat, 1991; Giffin et al.,
1988). Nonetheless, it should be mentioned that the initial rapid [K]0-t and APD--I- may
be an adaptive mechanism of cardiac ceils to minimize ischemic injuries because [Kj0-t
may reduce ceil excitability thereby contractility and energy consumption and APD-I- can
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limit excessive Ca2 entry so as to prevent intracellular Ca2 overload and ceil death.
Unfortunately, this adaptation is at the cost of increased risk of cardiac arrhythmias,
ofien-lethal arrhythmias. This contradiction creates a difficulty of handiing [Kj0-t and
APD-’.I-. Obviously, restoration of [Kj0-t and APD-1- alone may not be clearly beneficial
to ischemic heart. Combination of I]HERG blocker and Ca2 channel blocker might be
the way to go because the approach can restore [K]0-t and APD-I- on one hand and
diminish intracellular Ca2 overload on the other hand. This notion warrants further
investigation. It should also be noted that our study does not provide definite link between
LPC-16 and 4cJHERG due to lack of LPC-16 inhibitors currently. In addition, the
possibility of that LPC- 1 6/LPG- 16 modulates HERG channel function via a third party is
not completely excluded.
It is known that inhibition of I/HERG function can generate long QT type of
arrhythmias. Our present study revealed that enhancement ofIjc/HERG flinction can also
be proarrhythmic, causing short QT type of arrhythmias such as reentry and DAD. The
latter concept has actually been proposed by a recent study that describes a form of
inherited malignant ventricular anhythmias associated with short QT syndrome (Brugada
et al., 2004; Gaita et al., 2004). Short QT syndrome is a genetic syndrome characterized
by constantly short QT intervals, sudden death, short refractory periods, and inducible
ventricular fibrillation. This short QT syndrome is caused by mutation in HERG gene,
which increases HERG function and can be treated by agents that block I/HERG. Our
data suggest that firnctional enhancement of HERG channel activity can produce acquired
“short QT syndrome”.
Ouï experiments with the Iy blockers chromanol 293B and HMR compound
suggest that IK is unlikely significantly involved in ischemic [K]0-t and QTc-.1’. In
addition, we have also conducted experiments studying the effects of LPC- 16 on I in
guinea pig ventncular myocytes and KvLQT1 transiently expressed in COS-7 ceils and
we found that LPC-16 did flot alter Iy (data not shown). Therefore, contribution ofJy to
ischemic [K]0-t and QTc-1 in our model can be excluded. Nevertheless, in in vivo
system where sympathetic innervations are intact, enhanced adrenergic stimulation during
acute iscliemia may well serve to enhance and in this case Iy. may also contribute to
ischemic {K]0-t and QTc-’.
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V-2-2 The lack of mechanistic link between ceramide/TNF—cz and intracellular ROS
Production
Another imperative limitation of the present study is the lack of evidence
supporting the mechanistic link between ceramide/TNF—Œ and intracellular ROS
production. We do not know what the source of ROS is, mitochondrial or cytosolic;
neither do we answer how ceramide/TNf—Œ increase intracellular ROS. The second
weakness of the work is that our study was carried out in HEK293 celis expressed only
the pore-fonning subunit of Iy, HERG, which may flot be adequate to address the
questions because it has been proposed that Iy is formed by co-assembly of HERG with
mink (McDonald et aI., 1997) or with MirPi (Abbott et al., 1999). These auxiliary
subunits might profoundly affect the effects of ceramide/TNF-Œ on ‘HERG, although a
recent study indicates that HERG itself is sufficient to account for the biophysical and
pharmacological properties of the native Iyj. (Weerapura et al., 2002).
V-3 Future Researcli Directions
To provide the direct evidence regarding the LPC—IHERG interactions, further
studies by in vitro protein-binding pull-down assays and in vivo coimmunoprecipitation
experiments will be required to address whether LPC is physically associated with HERG
channels; if so, to identify LPC binding region to HERG channels and to evaluate the
functional consequences by disrupting LPC-HERG interaction, for instance, by mutation
or/and deletion of binding sites. Further experiments are therefore necessaiy to delineate
the potential unidentified pathways. To highlight the interaction between LPCs and
‘HERG/’K, particularly in the situation of acute myocardial ischemia, single channel
recording in HEK293 ceIl expressing HERG should be conducted in the near future, and
more feasibly, reconstitution of the sole HERG protein or association of HERG protein
with the candidate auxiliary subunit such as MiRP1 or minK into lipid bilayer will be
very promising (Ardehali et al., 2004). If the lipid bilayer studies are performed in the
setting of mimicked acute ischemia, such as acidosis and high [Kf], it could provide
direct evidence to explain the low LPCs affect the channel fiinctions.
In the view of the mechanisms underlying [K]0-t and APD-1 in the early phase of
acute myocardial ischemia, the future study should be directed to strive for a better
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understanding of the behavior of other chaimels, including ‘Ks, ‘to, IKAA, ‘KATP, ‘KNa, etc. at
in vitro and in vivo cellular, tissue, and whole organ levels by combining classical
electrophysiological techniques and molecular biology approaches. Especially, it is
prospective that genetically modified animal models (GMAM) in which certain channels
are either knockout (KO) or mutated or overexpressed will provide useful arrhythmia
models. Similarly, to determine the role of LPCs in inducing the alteration of channel
expression and fiinctions we can also utilize the GMAÏvI in which the enzymes that
responsible for generation or deletion of LPCs are modified. For instance, phospholipase
A2 (PLA2) is a key enzyme that initiates the generation of LPCs (Corr et al., 1995);
ischemia increases PLA2 activity, resulting in increased lysophospholipid and
arachidonic acid production and contributing to arrhythmogenesis in IHD. It is therefore
possible to minimize LPC production through KO of PLA2, or altematively, through
RNA interference (RNAi) techniques (Brummelkamp et aï., 2002;Miyagishi & Taira,
2002) in which small interfering RNAs (siRNAs) targeting plasmalogenase, an enzyme
that directly catalyzes the reaction to generate LPCs will be employed to block the
generation ofLPCs (Tanaka et al., 2003).
Another intriguing future direction regarding this project is to pay more efforts to
chronic myocardial ischemia. Accumulating data have shown that next to acute
modulation by electrical and metabolic disturbances, ion channels undergo changes on a
longer time scale with which a variety of signaling cascades may result in multiple
remodeling process, leading to the alterations in ion channel gene and protein expression,
channel protein trafficldng, electrical behavior, and architecture of heart. The
investigation of these remodeling processes as well as the related signaling pathways
involving in ischemic molecules such as sphingolipids, TNF—a, and ROS would provide
the insights into the understanding of the changes occurring during chronic myocardial
ischemia and accordingly rationally and improved therapeutic approaches in future.
V-4 Conclusions
1) Apart from being a well-recognized target for drug inhibition, ‘HERG can
also be enhanced by natural substances lysophospholipid LPCs. The increase in ‘HERG
might be best described by direct interactions between lysophospholipid molecules and
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HERG proteins, which is consistent with lack of effects via membrane destabilization or
modulation by intracellular signaling pathways. It is possible that LPCs, acting as HERG
channel activators, could someday find utility in the treatment of repolarization disorders
in the heart, including acquired and congenital long QT syndrome, and heart failure.
2) Association of LPC-1 6 accumulation, as the metabolic substrate, with
I/HERG enhancement, as the electrical substrate possibly represents a additional
mechanistic link between metabolic trigger and ionic pathway for ischemic [Kj0-t and
QT--. Inhibition of LPC-16 production and accumulation andlor blockage of I1JHERG
may be a promising therapeutic strategy to attenuate the incidence of lethal arrhythmias
associated with the early phase of iscliemic heart disease.
3) Sphingolipid metabolite ceramide and TNF-cx/TNFRY system, mainly via
ROS overproduction, depress J1jHERG function in the prolonged incubation. The salient
effects may contribute to QT prolongation in prolonged ischemia of myocardium and in
failing heart. It is feasible that blockage of ceramide and TNF-a reduces ROS-induced
QT prolongation by attenuating Ijc]HERG impairment. Thus, the inhibition of ceramide
and TNF-a/TNFRY signaling may be an effective strategy to prevent not only the
arrhythmogenesis but also the cardiac sudden death in chronic myocardial ischemia and
CHF. On the other hand, the enhancement of ceramide and TNF-a/TNfR1 signaling can
be a promising strategy for anticancer therapy.
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